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Project Summary 
Urinary and Intravenous (IV) catheters are two of the most commonly used medical devices for 
administering vital drugs and obtaining diagnostic samples from patients. Unfortunately, hospital 
acquired infections (HAis) occur at alarming rates due to catheter usage. The aim of this project 
was to design a urinary catheter that would decrease the occurrence of these infections with a 
catheter coating that utilizes the antimicrobial properties of synthetic spider silk in combination 
with the antiseptic chlorhexidine. This synthetic spider silk catheter will introduce a novel 
approach to catheterization in the medical industry. 
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Abstract 
Urinary and Intravenous (IV) catheters are two of the most commonly used medical devices for 
administering vital drugs and obtaining diagnostic samples from patients. Unfortunately , hospital 
acquired infections (HAis) occur at alarming rates due to catheter usage. The aim of this project 
was to design a urinary catheter that would decrease the occurrence of these infections with a 
catheter coating that utilizes the antimicrobial properties of synthetic spider silk in combination 
with the antiseptic chlorhexidine. This synthetic spider silk catheter will introduce a novel 
approach to catheterization in the medical industry. 
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1. Introduction 
Intravenous catheters have been used for almost 350 years as an integral tool in patient care. IV 
catheters are used in 60-90% of patients admitted to hospitals each year and introduce a potential 
source of infection (Helm, 2015) . Annually , 16,000 central-line associated infections occur in 
intensive care units around the United States , with approximately 500 to 4000 deaths from 
catheter related bloodstream infections (Mermel , 2000). These infections are caused by the 
formation of microbe colonies on the catheter and the skin surrounding the insertion site . 
Advances in the catheter industry such as the Dacron cuff and antimicrobial coatings decrease 
the rate of infections caused by catheterization. Most tunneled central venous catheters are 
equipped with a Dacron cuff to introduce an inflammatory response that keeps the catheter in 
position. It also acts as a physical barrier to microorganisms that are present on the skin. 
Additional strides have been made to combat infection by investigating the use of different 
catheter materials and biocompatible coatings. 
Mechanical failure is another catheter problem. Peripheral venous catheters (PVCs) have failure 
rates between 35-50% that are caused by phlebitis , infiltration , occlusion , and dislodgement 
(Helm, 2013) . Phlebitis is inflammation of a vein caused by trauma to the walls of the vessel and 
is combatted by smaller-gauge catheters . Infiltration occurs when the vein is perforated by the 
catheter and leads to the inadvertent administration of medications into tissue . Occlusion is a 
partial or complete blockage in the catheter and can delay the administration of medications . 
Dislodgement can be a result of movement and leads to other failure in the body. These problems 
are addressed using different catheter gauges and mechanical improvements. The composition 
and surface characteristics of catheters also contribute to failure. To alleviate this problem , 
catheters have been created out of softer, smoother , and less porous plastics such as 
polyurethane. 
The most common urinary catheter in use is the Foley catheter , which has similar drawbacks that 
lead to catheter-associated urinary tract infection (CAUTI). CAUTis are the most common 
hospital acquired infections (HAI) and are a leading cause of morbidity and mortality in patients 
with life-threatening conditions. The incidence of CAUTI is more common in females and it 
increases with age and frequent disconnections. Infections occur from bacterial colonies found 
on skin and are introduced into the body when the catheter is inserted (Khan , 2016). Bacterial 
colonies that cause CAUTis are typically different from the microbes that cause bloodstream 
infections from central venous catheters. 
Certain material coatings lead to increased antimicrobial activity. It is important to consider the 
surface properties , antimicrobial activity , and biocompatibility when designing and testing a new 
catheter, whether IV or urinary. Several different tests have been performed to evaluate surface 
properties, tensile strength, antimicrobial and biocompatibility properties , and to minimize 
contact with vessel walls. It is also important to ensure that the catheter can maintain these 
properties during long term use within the human body . 
The initial objectives of this project focused on updating current IV catheter coating methods to 
implement a coating step in assembly line mass production of IV catheters. Initial mechanical 
testing and standard operating procedures (SOPs) for coating catheters were created. Upon 
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further examination of coating methods and assembly line production of IV catheters, the project 
objectives were reevaluated. New objectives focused on coating Foley catheters using three IV 
catheter coating methods adapted to coat Foley catheters. These methods have been evaluated for 
their roughness, friction coefficients, and antimicrobial properties. The coatings were further 
evaluated for their ability to stick to the catheter when the catheter is bent in a manner to 
simulate Foley catheter usage. 
a. Significance and Innovation 
Catheters have medical applications that range from peripherally inserted central venous 
catheters (PICCs), to suprapubic and indwelling urinary catheters. PICCs have a fail rate that 
ranges between 30-50%. The three most common problems that lead to their inability to be 
maintained throughout the entire therapy of a patient are infections, fibrin deposition, and 
thrombotic occlusion. There is research being performed to combat these fail types individually, 
but not simultaneously. The fail time for PICCs inserted in a non-central vein is approximately 
11.4 days and central veins take 16.6 days before failing (Thiagarajan, 1998). As the time before 
failing increases, a direct negative correlation to the fail rate can be expected. 
The antimicrobial properties of synthetic spider silk are widely reported. Other antimicrobial 
coatings have been used to decrease the rates of HAis due to catheter usage, however, no 
coatings have utilized synthetic spider silk. This project will create novel catheters for urinary 
use that have enhanced antimicrobial properties due to synthetic spider silk coatings. A 
standardized protocol for various coating techniques will be developed that will allow for 
uniform and consistent coating thicknesses. 
As mentioned above, the original goal of the project was to modify existing intravenous catheter 
coating methods to methods for mass production of synthetic spider silk coated catheters (Lewis, 
2016). Initial testing was performed and further research showed existing methods to be 
compatible with catheter production lines. Therefore, due to the lack of a design element in the 
original project objectives, the decision was made to coat Foley catheters, in the hopes of 
reducing CAUTI rates. 
2. Project Objectives 
The aim of this project was to create a synthetic spider silk coated Foley catheter that met design 
needs dictated by catheter usage in nursing clinical practice guidelines. Urinary catheters must be 
inserted through the urethra, smoothly snake up through the urethra and into the bladder. The 
synthetic spider silk coated Foley catheters must have a roughness comparable or better than 
current Foley catheters. They must also exhibit a lower or equal insertion force. The synthetic 
spider silk coating must provide an antimicrobial effect greater than that of uncoated Foley 
catheters. Finally, the adhesion of the coating to the Foley catheters must be strong enough to 
avoid flaking during a bend and bunch test developed by the team. 
3. Evaluation Criteria 
• Requirements 
o Measured qualitatively using Atomic Force Microscopy and Scanning Electron 
Microscopy 
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o Exhibits either a smoother surface or equally smooth surface to uncoated catheters 
• Insertion Force Requirements 
o Measured using MTS Instron 
o Requires statistically less insertion force or insertion force equal to uncoated 
catheters 
• Antimicrobial Requirements 
o Coated catheters exhibit statistically significant larger zones of bacterial inhibition 
(using three CAUTI-causing bacteria). 
• Coating Adhesion Requirements during Bending / Bunching 
o When bent at various angles and when bunched, catheter coatings may crack, but 
cannot flake off the catheter. 
a. Design Context 
A zone of inhibition test was utilized to test the antimicrobial properties of the final catheter 
coatings. Antibiotic-resistant strains of bacteria , particularly methicillin-resistant Staphylococcus 
aureus (MRSA) have become a more prevalent issue in the medical field and were included in 
the tests. It was proposed that the Kirby-Bauer method be used to measure the resistance of the 
bacteria to the antimicrobial coating . An agar plate was uniformly streaked with the bacterium to 
be tested; then, small pieces of coated catheters were placed on the surface. As the antimicrobial 
diffused from the surface of the catheter , a zone around the catheter material appeared where no 
growth occurred , also known as the zone of inhibition (Brown, 2015) . 
In addition to antimicrobial testing , a friction test method was also designed to accurately 
measure the force of insertion of the coated and uncoated Foley catheters based on surface 
properties . Catheters were attached to the load cell of a vertical MTS machine and inserted 
through a layer of silicone material , similar in durometer to human skin. This system was able to 
measure the difference in forces caused by various coatings in comparison to an uncoated Foley 
catheter . 
SEM imaging was used to measure the thickness and uniformity of the coatings. Imaging also 
revealed if the coating was attached firmly to the catheter or not. Samples were cut transversely 
to an approximate thickness of 1 cm, secured to a mount , and placed in the machine for imaging. 
AFM imaging was used to measure the roughness of the coatings. Catheters sections were cut 
into strips about 8 cm long, secured to a glass slide using double-stick tape , and placed in the 
machine for imaging . 
Elderly male patients often have enlarged prostates , which can cause Foley catheters to bend 
and/ or bunch when pushed against the prostate. Therefore , a bend and bunch test was applied to 
coated catheters . This test recorded the ability of the device to conform to predetermined relevant 
angles or radii. It was expected that the device would maintain acceptable mechanical properties 
following the administration of the bend and bunch test. A similar torque test could have been 
applied to measure these qualities as well ("Flexibility Kink Resistance ," 2012) . 
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4. Background 
a. Anatomy of Catheter Usage 
Intravenous catheters are one of the most commonl y utilized medical interventions for 
administering medication directly into the patient's bloodstream . Intravenous catheters are a 
plast ic holding mechanism with a small needle extruding from them. The needle is surrounded 
by a thin plastic cannula. After the catheter is inserted into a vein, the needle is removed and 
discarded , and the plastic cannula is left inside the vein. The cannula is connected to external 
tubing which can be used to administer medications . This process is shown in Figure 1 (Nucleus 
Medical Media , 2009). 
P:roper Technique for the insertion of an 
] 
Intravenous Catheter 
f'l.lQbbadl 
C be, 
Figure I : The correct process for insertion of an intravenous catheter. Note the removal of the 
needle and the cannula that is left inside the patient's vein. 
Human skin is made of three layers : the epidermis , dermis , and hypodermis . The epidermis is the 
most external and is responsible for protection against harmful radiation from the sun. Below the 
epidermis is the dermis , which contains nerve endings , sweat glands , hair follicles and blood 
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vessels. The hypodermis is a layer of adipose (fat) tissue below the dermis. The blood vessels 
inside the dermis are the target for both venipunctures and intravenous catheters. Veins in this 
layer tend to be more superficial and visible than arteries. Veins and arteries are also 
distinguishable by palpitation. Veins are bouncy while arteries have a pulse (Netter, 2014). 
Urinary catheters are used in many patients to obtain sterile urine samples or relieve full 
bladders. These catheters are inserted into the urethra and are snaked into the bladder. Once 
there, urine flows out through the catheter. Foley catheters are catheters placed for long term use 
and have a balloon that is inflated with saline once inside the bladder to hold the catheter in 
place. Male and female urinary catheters are different due to anatomical differences. Men have 
much longer urethras and must have longer catheters. The male prostate can also complicate 
catheterization. As men age, their prostates enlarge and cause the urethra to contract. As a result, 
catheters with a rigid tip, called Coude catheters, must be used to force a way through the 
prostate. Figure 2 shows the anatomy of the male prostate. The female urethra is much harder to 
locate which can cause difficulties in catheter insertion (Netter, 2014). Figure 3 shows the 
comparison between a female and male urinary catheter (Duyao, 2015). 
~-,,..a....,_,,....,.. ___ +--Prostate 
gland 
Penis 
-----Testicle 
Figure 2: An enlarged prostate can require the use of a Coude catheter in male patients . 
9 
Folc Catheter lnscnion 
... 
Figure 3: The differences between a male (left) and female (right) catheter are shown. Note the 
longer catheter used in the male patient. 
b. Current Issues 
Hospital acquired infections (HAis) are a leading concern among the global medical communit y. 
Approximately 800,000 patients each year in the United States are introduced to an infection 
while in hospital care . These infections cost the medical industr y an estimated $4 billion 
annually. Critically ill patients in intensive care units have the greatest risk for contracting an 
infection due to increased exposure compared to other areas of the hospital and weakened 
immune systems . The most common HAis are urinary tract infections (UTis ), pneumonia , and 
primar y bloodstream infections. Approximatel y 64% of HAis are caused by gram-positive 
bacteria , 27% are caused by gram-negative bacteria , and 8% are caused by fungi (Edmond, 
1999). Necessar y medical devices such as catheters are one of the leading mechanisms for these 
infections to occur . Many HAis are a result of drug resistant strains of bacteria such as 
methicillin-resistant Staphy lococcus aureus (S. aureus) (Edmond , 1999). 
Medications are administered to patients in three primary ways: orally , intramuscularly , or 
intravenously. Medications given orally are absorbed through the digesti ve system and into the 
bloodstream , usually by either the stomach ( as in the case of nonsteroidal anti-inflammatory 
drugs) or the small intestine (as in the case of acetaminophen) . Though these medications last 
much longer than medications given through other administration methods , they do not act 
quickly. Medications such as norepinephrine, which is used to raise blood pressure in cardiac 
arrest patients, or haloperidol , which is used to sedate violent patients, must act immediatel y. 
Intravenous medications such as these are injected directl y into the bloodstream , meaning they 
act much quicker. However , as a result , they do not last nearly as long. Some medications are 
harmful to the inner linings of veins and cannot be given intravenously . Because of the damage 
they cause when administered intravenousl y, they are given intramuscularl y. This allows for a 
faster route to the bloodstream than oral medications , but it doesn't damage veins (Spencer & 
Gilliam , 2015 ; Vacca , 2013) . 
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PVCs are the most common tools used to administer drugs directly to the bloodstream. These are 
inserted into a small vein, usually located on an extremity , and are used in 60-90% of patients 
admitted to United States hospitals . Based on the age of the patient, the size of available veins, 
and the medication that must be given, different sizes of PVCs can be used. 22 or 24 gauge 
catheters are generally used for pediatric patients. Adult patients receiving medications such as 
vancomycin require 18 gauge or larger PVCs. PVC failure rates vary between 35-50% , and occur 
in the form of phlebitis , infiltration, occlusion , dislodgment, and infection (Helm , 2015) . 
Phlebitis is the inflammation of a vein caused by trauma to the walls of the vessel. There are two 
types of phlebitis: superficial phlebitis and deep vein thrombophlebitis (DVT). Insertion of PVCs 
can cause superficial phlebitis which is usually not harmful to the patient. However , they can 
increase the chances of an HAI, which can cost thousands of dollars in treatment per case. Even 
in cases where phlebitis does not cause infection , it can require extra treatment , raising the costs 
of hospital stays (Feldman, 2004). Phlebitis risk factors include inactivity , which explains why 
most of phlebitis cases occur in intensive care units. These patients are usually bed-ridden for 
most of their stay. Phlebitis is treated by pain control , elevation, and warm compresses, provided 
it is discovered early. However , delayed detection of superficial phlebitis can lead to infections, 
as discussed above (Tintinalli , 2016). An image of phlebitis is shown in Figure 4 (Smeltzer , 
2010). 
Figure 4: Phlebitis in a pati ent. Note the ery thema (redness) surrounding the catheter insertion 
site. 
Infiltration occurs when the PVC is placed improperly or dislodges and perforates the side of the 
vein. This causes medications given through that catheter to leak into the surrounding tissue. 
This can lead to tissue damage , infection , necrosis of the tissue, and amputation. When a PVC is 
inserted, it is flushed with approximately 10 mL saline to ensure that the catheter is inside the 
vein. If it has infiltrated, the saline will flush into the surrounding tissue , causing a visible bump , 
and the catheter will be removed. Infiltration can also occur due to patient movement. This can 
be much harder for a provider to notice until new medication is given (Feldman, 2004). A 
diagram of infiltration is shown in Figure 5 (Smeltzer , 2010). 
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Figure 5: Infiltration of a vein. If medications were administered they would leak into tissue 
surrounding the vessel. 
As mentioned above , certain medications are harmful to the inner lining of veins. If medications 
such as those used for chemotherap y leak into surrounding tissue , they can damage the tissue as 
well as the surrounding blood vessels (Robl, 2016). Infiltration is the inadvertent administration 
of non-vesicant drugs , or drugs that do not damage the tissue they come into contact with. In 
contrast , extravasation is the inadvertent administration of vesicant drugs and can lead to tissue 
necrosis and potential amputation (Feldman , 2004). Risk factors for PVC infiltration include 
diabetes , hypertension, dehydration , and local trauma due to frequent PVC insertion or IV drug 
use. Conditions such as diabetes , hypertension , and dehydration cause the walls of veins to thin 
and therefore lose structural integrity . Local trauma causes scarring and makes it harder for the 
healthcare provider to insert the PVC correctly and can weaken the walls of veins. Infiltration 
can be treated by either cold or warm compresses to either limit exposure to tissue or stimulate 
blood flow to dilute the medication (Kagel , 2004) . 
Occlusion occurs when the catheter is obstructed in some way . Hard , or complete occlusions , 
occur when the obstruction completely blocks the pathway of medications. Soft occlusions occur 
when the pathway for medications is only partially blocked. The former is far more dangerous 
because they cause an increase in pressure in the catheter line and cause the vein with the PVC to 
collapse. Furthermore , occlusions can delay the administration of vital medications (Scott , 1996). 
A diagram showing the difference between hard and soft occlusions is shown in Figure 6 
(Genetech , 2017). 
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Figure 6: A soft occlusion (left) partially blocks fluid flow while a hard occlusion (right) 
completely blocks fluid flow . 
The main concern with any medical procedure is infection. Hospitals are constantly attempting to 
lower the rates of HAis, and PVCs can cause bloodstream infections. HAis cost hospitals nearly 
$10 billion annually and they increase the length of stay for patients. Hospital acquired 
bloodstream infection rates range from 1.3 to 14.5 infections per 1000 hospital admissions. 
Every year 62,500 people die of these infections (Zimlichman , 2013 ; Heister, 2017). 
In the past , bloodstream infections originated from gram-negative rods. However , the rate of 
bloodstream infections caused by gram-positive cocci has surpassed the rate of infections caused 
by gram-negative rods. This is thought to be a result of the increased use of intravenous 
catheters . For example, at least one third of all S. aureus (gram-positive coccus) infections 
caused in a hospital are a result of intravenous catheters . An infection from S. aureus can lead to 
complications such as MRSA, which typically requires 4 to 6 weeks of daily IV therapy (Meier , 
1998). 
Patients who are paralyzed, temporarily bedridden, or patients who have had epidurals do not 
have the ability to urinate normally. Depending on the situation, medical professionals use either 
short-term or indwelling urinary catheters . Concerns with urinary catheter usage include patient 
sex, type of urinary catheter , blood clotting in and around the catheter, and infection. When using 
a catheter, a larger lumen diameter catheter is used for male patients, a smaller lumen is used for 
female patients, and the smallest diameter is used for infants. Because male urethras are much 
larger than female and infant urethras, catheters used for male patients must have larger lumen 
diameters (Stephens, 2017). 
There are two main types of urinary catheters : quick-caths and Foley catheters. Quick-caths are 
catheters inserted into the bladder to collect a urine sample or empty a bladder and are 
immediately removed. The main issue associated with these catheters is insertion trauma, 
especially in male patients. However , significant long-term effects of quick-caths are minimal 
(Fink , 2012). Foley catheters come in two styles depending on the intended dwell time. Regular 
Foley catheters are intended for shorter dwell times while patients requiring catheters for long 
term use utilize silver-coated urinary catheters. The antimicrobial properties of silver are useful 
because infection rates increase as dwell time increases (Hashmi , 2003). Guidelines for dwell 
times requiring silver-coated urinary catheters are facility-dependent. 
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Foley catheters are far more common and come in various lumen diameters , measured on the 
French scale. The diameter in millimeters is equivalent to the French measurement divided by 3. 
However , many elderly male patients have enlarged prostates. This causes resistance in the 
insertion process. Healthcare workers can use Coude catheters which have a stiff tip to help push 
the catheter through any inflamed prostate tissue. These types of catheters cause more pain and 
are therefore used less frequently than Foley catheters (Stephens , 2017) . 
Another concern with enlarged prostates is the possibility of blood clots forming in and around 
the catheter. When this happens, catheters must be irrigated and flushed. Blood clots form when 
blood encounters a surface, such as a catheter , and initiates the intrinsic pathway of the 
coagulation cascade , forming a clot that occludes the catheter (Ratner , 2013) . 
The primary concern with any urinary catheter is a urinary tract infection (UTI) . 95% of UTis in 
critical care patients are a result of urinary catheter usage and are caused by a variety of different 
organisms (Rupp , 2004). Catheter-associated urinary tract infections (CAUTis) are one of the 
most common HAis that patients receive during their hospital stays (Rupp, 2004 ). CAUTis 
contracted in the first few days of catheter use are caused by Staphylococcus epidermidis (S. 
epidermidis), Enterococcus faecalis, and Escherichia coli. However, as dwell times increase , 
CAUTis can also be caused by Proteus mirabilis and Pseudomonas aeruginosa (Stickler & 
Sabbuna, 2007) . 
CAUTis follow a specific progression . Bacteria attach to the uneven surfaces of catheters which 
contain microscopic imperfections (Stickler , 2003). Bacteria can attach either intraluminally 
(inside the catheter) or extraluminally ( outside the catheter between the urinary tract and the 
catheter) (Garcia, 1999; Tambyah, 2004) . The bacteria then form an antibiotic resistant biofilm 
which harbors , nurtures, and protects bacterial growth on the catheter. These biofilms infect the 
bladder (Kumon et al., 2001; Cormio et al., 2001; Burton et al., 2006; Trautner & Darouiche, 
2004 ; Helm, 2015). 
c. Current Antimicrobial Solutions 
Antibiotic resistance is a major concern in today's medical community . Over the course of the 
past several years, antibiotics have not improved and diseases such as MRSA and other 
"superbugs" are on the rise . Approximately 70% of infections that happen while a patient is in 
the hospital are bacterial infections that are resistant to at least one traditional antibiotic used for 
treatment. They are hard to combat without providing a "cocktail" of antibiotics which leads to 
antibiotic resistance (Lara, 2009) . 
The source of most catheter-related bloodstream infections occurs in catheter hubs and the skin 
surrounding the insertion site. Therefore, most research is focused toward preventing bacterial 
colonization at these locations to keep the bacteria from spreading into the bloodstream and 
creating a biofilm on the surface of the catheter. 
UTis are the most common hospital acquired infection in patients who are in intensive care units 
(ICUs). The infection can travel up the urinary tract and into the kidneys which causes 
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inflammation. If the pathogenic organism reaches the bloodstream, the patient can become septic 
(infected). Catheters account for more than 40% of cases of sepsis in acute-care hospitals 
(Samuel, 2004). 
i. Metal Coatings 
Various metals exhibit antimicrobial properties. Silver is the most popular metal for catheter 
coating because it combines high antimicrobial activity with low human toxicity (Schierholz, 
1998). Since the 19th century, silver compounds have been used in a variety of antibacterial 
solutions. The properties of silver as a medical compound have been recognized for about 2,000 
years (Prabhu, 2012). 
Unfortunately, there are drawbacks to this approach. The manufacturing costs of these catheters 
are very high. A silver alloy-coated catheter costs $13 compared to $7 for a standard catheter 
(Saint, 1998). Silver can affect patients differently based on gender because men and women 
develop CAUTis differently. The catheters are more effective at preventing infection with gram.-
negative rods (most common infection in women) than gram-positive cocci (most common 
infection in men). For this reason, women benefit from the silver-coated catheters more than men 
(Saint, 1998). Metals may also leach poison into the patient's body. A product under United 
States patent US5520664A seeks to solve this issue by embedding silver into a catheter to ensure 
that the atoms of the antimicrobial metal are substantially non-leaching. 
ii. Antibiotics and Antiseptics 
Antibiotics such as vancomycin have been shown to reduce the risk of catheter-related 
bloodstream infections. Centers for Disease Control and Prevention guidelines recommend 
against prophylactic use of vancomycin because it is an independent risk factor for acquisition of 
vancomycin-resistant enterococci (Mermel, 2000). It has been suggested that additional 
antibiotics such as minocycline and rifampin be used to avoid systematic use of a single 
antibiotic. However, antibiotic coatings are more expensive and can lead to antibiotic resistance 
(Kusek, 2012; Samuel, 2004). Therefore, solutions should be focused on interventions that will 
not encourage the emergence of such resistance. 
Antiseptic coatings also show antimicrobial effectiveness. The cuff of the catheter, known as the 
Dacron cuff, is an important site for this type of coating because it is tunneled into the patient's 
skin to provide a tissue-interference barrier. The Dacron cuff is used to introduce an 
inflammatory response within the tissue. The response acts as a barrier to microorganisms and 
helps prevent dislodging of the catheter. Short-term use catheters that are coated with antiseptics, 
such as chlorhexidine and silver sulfadiazine, reduce the risk of central venous infections. Not 
only do these methods decrease the risk for infection but also reduce the cost per catheter. 
Antimicrobial activity of the catheter decreases over time so antiseptic coatings should only be 
used for short-term catheters that are in use for less than two weeks (Mermel, 2000). 
iii. Nanoparticles 
N anoparticles are also a field of interest because of their ability to create a smooth surface that is 
non-toxic to the human body. Nanoparticles are nanomaterials that measure less than 100 
nanometers in at least one direction. Commonly researched nanoparticles include copper II 
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oxide, silver, gold, and zinc oxide. The addition of nanoparticles into a known antibiotic 
enhances the bactericidal effects of the antibiotic (Lara, 2009). Silver shows the most promise in 
combating infections and antibiotic resistance (Kim, 1994). Silver nanoparticles inhibit the 
activities of interferon gamma and tumor necrosis factor alpha which are biomarkers of 
inflammation (Prabhu, 2012). 
United States patent US 8647675B2 describes a silver nanoparticle antimicrobial coating for 
implantable medical devices that can be used for long-term and short-term infection resistance. 
The coating consists of three distinct layers of silver nanoparticles of different sizes that extend 
over the surface. A Chinese patent CN 102380130 specifically describes the coating of a 
modified polyurethane central venous catheter with silver nanoparticles. The process consists of 
immersion of the catheter in a mixed solvent of ethanol and deionized water before being 
immersed in a silver nitrate solution by UV irradiation. Nanotechnology is a promising coating 
mechanism. A thin coating ofnanoparticles, approximately 100 nanometers thick, slowly 
releases silver ions over the course of several days (Roe, 2008). Due to their large surface area, 
they are more effective. The silver ions bind to the cell wall of the bacteria and, due to their 
toxicity, cannot be removed (Prabhu, 2012). 
Despite showing a reduced risk of infection , nanoparticles in central venous catheters (CV Cs) 
can cause catheter-associated thrombosis in critically ill patients (Stevens , 2009). Nearly 54% of 
patients in ICUs have a CVC which are associated with an infection rate of 5 per 1000 catheter 
days. In critically ill patients , approximately 87% of blood infections are a result of CVC use 
(Raad, 2011). Primary blood infections from CVCs are caused by various strains of 
Streptococcus, Staphylococcus , Enterococcus, and Candida (Stevens, 2009) . Streptococcus 
bacteria cause approximately 36% of blood infections that arise from CV Cs (Richards , 1999). In 
the United States , approximately 3 million CVCs are inserted each year. Approximately 850,000 
of CV Cs inserted result in an infection , of which 20% are serious and 28% are fatal (Furno , 
2004) . 
Despite the strong antimicrobial properties of silver nanoparticles, these can affect the 
biocompatibility of blood (Stevens, 2009). However, exposure to metallic nanoparticles over a 
ten-day period does not pose a toxic risk to the patient. In addition, silver nanoparticles applied 
to an intravenous catheter continue to release silver ions that inhibit bacterial infections over a 
ten-day period (Roe, 2008). There is no change in silver concentration over 3 70 days in urinary 
catheters and no dangerous levels of silver reach the bloodstream (Samuel , 2004) . Silver 
nanoparticles are a much more viable solution to reduce the risk of infection in urinary catheters 
compared to broad-spectrum antibiotics. 
To ensure biocompatibility, nanoparticles must be biologically synthesized. Chemically 
synthesized nanoparticles are toxic to humans. If they enter the bloodstream the particles can 
easily enter the blood-brain barrier. Certain strains of bacteria , plants, and fungi can synthesize 
silver nanoparticles. Plant extracts are nontoxic , cheaper , and synthesize nanoparticles quickly , 
and can be used to synthesize nanoparticles for biological use (Prabhu , 2012). 
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d. Other Current Solutions 
Many patented catheter modifications are intended for reducing pathogens entering the body and 
causing infection. The products often focus on elimination of the rough catheter surface using a 
coating. Plastic catheters and various coatings exhibit a smoother surface that improves 
performance and lowers failure rates. Catheter research focuses on preventing infections, fibrin 
buildup, and thrombosis (blood clots). Several of these techniques can be combined to further 
reduce the chance of complications from catheter use. 
i. Preventing Infections 
Improvement of techniques for insertion is centered primarily on proper training and 
preventative measures such as avoidance strategies, hand hygiene, and daily catheter checks. 
Proper intervention techniques combat CAUTis which can be caused by improper insertion 
techniques. It is important for improvements to occur to increase patient health and decrease 
costs for hospitals and other healthcare institutions. Direct observation decreases healthcare costs 
and patient safety, but the most successful strategy to fight CAUTI is to decrease the use of 
indwelling catheters (Galiczewski, 2017). Due to the necessity of urinary catheters, there is a 
demand for an improved product. 
The use of silicon coated catheters has also been studied as a solution to CAUTis. Unfortunately, 
there are no statistically significant data that reveal an advantage to using silicon as a catheter 
coating (Stenzelius, 2016). Antimicrobial coatings based on antimicrobial peptides are also 
suspected to combat CAUTis. A polyurethane catheter coated with an anti-adhesive hydrophilic 
polymer coating and antimicrobial peptides prevented bacterial adhesion and inhibited 
planktonic bacterial growth. These results provide a significant start to understanding the 
benefits of non-metallic and non-antibiotic coatings for urinary catheters (Yu, 2017). 
ii. Preventing Fibrin Buildup and Thrombosis 
Fibrin is an important protein that is involved in blood clotting. It forms a fibrous mesh that, 
together with platelets from the blood stream, impedes blood flow. Fibrin is activated in the final 
stage of the coagulation cascade, which can be initiated by the presence of foreign substances 
like catheters. Fibrin adhesion to these surfaces can lead to thrombosis. Fibrin deposits have been 
shown to increase bacterial colonization of S. aureus (Vanassche, 2013). Antibodies have been 
developed to prevent the adhesion of S. aureus to fibronectin, but the simplest solution for this 
problem is catheter replacement (Sun , 1997). Current protocols suggest that intravenous 
catheters should be changed at least every 3 days, and urinary catheters should be changed at 
least every 7 days, though daily inspection of the catheter is necessary (Kusek, 2012). 
Systematic application of heparin, a blood thinner, prevents fibrin deposition. Intravenous 
catheters coated with heparin delay fibrin deposition on the outside of catheters (Amplatz, 1971 ). 
Heparin medication can be administered during short-term intravenous catheter use but must be 
administered twice a day and requires constant monitoring to prevent thrombocytopenia (low 
blood platelet count). Patients with PICC lines must be put on blood thinners such as Prophylaxis 
with low-dose Coumadin to reduce the risk of thrombosis (Mermel, 2000). Both solutions are 
effective, but require great care on the part of healthcare professionals. Though catheter 
replacement reduces the risk of catheter failure and fibrin buildup, it can also increase the risk of 
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infection. Clot formation occurs in both intravenous and urinary catheters, though there are no 
universally accepted solutions to prevent clot formation with urinary catheter use. 
iii. Ease of Insertion Solutions 
Progress has been made in catheter technology due to new polymers that combine lubricity, 
softness , and bunch resistance . In addition, the texture and shape of the catheter tip could also 
play a role in reducing infiltration . Some of the most common strategies to increase ease of 
insertion include the use of specialized personnel , bevel-down needle insertion in small vessels, 
the use of local anesthetics , and topical visualization agents . Imaging techniques which assist in 
vein visualization are also being developed (Helm, 2015). 
Ultrasound-guided cannulation (insertion of a thin tube) of deep mid-arm veins by a modified 
Seldinger technique (US-Seldinger) yields better puncture success rates and lower postoperative 
complication rates . The technique includes features such as application of pressure with gauze, 
skin stretching , and immediate delivery of the catheter upon insertion of the catheter sheath. 
When an ultrasound is used in conjunction with the Seldinger technique, the operator can obtain 
a clear image of blood vessels which makes it easier to choose an ideal vein for catheter 
insertion . For this reason , ultrasound guidance provides more precise targeting for needle 
puncture. The use of the Seldinger technique was also proven to reduce bleeding, pain, 
complications , and discomfort. Ultrasound equipment used in association with US-Seldinger for 
a single catheterization operation cost more than the traditional non-US trans-cannula PICC 
insertion method , but it has a reduced complication rate. It was concluded that the US-Seldinger 
technique improves catheter insertion and is suitable for clinical application (Tan, 2016) . 
The site of insertion has been considered in the fight against pathogens. Insertion of a catheter 
into the subclavian vein reduces the risk of infection when compared to insertion into the internal 
jugular vein. Subcutaneous tunneling is an additional catheter insertion technique . According to 
US patent US4832687 , two remote incisions are made and the patented subcutaneous tunneling 
instrument and method are used to tunnel from one incision to the other. The catheter can then be 
inserted into the body. However, this technique should not be used if the catheter is intended to 
draw blood (Mermel , 2000) . 
Urinary catheters are one of the most uncomfortable medical procedures for patients . As such, 
many ideas have been implemented to ease the insertion of these devices. The use of lubricant is 
the primary method used to reduce friction. However, silicone coatings, proper patient 
compliance, and the use of the smallest possible catheter can also help to make the experience 
more comfortable for patients (Fink, 2012). 
Lubricant helps to minimize the friction between the urethral wall and the catheter. Though its 
use is vital, often, the lubricant only helps for the first 5 cm of insertion . After that point , the 
lubricant rubs off. Catheters can be coated in silicone to also minimize the friction force during 
insertion. 
Another factor in patient comfort is their own compliance. The most important factor patients 
can control is the tension in their muscles . A tense patient will experience more pain . Another 
nursing technique to ease the insertion of a urinary catheter in a female patient is to position the 
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patient lying flat on their back, with their knees bent. This allows the healthcare provider easy 
access to the urethra and avoids any unnecessary bending or bunching in the catheter as it is 
being inserted. In male patients, healthcare providers instruct the patient to lie flat on their back 
with their legs straight. The key to avoiding unnecessary bending or bunching during catheter 
insertion in male patients is to hold the penis perpendicular to the body. This position places the 
urethra in a straighter position, allowing for easier catheter insertion (Fink, 2012). 
e. Current Spider Silk Technology 
Synthetic spider silk is a tough fibrous material with high bond energy and strength comparable 
to Kevlar. This biomaterial has biocompatible protein fibers and tunable mechanical properties. 
The spider in study, Nephi/a clavipes, produces six different types of silk that have unique 
qualities and purposes for the spider. Harvesting silk from the spiders in large quantities is 
difficult because they are territorial and cannibalistic. Largescale production of synthetic spider 
silk has been studied through recombinant protein production. 
Although all six of the proteins have been sequenced, there are varying levels ofresearch for 
each one. The Dragline silk is the strongest, while the Flagelliform has the greatest strain-to-
break; these silks are the most understood and studied. Beta-sheet secondary structures are 
common, highly repetitive motifs found in each of these proteins. These structures create a high 
crystallinity and play an integral part in the strength of the fibers which, when combined with 
other alpha-helices, contribute to the extendibility (Guerette, 2014). These protein structures 
allow researchers to develop custom proteins that include many of the motifs common in the 
sequenced Dragline and chimera proteins. Recombinant proteins created for the Dragline silk, 
namely MaSPl and MaSp2, are the only proteins that have been expressed in and harvested from 
goat milk (Hinman, 2000). This is significant as there is limited scalability available in using 
goat-derived spider silk proteins. Most spider-silk proteins are goat-derived and any major 
applications will require recombinant proteins scaled in E. coli. 
Synthetic spider silk has shown promising results for many medical applications as it does not 
elicit an immune response, allowing the silk and its products to integrate with tissue. No 
significant immune response is observed from implanted silk in rats which shows promise for 
human trials. Synthetic spider silk has also shown improved results in wound closure 
applications (Hayashi, 1999). Fibroblasts, osteocytes, and mammalian cells can grow on natural 
spider silk fibers, synthetic spider silk films, and silk hydrogels (Brooks, 2005). Modified silk 
structures can increase cell proliferation and attachment. Other complementary structures of the 
synthetic spider silk proteins such as hydrogels, glues, and coatings show promising results in 
biocompatibility with tunable degradation. Silk films show potential in vaccine storage systems 
because of decreased bioactivity of the vaccines. Furthermore, silk films can store vaccines at a 
higher temperature which indicates that a less expensive and stringent storage requirement could 
be possible (Riekel, 2000). 
Synthetic silk production is significantly different from natural fiber production. A spider forms 
silk protein in individual glands at concentrations of 30-45% weight to volume (w/v) which feed 
through spinnerets. These proteins are then pulled into a fiber by the back leg of the spider. The 
protein is secreted and stored in the gland as an aqueous solution and is transformed into a solid 
fiber as it travels through a fine duct. Synthetic fiber resists solubilizing in water and many other 
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organic solvents. The high concentration found in spider glands has not yet been created in a 
laboratory setting. When solubilized in hexaflourophosphoric acid, synthetic spider silk reaches 
concentrations of 12-17% weight to volume. 
Aqueous solutions of synthetic spider silk proteins yield lesser concentration. However, the 
absence of harsh organic solvents increases safety , cost effectiveness, and decreases the 
environmental impact. Aqueous based synthetic spider silk proteins have been investigated for 
use as adhesives and coatings. Silk protein based coatings can adhere to numerous substrates 
(Harris, 2016). Silk materials also possess a smooth surface that does not interfere with blood 
flow which helps to decrease these inflammatory responses (Hess, 2001 ). Due to the 
recombinant nature of the protein and their capability to include other solutes, these coatings can 
be functionalized for a range of applications. These include prevention of blood clotting and 
biofouling. This is accomplished by forming drug-eluting coatings that release compounds such 
as heparin or antibiotics to improve the longevity of intravenous catheters. 
There are currently no patents for catheters that incorporates synthetic spider silk technology. 
However, it is being investigated for other medical applications and a synthetic spider silk 
coating has been approved for stents. A World Intellectual Property Organization patent WO 
2001038373 claims the creation of an improved implantable stent-graft prosthesis to minimize 
tissue inflammatory responses. 
5. Design Process 
a. Project Overview 
Catheter-related infections are currently combatted using different catheter materials, metal 
catheter coatings, and antibiotic catheter coatings . The purpose of this project was to create a 
urinary catheter with antimicrobial properties by introducing a synthetic spider silk protein 
coating. In this experimental design, a standardized method for uniform synthetic spider silk 
protein coating has been developed to provide accurate results for all subsequent testing. To 
produce a product comparable or superior to current catheters in use, specific evaluation criteria 
were satisfied. AFM and SEM imaging were used to study the roughness of the synthetic spider 
silk coated catheter and uncoated catheters. The insertion forces of the coated catheters were 
measured using a vertical MTS to introduce the devices through a layer of silicone material with 
similar durometer to human skin. Additionally, the antimicrobial properties of the catheter were 
confirmed using zone of inhibition testing, and the adhesion of the coating to the catheter was 
observed using a bend and bunch test. A summary of the design decisions made is shown in 
Figure 7. 
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Figure 7: Design tree detailing all the design decisions that were developed over the course of the project. 
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b. Design Steps 
i. IV Catheters vs. Urinary Foley Catheters 
The first major decision made in this project was deciding to pursue the coating of IV catheters 
or urinary catheters . At first, IV catheter coatings were pursued. Though synthetic spider silk 
coatings had been used for IV catheters in the past, the effect of thickness on these coatings had 
not been explored. The goal of the project would have been to design a method capable of being 
upscaled to mass production levels. However, faculty advisor Dr. Randolph Lewis clarified that 
coating thicknesses have little effect on antimicrobial properties. After exploring the catheter 
coating process previously studied, upscaling to mass manufacturing levels would not require 
any major design decisions. 
Synthetic spider silk coatings for urinary catheters have not been previously investigated. Due to 
the increasing rate of CAUTI infections and the healthcare industry 's prioritization on lowering 
CAUTI rates, catheter manufacturers are highly interested in antimicrobial coatings. Foley 
catheters were coated instead of Coude catheters due to the lack of a hardened tip which 
simplified the coating process. A summary of the benefits of coating urinary catheters are shown 
in Table 1. 
Table I : Summary of decisions to coat urinary catheters over intravenous catheters . 
Catheter 
Type 
Urinary 
Intravenous 
Pros 
Cheaper 
Many design decisions 
Easier Imaging 
Method Established 
Cons 
Requires more spider silk 
No established methods 
Minimal Designing Involved 
Difficult to image 
More difficult to coat 
ii. Synthetic Spider Silk Solution Optimization 
Prior to antimicrobial testing with the final catheter samples , initial testing was performed to 
assess the effect of synthetic spider silk and chlorhexidine, an antiseptic commonly used in 
medical applications, against three common sources of CAUTis : E. coli, S. aureus, and S. 
marcescens. Since chlorhexidine had never been used as part of a coating method it was 
imperative to know whether it would be beneficial to include as part of the final methods . 
Materials 
• Liquid Luria-Bertani (LB) media 
• Solid LB media with 2% Agar 
• Petri dishes 
• Sterile Cotton Swabs 
• Medical grade silicone 
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Methods 
A 6% synthetic spider silk solution was prepared according to protocol in Appendix a. Medical 
grade silicone was cut into disks ten millimeters in diameter before sanitization with 70% 
ethanol. The disks were coated using one of three options: synthetic spider silk, synthetic spider 
silk+ 1.5% chlorhexidine, or 20% chlorhexidine. As a negative control, several disks were left 
uncoated. Chlorhexidine swabs that are used in hospitals contain 2% chlorhexidine. For the 
second round of trials, the chlorhexidine was diluted from 20% to 1.5%. The 1.5% chlorhexidine 
was chosen after examining data from prior trials performed by the faculty mentor, Dr. Lewis. 
These trials showed that a 1-2% chlorhexidine solution is ideal. Each disk was dipped in the 
correct solution for three seconds before it was placed on a paper towel to dry. The disks 
received the appropriate coating method three times. Once the three coatings were completed, 
the disks were allowed to dry completely. Agar plates were prepared according to the recipe in 
Appendix a and streaked with E. coli, S. marcescens, S. aureus. Three plates were streaked for 
each bacteria species. One plate was the control which contained only the target bacteria. The 
additional two plates each had four disks containing an uncoated disk and a disk with each of the 
above coating methods. The plates were incubated inverted at 37° C for 24 hours before zone of 
inhibition measurements were taken. 
Several issues were observed when the plates were checked on the first day. The bacteria were 
not streaked effectively ( the bacteria appeared in grids instead of lawns) and a few of the 
uncoated silicone disks had moved from the designated grid. An inoculation needle had been 
used to spread the bacteria on the plates and the needle had gouged the agar in several locations. 
The results from the first day are shown in Figure 8. It was decided that the initial antimicrobial 
testing needed to be repeated to resolve the errors that arose. 
To ensure proper solvation of synthetic spider silk protein in solution, three mL of the 6% 
synthetic spider silk solution was prepared for the second round of initial antimicrobial trials 
instead of two mL. Bacteria were inoculated for 48 hours at 3 7° C in LB broth instead of agar 
slants so that cotton swabs could be used to streak the plates in order to form confluent bacterial 
lawns. Once again, the disks were dipped a total of three times. The same three bacteria (E. coli, 
S. marcescens, S. aureus) were used for the trials. Inspection of the plates upon the first day of 
measurements showed the desired bacterial lawn. The zone of inhibition that was measured on 
the first day was marked with a Sharpie to report a consistent measurement each day. 
Measurements were recorded every 24 hours for a total of 7 days. 
Results 
Results from the last day of measurements are shown in Figure 9. All pictures and data are 
shown in Appendix b. Note that the diameter of the zone measured on the first day are marked 
with a Sharpie in order to keep measurements consistent. Statistical analysis of antimicrobial 
data is shown in Tables 2, 3, and 4. Statistical analysis was run using GraphPad Prism using 
column statistics and one-way analysis of variance (AN OVA) with Tukey HSD post-hoc test. 
Significance when compared to the uncoated control has a p-value less than 0.05. 
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Figure 8: Picture of plates after the first day of zone of inhibition measurements . (I) From top to 
bottom : S. marcescens control plate , S. marcescens replicate plate one, S. marcescens replicate 
plate two. (2) From top to bottom: S. aureus control plate , S. aureus replicate plate one, S. 
aureus replicate plate two. (3) From top to bottom: E. coli control plate, E. coli replicate plate 
one, E.coli replicate plate two. On all replicate plates starting from the top left and moving 
clockwise : uncoated disk, synthetic spider silk coated disk, synthetic spider silk + 1.5% 
chlorhexidine disk, and 1.5% chlorhexidine disk. Note that several disks movedfrom the 
designated quadrant . 
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Figure 9: Picture of plates after the seventh day of zone of inhibition measurements . (I) From 
top to bottom: E. coli control plate , E. coli replicate plate one, E. coli replicate plate two. (2) 
From top to bottom : S. aureus control plate , S. aureus replicate plate one, S. aureus replicate 
plate two. (3) From top to bottom: S. marcescens control plate , S. marcescens replicate plate 
one, S. marcescens replicate plate two. On all replicate plates starting_from the top left and 
moving clockwise : uncoated disk, synthetic spider silk coated disk, synthetic spider silk + 1.5% 
chlorhexidine disk, and 1.5% chlorhexidine disk. 
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Table 2: Statistical analysis for the disks using the seventh day zone of inhibition measurements 
for E.coli. 
Standard Lower 95% Upper95% Significant 
Error of the Standard Confidence Confidence Compared to 
Average (rrrn) Mean Deviation Interval of Mean Interval of Mean Uncoated 
Uncoated 10.00 0.00 0 .00 10.00 10.00 No 
Synthetic Spider Silk 12.75 0.75 1.06 3.22 22 .28 Yes 
Synthetic Spider Silk + 
Chlorhexidine 18.00 0.00 0.00 18.00 18.00 Yes 
Chlorhexidine 17.50 0.50 0.71 11.15 23 .85 Yes 
Table 3: Statistical analysis for the disks using the seventh day zone of inhibition measurements 
for S. aureus. 
Standard Lower 95% Upper 95% Significant 
Error of the Standard Confidence Confidence Compared to 
Average (mm) Mean Deviation Interval ofMean Interval ofMean Uncoated 
Uncoated 10.00 0.00 0.00 10.00 10.00 No 
Synthetic Spider Silk 14.50 0.50 0.71 8.15 20 .85 No 
Synthetic Spider Silk + 
Chlorhexidine 28.50 5.50 7.78 -41.38 98 .38 No 
Chlorhexidine 32 .00 6.00 8.49 -44 .24 108.20 Yes 
Table 4: Statistical analysis for the disks using the seventh day zone of inhibition measurements 
for S. marcescens. 
Standard Lower95% Upper 95% Significant 
Error of the Standard Confidence Confidence Compared to 
Average (mm) Mean Deviation Interval ofMean Interval of Mean Uncoated 
Uncoated 10.00 0 .00 0.00 10.00 10.00 No 
Synthetic Spider Silk 12.00 1.00 1.41 -0 .71 24.71 No 
Synthetic Spider Silk + 
Chlorhexidine 20.00 1.00 1.41 7.29 32.71 No 
Chlorhexidine 21.50 4.50 6 .36 -35 .68 78 .68 No 
Conclusions 
It was decided that sterile cotton swabs needed to be used in all further experiments to create the 
bacterial lawn due to the grid-like appearance shown in Figure 8. Figure 9 shows the confluent 
lawns that were created when using the cotton swab. The disks that were coated with 
chlorhexidine showed successful zones of inhibition and were included in the final catheter 
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coatings. Chlorhexidine was shown to enhance the antimicrobial properties of the coating 
solution and was later used in trials with Foley catheters. 
iii. Catheter Coating 
To test the mechanical and antimicrobial properties of the coated catheters , coating methods had 
to be optimized . Previous results in literature suggested methods such as dip and spray coating 
(Lewis, 2016) . Based on suggestions from the faculty mentor and industry representatives , an 
aerosolize coating was developed along with coatings combining methods. Based on the 
qualitative results from synthetic spider silk solution optimization , coatings were made using 
synthetic spider silk and synthetic spider silk with 1.5% chlorhexidine solution. 
1. Dip Coating 
Materials 
• Polycarbonate (thickness of 0.6 cm) 
• Loctite Plastic Epoxy 
• Loctite Super Glue (Cyanoacrylate) 
• 6% w/v Synthetic Spider Silk Solution 
• 20% Chlorhexidine Solution 
• Latex Urinary Catheters 
• Stren Super Knot Monofilament Fishing Line 
• Dritz Yarn Darners 
• 10% Bleach Solution 
• 20% isopropyl alcohol (IP A) 
Methods 
A volume of six rnL of synthetic spider silk solution was prepared according to the protocol in 
Appendix a. A trough of polycarbonate was made with the dimensions 19.8 cm x 1.5 cm x 2 cm 
using epoxy and cyanoacrylate (Figure 10). The trough held 59 .4 rnL of solution. A minimum of 
20 rnL of solution were needed to submerge the catheter which was impractical and wasteful. To 
decrease the necessary volume of spider silk, an insert piece of polycarbonate was added to the 
trough (Figure 11). The new dimensions of the trough were 6.5 cm x 1.5 cm x 2 cm. To 
submerge the catheter in this new setup, approximately 6 rnL of solution were sufficient. It was 
discovered that using more than six rnL of solution at a time caused the solution to gel before the 
coating process was finished. 
Uncoated catheters were pierced through one of the forked ends with a needle , then a length of 
fishing line was pulled through the hole to tie a loop, while another length of fishing line was 
used to create a loop at the tip of the catheter (Figure 12). The loops were used to pull the 
catheter through the trough to avoid unnecessary contact. With the smaller trough , touching the 
catheter while coating was unavoidable. Contact was kept to just below the forked end and at the 
very tip where the coating would drip down while drying. 
Prior to coating , the catheters and the trough were sterilized in a 10% bleach solution for 10 
minutes then rinsed with 20% IP A The sterilization step was required to prevent contamination 
during the antimicrobial trials. All 6 rnL of solvated synthetic spider silk or synthetic spider silk 
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solution with chlorhexidine were pipetted into the trough. The catheter was pulled through 
solution , rotated , and then pulled back through to ensure full coverage. Once both passes were 
complete, the catheter was hung from a ring stand to dry for approximately five minutes (Figure 
13). A total of three coatings were deemed necessary based on literature (Lewis, 2016). 
A blue food coloring was added to the solution during some initial trials to easily visualize the 
coating. The coloring made it easier to see the bubbles trapped on the surface of the catheter 
from bubbles that formed while pipetting the solution into the trough. This was mitigated by 
pipetting very slowly into the trough . 
Based on industry needs, the team attempted to create an inside coating using the dip method. 
The catheter was pulled through the trough , the opening on the forked end allowed the coating 
solution into the catheter. Excess solution was then pipetted into the catheter while hanging from 
the drying apparatus , moving the catheter around the inside to assist in a consistent coating. The 
coating then dripped out of the opening in the tip of the catheter. 
Figure 10: The polycarbonate trough. 
Figure 11: Insert addition to reduce volume of trough. 
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Figure 12: Loopedfishing line to pull the catheter and hang to dry. 
Figure 13: The apparatus to hang dry the catheters . 
Conclusion 
The dip coating method left a visible coating on the catheters, but the food coloring made the 
bubbles on the surface stand out. The catheters needed to dry after coating for several hours , but 
the catheters remained sticky after drying. The dip-coated catheters made a crinkling sound when 
bent. 
The inside of the catheter near the forked opening appeared to be evenly coated; however, later 
SEM imaging revealed that the inside was not consistently or evenly coated. 
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2. Aerosolize Coating 
Materials 
• 6% w/v Spider Silk Solution 
• 20% Chlorhexidine solution 
• Isopropyl Alcohol (IPA) 
• Ultrasonic Lumiscope Nebulizer (Model 6700) 
• Salter Labs Nebulizer (Model: 8900- 7) 
• Glass vacuum adapter 
• Vinyl hose , 1" O.D . 
• Urinary catheters 
Methods 
A two rnL solution of 6% (w/v) synthetic spider silk solution was prepared in a glass vial via 
protocol in Appendix a. The solution was pipetted into a portable Lumiscope ultrasonic nebulizer 
to coat a catheter sterilized in a 10% bleach solution and rinsed with IP A. The first coating 
attempt was aimed at coating the inside surface of the catheter. A glass vacuum adapter was 
purchased in order to connect to the vacuum outlet in the fume hood . The catheter was attached 
to one end of the adapter and held by hand in the other. The vacuum and nebulizer were turned 
on and the nebulizer nozzle was focused into the tip of the catheter. The aerosolized synthetic 
spider silk solution was difficult to see which made it impossible to determine if the inside of the 
catheter was coated effectively. It appeared that the synthetic spider silk was not exiting the 
nebulizer in a continuous stream and upon inspection it was determined that the solution had 
solidified. The Lumiscope model that was being used relied on an outlet and could handle a 
maximum of fifteen watts of power. Unfortunately, the nebulizer was not strong enough to 
aerosolize the solution . 
The team decided to reduce the percentage of synthetic spider silk in solution to 3% (w/v) to 
ensure release by the nebulizer and to find a new nebulizer that relied on an air source instead of 
a battery. A new nebulizer was purchased from Alpine Medical made by Salter Labs (Model: 
8900-7). An extra vinyl hose (1" O.D .) was purchased with the idea of creating a "T" shape with 
the existing hose. The catheter could then be placed through the two hoses which would allow 
the synthetic spider silk solution to aerosol down the two hoses and across the entire catheter. 
After discussing this idea , it was discarded for three difference reasons. First , the vinyl hose that 
was purchased was too small to fit around the "T" attachment of the nebulizer. Second , the 
synthetic spider silk is only released out of one side of the "T". This means that only one side of 
the catheter would be coated with synthetic spider silk. Lastly , the catheter would not be coated 
evenly . The middle of the catheter would have a thicker coating than the two ends because the 
synthetic spider silk meets the middle first before moving outward more slowl y. 
The next coating trials were performed using the new nebulizer with a 3% (w/v) and 6% (w/v) 
synthetic spider silk solution. The air connection was only available on a lab bench so the 
coating was performed outside of the fume hood. The catheter was hung from a ring stand with 
fishing line and the nebulizer head was passed down the catheter and back up. This up and down 
coating motion was repeated rotating around the entire catheter. Both the 3% and 6% solutions 
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were aerosolized and sprayed onto the catheter with two coatings with a ten-minute break in 
between for drying. 
Although the new nebulizer successfully released the spider silk as an aerosol , it was difficult to 
determine whether the synthetic spider silk was adhering to the catheter. During the next coating 
trial, red food coloring dye was added to the synthetic spider silk solution after centrifugation 
and before it was pipetted into the medicine cup to help visualize attachment of the synthetic 
spider silk to the catheter. The nozzle head was also turned 90 degrees so that it was parallel to 
the hanging catheter instead of perpendicular as in the previous trial. This directed the 
aerosolized synthetic spider silk up and down the catheter. 
Previously , the solution was moving around the catheter which reduced the amount of surface 
area that was coated. A three mL solution was used for a total of three coatings. There was an 
obvious red discoloration to the nebulizer hose and attachment but not to the catheter. An 
additional three mL of synthetic spider silk solution was used to coat the catheter for three more 
coatings . Upon inspection , there appeared to be a change in color to the catheter as well as a 
matte finish that contrasted with the initial shiny appearance of the surface. 
Antimicrobial testing with samples from the coated catheters verified coating results from the 
nebulizer trials and results are discussed in the antimicrobial testing section. The 3% synthetic 
spider silk coating had no effect on antimicrobial properties. Therefore , it was decided not to 
continue with this coating method . The 6% synthetic spider silk coating showed inhibition to 
bacteria growth but the coating was not as effective as other coating methods such as dip coating. 
Using the nebulizer as a coating method is still a viable option but serves better as a secondary 
coating method . Since antimicrobial results showed that a combination of coating methods seems 
to be the most effective at inhibiting bacterial growth , a new coating option was created: dip coat 
with a secondary aerosolize coat. 
It was also decided to attempt an inside catheter coating with the nebulizer. To accomplish this, a 
nozzle apparatus was created by the team and is shown in Figure 14. Cake decorating tips were 
attached to one end of the hose using tape so that the tip could be inserted into the open end of 
the catheter (Figure 15). The other end of the catheter was attached to the glass vacuum adapter 
using piping bags and tape (Figure 16). The nebulizer was connected to the air source on the 
bench top and the vacuum adapter was attached to the vacuum source in an attempt to create a 
continuous flow of aerosolized synthetic spider silk solution through the catheter. The vacuum 
pulled the air through the catheter and cooled it down which caused the synthetic spider silk 
solution to aerosolize. This was visible when the nozzle was removed from the catheter and led 
us to believe that the inside coating had coagulated. In order to determine if this was the case, 
SEM imaging was performed for this method. SEM images of the inside coating are shown in a 
later section. 
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Figure 14: Image of apparatus set up for the inside aerosolize coating method. 
Figure 15: Image of the nozzle that was designed for the inside aerosolize coating method. 
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Figure 16: Image showing the vacuum adapter set up for the inside aerosolize coating method. 
Figure 17: Image that shows coagulation of the spider silk after an attempt to coat the inside of the 
catheter . 
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Conclusions 
The aerosolize coating method is very straight forward and easy to set-up . However, the 
synthetic spider silk aerosol that is released by the nebulizer creates a thin coating. Because of 
this , it is recommended that the aerosolize coating method be used as a secondary coating 
method if a thicker coating is desired . 
The catheter felt cool to the touch when the above-mentioned protocol was used in an attempt to 
coat the inside. As shown in Figure 17, the synthetic spider silk solution precipitated from 
solution and formed beads. This led to the assumption that if the inside was coated it was most 
likely an uneven surface of coagulated spider silk solution. 
3. Spray Coating 
Materials 
• 6% w/v Spider Silk Solution 
• 20% Chlorhexidine solution 
• Airbrush Master Series II 
• DACA Winder 
• Steel Rod 70 cm in length 
• Urinary Catheters 
Methods 
Before coating, the apparatus used to generate uniform rotational velocity was prepped. The 
DACA winder featured a steel bar that was 25 mm in diameter and 220 mm long. Approximately 
40 mm of the bar at the suspended end was threaded. The mounted end is connected to the motor 
that rotates the bar at tunable velocities. A 3D printed mount was designed in SolidWorks and 
constructed of poly lactic acid. It included a hollow cylindrical end with a 45 mm outside 
diameter , a 19 mm inside diameter, and is 40 mm long. The center of the mount was originally 
designed as a transitional piece with a stepped cut to accommodate different sized catheters 
(Figure 18). This design was modified when the decision to no longer test IV catheters was 
made . A tapped hole in the fixture threaded the hollow end of the mount with grooves to match 
those of the steel bar. Once the grooves were tapped into the mount it was placed onto the steel 
rod by screwing the threaded pieces together. The catheter was cut and attached to the small 
diameter until it fit tightly and was centered on the winder (Fi"gl!l!fe 18). 
The DACA winder was a key element in the spray coating method because its constant rotation 
promotes continuous coating across the catheter surface. An issue arose in attempting to 
attach Foley catheters to the rotational piece. It was impossible to maintain a permanent position 
for the Foley catheter so a fixture was designed to fit on the DACA winder rotating arm with a 
snug fit for catheter hubs to be inserted to . To create such a fixture , dimensions of the winder 
were measured using calipers to determine the diameter , length, peak length and pitch of the 
threads. The drawing seen in image Figure 19 was the initial design for a mounting solution. The 
final design was then sent to the USU 3D printing office using ABS plastic in a low density 
setting to decrease the amount of overall material used in the printing process . 
Exact dimensions were difficult to obtain so plumber ' s tape was wrapped around the threaded 
portion of the DACA winder rotating arm several times to thicken the diameter and fill in the 
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gaps (Figures 20 and 2 ] . This served to further secure the mount and ultimately proved as a 
successful solution to mounting IV catheters. 
The fixture to be added to the mounting assembly was designed in a way that it could be 
inserted into the original DACA winder mount. This converted the initial part from mounting IV 
catheters to being able to mount Foley catheters (Figure 22). The final design was then sent to 
the USU 3D printing office using ABS plastic in a low density setting to decrease the amount of 
overall material used in the printing process (Figure n) . 
After the mounts were completed and assembled the first coatings began. Once the DACA 
Winder was started, the "Winder Only" option on the display was selected. The prompt to enter 
the spool diameter ( outside diameter of catheter) in millimeters and 30mm was entered. The 
winder speed was set at 6 meters per second (mis). The last prompt was to choose the step size of 
each velocity increase which was set at 1 mis. These parameters were not chosen to be accurate 
to the diameter of the catheter. They were instead chosen as a benchmark for all the catheters to 
be coated at the same speed. It was imperative that the winder spin quickly enough to get a thin 
even coating, and that the rotational speed (winder settings) was uniform throughout coatings. 
Before winding, the catheter was to be marked with a pen to distinguish the start and stop 
positions for the air brush. 
Using the Airbrush Master Series II 6% synthetic spider silk solution was loaded into the liquid 
chamber of the airbrush gun. The airbrush features a small air compressor and mechanical 
settings designed to tune the quantity of liquid allowed to disperse into the otherwise constant 
airflow. Of, course this airflow was only constant after it had been allowed to dispense excess 
pressure. Because of this, the catheter was only sprayed after the gun had sprayed for several 
seconds. The catheter was then moved at a constant lateral velocity along the entire length of the 
catheter. The catheter was promptly removed using sterile forceps and secured to dry vertically. 
Upon coating the first several catheters, it was discovered that the lateral speed was not 
consistent. The DACA Winder features a speed variable guide that travels 14 cm back and forth 
parallel to the catheter. However, the guide is offset about 30 cm from the position of catheter 
being spun. A steel rod used in the drying apparatus was placed on the operator's shoulder and 
the other end on a clamp attached to the sliding guide. The rod would move at a constant velocity 
with the guide and slide freely across the shoulder the airbrush would be placed and held at a 
constant position along the steel rod. This limited lateral movement of the airbrush to the 
velocity preset by the sliding guide. By keeping the preset velocity the same, uniform lateral 
movement was permitted across all samples. The limited 14 cm tract of the guide also meant that 
the position of the airbrush on the steel rod would need to change to cover the entire length of the 
catheter. This required careful observation of where the spray coating ended to align that position 
to the spray coating coming from the other direction. Due to human error, double coating for this 
small segment of the catheter was inevitable. 
Further issues arose with the mechanical settings on the airbrush that moved slightly with the 
vibration of the air compressor and would not return to the exact same setting after each use. 
This meant the settings were adjusted after each spin and there was no way to determine if there 
were an equal flow rate between trials except to allow the airbrush to spray a glove and the rate 
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at which the glove was wetted was observed and adjusted so that it would be similar each time. 
The instruments available did not allow measurement of these flow rates to ensure uniformity 
over each coating. 
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Figure 18: Depiction of initial iteration for 3D printed mount for use in catheter spray coating 
procedures . This design had originally considered coating IV catheters and was discarded due to 
the design change from IV catheters to Foley catheters . 
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Figure 19 First edition of 3D printed catheter mount for DACA winder . This second design 
iteration was discarded because it did not fit the dimensions of the DA CA winder and threads 
were deemed a necessary design addition. 
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Figure 20: Final edition of JD printed catheter mount for DACA winder. Threading was added 
in the final design to allow for a more secure fit. Accurate thread dimensions were difficult to 
obtain.from the DACA winder and so plumbing tape was wrapped around the threaded portion 
to fill in spaces between the printed part and instrument . 
Figure 21: Final iteration of JD printed spray coating mount secured on DACA Winder. An 
additional fixture was later deemed necessary to allow a dowel to be inserted upon which the 
Foley catheter would be secured. 
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Figure 22: Complete assembly of 3D spray coating fixture , additional dowel fixture , and dowel 
held securely on DACA winder . 
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Figure 23: Details for 3D dowel fixture which was designed to allow a metal rod to be attached 
to the winder . The catheters were slid over the rod to ensure smooth and consistent rotation. 
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Conclusions 
The spray coating method required several moving parts and dried almost immediately upon 
contact due to the use of compressed air as a mobilizing spray. The coating was difficult to 
observe with the naked eye, and SEM imaging was performed to ensure the spray technique 
provided a uniform coating. Images confirmed that the coatings were present and smooth. Inner 
coatings were not feasible and were not attempted with this method. 
4. Spray and Dip Coating 
Materials 
• 6% w/v Synthetic Spider Silk Solution 
• 20% Chlorhexidine Solution 
• Latex Urinary Catheters, Spray coated 
Methods 
After a catheter was coated using the spray coating method, the catheter was allowed to dry for 
24 hours. The catheter was then dip coated using the dip coat protocol described previously. The 
catheters were sterilized prior to spray coating however, no sterilization took place before the dip 
coating. If the first coating contained chlorhexidine, the second layer also contained 
chlorhexidine. 
Conclusion 
The spray coated catheter became sticky after dip coating . There was less of a crinkling when the 
spray and dip coated catheter was bent, but there was still visible cracking in the coating. 
5. Dip and Aerosolize Coating 
Materials 
• 6% w/v Synthetic Spider Silk Solution 
• 20% Chlorhexidine Solution 
• Latex Urinary Catheters, Dip coated 
Methods 
A catheter was dip coated and allowed to dry for 24 hours. The catheter was then coated using 
the aerosolize method described above. If the first coating method contained chlorhexidine, the 
second layer also had chlorhexidine. 
Conclusion 
After dip coating the catheter had a shine to the surface; after the additional aerosolize coating, 
the catheter was more matte in appearance. There was less of a crinkling sound when the catheter 
was bent as compared to the dip method. However, there were more cracks that showed in the 
dip and aerosolize coating compared to just an aerosolized coating. 
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iv. Antimicrobial Testing with Coated Catheters 
The antimicrobial effect of the catheter coatings needed to be measured in order to meet the 
specified design criteria. Zone of inhibition testing served as a quantitative test that allowed for a 
final catheter design decision. The bacteria used in initial testing (E. coli, S. aureus, and S. 
marcescens) were included in the final trials with catheters coated by the optimized coating 
protocols. 
Materials 
• Liquid Luria-Bertani (LB) media 
• Solid LB media with 2% Agar 
• Petri dishes 
• Sterile cotton swabs 
• Catheters coated with optimized coating protocols 
Methods 
Antimicrobial testing was performed once catheters were coated with all the final coating 
methods. A practice plate was inoculated with different sample shapes to determine which shape 
would stay attached to the agar during incubation. Scissors were used to cut an oblong shape and 
a scalpel was used to cut a sample of the cross-section (ring) and a rectangle from a dip coated 
catheter. A plate was inoculated with S. aureus bacteria and put in the incubator for 24 hours. As 
seen in Figure 24, the oblong sample fell off but the ring and rectangle stayed attached to the 
agar. The ring showed more uniform inhibition of bacterial growth when compared with the 
rectangle sample. Due to this, it was decided that final antimicrobial testing would be 
accomplished using a cross-sectional area sample from each catheter. Problems occurred when 
the catheters were cut for testing. The silicone catheters were difficult to cut which resulted in 
samples that were not completely smooth and did not lay flat on the agar. To combat this 
problem, the samples were gently pressed into the agar once they were deposited. 
The zone of inhibition test was performed using E. coli, S. aureus, and S. marcescens. A control 
plate was inoculated for each bacteria species. Then, each catheter sample was placed on an 
inoculated plate. Each coating method was plated twice. The following is a list of the catheter 
samples that were used for testing: 6% synthetic spider silk dip coat, 6% synthetic spider silk and 
chlorhexidine dip coat, 6% synthetic spider silk spray and dip coat, 6% synthetic spider silk and 
chlorhexidine spray and dip coat, 6% synthetic spider silk spin coat, 6% synthetic spider silk and 
chlorhexidine spray coat, 6% synthetic spider silk aerosolized coat, 6% synthetic spider silk and 
chlorhexidine aerosolized coat, 3% synthetic spider silk aerosolized coat, 3% synthetic spider 
silk and chlorhexidine aerosolized coat, and an uncoated catheter. Zones of inhibition were 
measured every day for a total of seven days. Despite pressing the samples into the agar a few 
samples fell off during the week of testing which required additional antimicrobial testing. 
During the first antimicrobial trial, a dip and aerosolized coating method was created. Catheters 
were coated with both a 6% synthetic spider silk solution and 6% synthetic spider silk with 1.5% 
chlorhexidine solution. The samples from the new coating method were added to the second trial 
of antimicrobial testing. The spray coating protocol was further optimized which required new 
samples to be incorporated into antimicrobial testing. Ultimately, the second round of testing 
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consisted of any catheter samples that fell off during the previous round, samples from the new 
coating methods, and samples from a catheter coated with the optimized spray protocol. 
To obtain the necessary number of measurements to ensure proper statistical analysis, a third and 
final trial of antimicrobial testing was set up. Samples from all five coating methods with both 
6% spider silk and 6% spider silk and 1.5% chlorhexidine were included. 
Results 
Images for the seventh day of testing for all trials are shown below in Figures 25 through 30. A 
scale bar has been added to all pictures for reference. All pictures are available in Appendix b. 
The average zone of inhibition in millimeters is shown for each coating method at day seven for 
each bacterium in Tables 5, 6, and 7 below along with the 95% confidence interval values, 
standard deviation, and the standard error of the mean .. All measurements for the three bacteria 
used can be seen in Appendix b. The values that are shown in the table below were used to 
create Figures 31, 32, and 33 respectively. Statistical analysis was run using GraphPad Prism 
using column statistics and one-way analysis of variance (AN OVA) with Tukey HSD post-hoc 
test. Significance when compared to the uncoated control has a p-value less than 0.05. 
Figure 24: Picture showing the different sample shapes that were tried to determine the best one 
for antimicrobial testing. From top moving clockwise : cross-section (ring), rectangle , and 
oblong. 
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Figure 25: Pictures of zones of inhibition from trial 1 for samples of coating methods against E. 
coli. Descriptions start in the top left quadrant and continue clockwise for each plate . (1, 2) 6% 
spider silk dip, 6% spider silk + 1.5% chlorhexidine dip, 6% spider silk + 1.5% chlorhexidine 
spray and dip, and 6% spider silk spray and dip. (3, 4) 3% spider silk aerosolized , 3% spider silk 
+ 1.5% chlorhexidine aerosolized , 6% spider silk + 1.5% chlorhexidine spray, and 6% spider 
silk spray . (5, 6) 6% spider silk aerosolized, 6% spider silk + 1. 5% chlorhexidine aerosolized, 
and uncoated. 
Figure 26: Picture of zones of inhibition from trial 1 for samples of coating methods against S. 
aureus . Descriptions start.from the top left quadrant and continue clockwise for each plate. (1,2) 
6% spider silk dip, 6% spider silk + 1.5% chlorhexidine dip, 6% spider silk + 1.5% 
chlorhexidine spray and dip, and 6% spider silk spray and dip. (3,4) 3% spider silk aerosolized , 
3% spider silk + 1.5% chlorhexidine aerosolized, 6% spider silk + 1.5% chlorhexidine spray, 
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and 6% spider silk spray. (5, 6) 6% spider silk aerosolized, 6% spider silk+ 1.5% chlorhexidine 
aerosolized, and uncoated. 
Figure 27: Picture of zones of inhibition from trial I for samples of coating methods against S. 
marcescens. Descriptions start from the top left quadrant and continue clockwise for each plate . 
(1,2) 6% spider silk dip, 6% spider silk+ 1.5% chlorhexidine dip, 6% spider silk + 1.5% 
chlorhexidine spray and dip, and 6% spider silk spray and dip. (3, 4) 3% spider silk aerosolized , 
3% spider silk + 1.5% chlorhexidine aerosolized, 6% spider silk + 1.5% chlorhexidine spray, 
and 6% spider silk spray. (5, 6) 6% spider silk aerosolized , 6% spider silk + I. 5% chlorhexidine 
aerosolized, and uncoated. 
Figure 28: Picture of zones of inhibition.from trial 2 for samples of coating methods against E. 
coli. Descriptions start in the top left quadrant and continue clockwise for each plate . (1,2) 6% 
spider silk spray, 6% spider silk + 1.5% chlorhexidine spray, 6% spider silk + 1.5% 
chlorhexidine dip and aerosolized , 6% spider silk dip and aerosolized. (3) 6% spider silk + 1.5% 
chlorhexidine aerosolized (sample I) , 6% spider silk + 1.5% chlorhexidine aerosolized (sample 
2), and 6% spider silk + 1.5% chlorhexidine spray and dip. (4) 6% spider silk aerosolized and 
6% spider silk + 1.5% chlorhexidine dip and aerosolized. 
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Figure 29: Picture of zones of inhibition from trial 2 for samples of coating methods against S. 
aureus . Descriptions start in the top left and continue clockwise for each plate . (I) 6% spider silk 
spray, 6% spider silk + 1.5% chlorhexidine spray, 6% spider silk + 1.5% chlorhexidine dip and 
aerosolized , 6% spider silk dip and aerosolized. (2) 6% spider silk spray, 6% spider silk + 1.5% 
chlorhexidine spray, 6% spider silk + 1.5% chlorhexidine dip and aerosolized, 6% spider silk 
dip and aerosolized. 
Figure 30: Picture of zones of inhibition from trial 2 for samples of coating methods against S. 
marcescens. Descriptions start in top left and continue clockwise for each plate. (I) 6% spider 
silk spray, 6% spider silk + 1.5% chlorhexidine spray, 6% spider silk + 1.5% chlorhexidine dip 
and aerosolized , 6% spider silk dip and aerosolized. (2) 6% spider silk spray, 6% spider silk + 
1.5% chlorhexidine spray, 6% spider silk + 1.5% chlorhexidine dip and aerosolized , and 6% 
spider silk dip and aerosolized. (3) 6% spider silk aerosolized and 6% spider silk + 1.5% 
chlorhexidine spray and dip. 
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Table 5: Statistical analysi s for the seventh day zone of inhibition measurements for E. coli. 
Lower95% Upper95% Significant 
Standard Error Standard Confidence Confidence Compared to 
Average (mm) of the Mean Deviation Interval of Mean Interval of Mean Uncoated 
Uncoated 8.00 0.00 0.00 8.00 8.00 No 
Spray 8.17 1.67 0.41 7.74 8.60 No 
Spray + Chlorhexidine 8.50 0.27 0.76 7.87 9.13 No 
Dip 8.00 0.00 0.00 8.00 8.00 No 
Dip + Chlorhexidine 11.00 1.63 4.00 6.80 15.20 Yes 
Aerosoliz.e 8.00 0.00 0.00 8.00 8.00 No 
Aero so liz.e + 
Chlorhexidine 8.50 0.50 1.41 7.32 9 .68 No 
Dip and Aerosoliz.e 8.00 0.00 0.00 8.00 8.00 No 
Dip and Aerosoliz.e + 
Chlorhexidine 12.43 0 .78 2 .07 10.51 14.34 Yes 
Spray and Dip 8.50 0.50 1.23 7.22 9.79 No 
Spray and Dip + 
Chlorhexidine 13.00 0.26 0.63 12.34 13.66 Yes 
Table 6: Statistical analysis for the seventh day zone of inhibition measurements for S. aureus. 
Lower95% Upper95% Significant 
Standard Error Standard Confidence Confidence Compared to 
Average (nnn) ofthe Mean Deviation Interval ofMean Interval of Mean Uncoated 
Uncoated 8.00 0.00 0.00 8.00 8.00 No 
Spray 9.00 0.51 135 7.90 10.39 No 
Spray + Chlorhexidine 8.65 1.28 4.04 8.21 13.99 No 
Dip 8.17 0.17 0.41 7.74 8.60 No 
Dip + Chlorhexidine 13.67 0.42 1.03 12.58 14.75 Yes 
Aerosolize 8.30 0.21 0.52 7.79 8.88 No 
Aerosolize+ 
Chlorhexidine 8.17 0.17 0.41 7.74 8.60 No 
Dip and Aerosolize 8.00 0.00 0.00 8.00 8.00 No 
Dip and Aerosolize + 
C hlorhexidine 14.60 0.85 2.56 10.48 14.41 Yes 
Spray and Dip 8.00 0.00 0.00 8.00 8.00 No 
Spray and Dip + 
C hlorhexidine 14.17 0.48 1.17 12.94 15.39 Yes 
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Table 7: Statistical analysis for the seventh day zone of inhibition measurements for S. 
marcescens. 
Lower95% Upper 95% Significant 
Standard Error Standard Confidence Confidence Compared to 
Average (nm) ofthe Mean Deviation Interval o fMean Interval of Mean Uncoated 
Uncoated 8.00 0.00 0 00 8.00 8.00 No 
Spray 8.00 0.00 0.00 8.00 8.00 No 
Spray+ 
Chlorhexidine 8.00 0.00 0.00 8.00 8.00 No 
Dip 8.00 0 00 0 00 8.00 8.00 No 
Dip + Chlorhexidine 10.50 0.22 0.55 9.93 1107 Yes 
Aerosolize 8.00 0 00 0.00 8.00 8.00 No 
Aerosolize+ 
Chlorhexid ine 8.00 0.00 000 8.00 8.00 No 
Dip and Aerosolize 8.00 0 00 0.00 8.00 8.00 No 
Dip and Aerosolize 
+ Chlorhexidine 11.27 0.65 2.15 9.83 12.72 Yes 
Spray and Dip 8.00 0.00 0.00 8.00 8.00 No 
Spray and Dip+ 
Chlorhexidine 1167 0.49 1.21 10.40 12.94 Yes 
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Figure 31: Data shown are the average zones of inhibition + standard deviation for each 
coating method against E. coli. Each number corresponds to one of the spider silk coating type 
(1 = spray, 2 = dip, 3 = aerosolize, 4 = dip and aerosolize, and 5 = spray and dip) and the 
addition of "C" represents coatings containing chlorhexidine. Different letters indicate groups 
are statistically different (p < 0. 05) from the control according to AN OVA with Tukey HSD post-
hoc tests (GraphPad Prism). To keep the figures easy to read, significance when compared 
between coating methods was not recorded. Significance between coating methods is detailed in 
Appendix/ 
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Figure 32: Data shown are the average zones of inhibition + standard deviation for each 
coating method against S. aureus . Each number corresponds to one of the spider silk coating 
type (1 = spray, 2 = dip, 3 = aerosolize , 4 = dip and aerosolize, and 5 = spray and dip) and the 
addition of "C " represents coatings containing chlorhexidine. Different letters indicate groups 
are statistically different (p < 0. 05) from the control according to ANO VA with Tukey HSD post-
hoc tests (GraphPad Prism) . To keep the figures easy to read significance when compared 
between coating methods was not recorded. Significance between coating methods is detailed in 
Appendix/ 
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Figure 33: Data shown are the average zone s of inhibition + standard deviation for each 
coating method against S. marcescens . Each number corresponds to one of the spider silk 
coating type (I = spray , 2 = dip, 3 = aerosolize , 4 = dip and aerosolize , and 5 = spray and dip) 
and the addition of "C " represents coatings containing chlorhexidine . Different letters indicate 
groups are statistically different (p < 0. 05) from the control according to ANO VA with Tukey 
HSD post-hoc tests (GraphPad Prism). To keep the figures easy to read significance when 
compared between coating methods was not recorded. Significance between coating method s is 
detailed in Appendix f 
Conclusions 
The results collected from the antimicrobial trials showed that spider silk alone does not provide 
a sufficient antimicrobial coating. The samples coated with synthetic spider silk and 
chlorhexidine showed much greater zones of inhibition than the samples that did not. Statistical 
analysis showed that the dip with chlorhexidine, dip and aerosolize with chlorhexidine, and spray 
and dip with chlorhexidine coatings exhibited significantly larger zones of inhibition than the 
other coating methods when compared to the uncoated catheter. 
v. Friction Testing 
The addition of a coating to the exterior of a urinary catheter will either increase or decrease the 
amount of force required to insert the device into the urethra of a patient. For this reason, a 
friction test was deemed necessary to evaluate the change in mechanical properties of coated 
catheters versus uncoated ones. The goal of this test was to prove that adding a layer of synthetic 
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spider silk coating will either decrease the resistant force/friction of silicon with skin, or maintain 
the same amount of force and demonstrate that the coating does not adversely affect the 
mechanical properties of a catheter. Several methods and approaches were attempted before 
finding a protocol that accurately measured the differences in friction between catheters 
accurately. 
Materials 
• 8-32 six-inch-long dowel rod 
• 8-32 nut 
• 10-32 one inch bolt 
• 10-32 washer 
• 10-32 nut 
• MTS tensile tester (lateral and vertical) 
• 10 N load cell 
• Pneumatic grips 
• TestWorks 4 Software 
• High Strength High Temperature Silicon Rubber Sheet (1/16") 
• Scissors 
• Marking pen 
• 2 large clamps 
• 5 stackable height test tube pieces 
• Copper pipe with set screws 
• Hex wrenches 
• Needle nose pliers 
• Punch press set 
• Hammer 
• Fishing line 
• Size 2 sewing needle 
• 4"x 1" scrap metal 
Method 1 
Several pieces of the silicon sheet were cut into one inch square pieces using scissors and 
punched through the center using a punch press set and hammer. This created an 11-mm 
diameter hole. The squares were then stacked to a height of approximately four inches and laced 
together using fishing line and a size two sewing needle. This fixture was made to simulate a 
human urethra. A 10-32 bolt and corresponding washer were attached at the end of the four-inch 
fixture and sewn on with 4 additional squares. A 10-32 nut kept the bolt secure within the silicon 
urethra. This fixture was then mounted to the lateral MTS and a catheter was placed in the 
pneumatic grips on the opposite side. As the load cell detracted, it measured the amount of force 
necessary to remove the catheter from the urethra. 
Changes to Method 1 
The urethra was too flexible under its own weight upon attachment to the lateral MTS and could 
not maintain a horizontal position to allow for accurate measurements. A piece of sheet metal 
scrap was bent to the outer shape of the urethra and a hole was extruded from the side to attach at 
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the bolted end of the urethra and provide further support. The supported fixture could maintain 
its horizontal alignment; however, the force of the catheter being pulled outward still bent the 
silicon urethra downward slightly and created unusable measurements (Figure 34). Ultimately, 
the lateral MTS was deemed a non-viable option because of the variability between each 
measurement. 
Figure 34: Profile view of silicon urethra attached to lateral MTS. Slight bending of the fixture 
can be seen from the desired 180° position. 
Method 2 
This second method utilized the silicon urethra assembled in method one, however the vertical 
MTS was used instead (Figure 35). This reduced variability between catheter trials and created 
more stability in the overall assembly. An 8-32 six-inch dowel was inserted into the catheter to 
ensure that for each test run, the catheter moved over the same path as the previous trial and 
output. The urethra was placed on the base of the MTS and the catheter was gradually pulled out 
of the fixture . To do this, the dowel inserted into the catheter was attached to the 10 N load cell 
using a copper pipe with set screws to convert the 8-32 diameter bolt to the appropriate size for 
the MTS. 
Changes to Method 2 
The data from this set up was still too variable due to ineffective clamps attached to the load cell. 
Several shims were placed to create a tighter fit and the positions of the silicon fixture and 
catheter assembly were switched . The 8-32 dowel was bolted to the base and the urethra was 
attached to the clamps of the load cell and moved up and down to simulate an insertion 
procedure. However, the program still did not output consistent results. 
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Figure 35: Test set up for method 2. The po sition of the silicon urethra and catheter were 
reversed to see if the location of each affected the results. 
Method 3 
It was made apparent by methods one and two that perhaps the interior of the silicon urethra was 
not completely uniform and could be the cause of so much variation between test samples. The 
fixture was therefore not included in method 3. This third method utilized the remaining sheet of 
silicon to simulate the force a catheter needs to overcome the friction coefficient between the 
surface of the catheter and the urethra of a patient. Continuing to use the vertical MTS, five 
stackable test tube holders were placed on the base of the MTS and held in place by two large 
table clamps (Figure 36). A 9-mm hole was punched through the silicon sheet using a hammer 
and punch press. This smaller hole caused a more uniform force to be measured as the catheter 
was inserted through it and contacted the sheet on its entire circumference (Figure 37). This 
piece of silicon sheeting was then placed between the first and second stacked test tube holders 
and the clamps were replaced to hold the material taught and centered on the measurement 
system. 
52 
Figure 3 6: Test set up for method three. Lateral view of the set up. This test method proved to be 
the most accurate by far of the three methods attempted for this .friction measurement test. 
Figure 37: Aerial view of the set up for test method 3 without catheter attached. 
Results 
Method 3 proved successful in providing consistent data for each catheter and little variation 
between catheters of the same coating as evidenced in Figures 38 and 39. Slight differences in 
force required for insertion were measured between coating methods and accurately account for 
the difference in surface which is readily described by the SEM images taken prior to this 
friction evaluation. The statistical analysis was run using GraphPad Prism software for a one-
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way ANOV A test. The data of these trials are shown in Tables 8 and 9. All friction data can be 
seen in Appendix d and complete statistical analysis can be seen in Appendix f. Overall, the 
coated catheters proved much easier to insert than the uncoated catheters and demonstrate that a 
synthetic spider silk coating decreases the friction involved in insertion. 
Table 8: Statistical analysis of the average insertion force for each of the catheter coating 
methods 
Lower95% Upper 95% Significant 
Average Force Standard Error Standard Confidence Confidence Compared to 
(N) of the Mean Deviation Interval of Mean Interval ofMean Uncoated 
Uncoated 3.764 0 .06836 0.2051 3.606 3.922 No 
Spray 0.73 0.05 0.15 0.62 0.85 Yes 
Spray + Chlorhexidine 0.74 0 .05 0.15 0.62 0.85 Yes 
Dip 0.74 0.05 0 .15 0 .62 0.85 Yes 
Dip + Chlorhexidine I.IS 0.16 0.47 0 .78 1.51 Yes 
Aerosolize 0 .83 0.11 0.34 0.57 1.09 Yes 
Aerosolize + 
Chlorhexidine 1.36 0.15 0.45 1.02 1.70 Yes 
Dip and Aerosolize 1.30 0.23 0.69 0.77 1.83 Yes 
Dip and Aerosolize + 
Chlorhexidine 1.02 0.15 0.46 0.63 1.38 Yes 
Spray and Dip 1.34 0.31 0 .93 0 .63 2.06 Yes 
Spray and Dip + 
Chlorhexidine 0.66 0.06 0.17 0.54 0.79 Yes 
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Table 9: Statistical analysis of the maximum insertion force for each of the catheter coating 
methods 
Lower 95% Upper 95% Significant 
Standard Error Standard Confidence Confidence Compared to 
Max Force (N) of the Mean Deviation Interval of Mean Interval ofMean Uncoated 
Uncoated 4.01 0.06 0.19 3.86 4.16 No 
Spray 1.05 0.05 0.15 0.94 1.17 Yes 
Spray+ Chlorhexidine 1.05 0.05 0.15 0.94 1.17 Yes 
Dip 1.73 0.24 0.71 1.18 2.27 Yes 
Dip + Chlorhexidine 1.45 0.14 0.42 1.12 1.78 Yes 
Aerosoliz.e 1.27 0.09 0.28 1.05 1.48 Yes 
Aerosoliz.e + 
Chlorhexidine 1.81 0.14 0.41 1.49 2.13 Yes 
Dip and Aerosoliz.e 1.63 0.23 0.68 I.I I 2.15 Yes 
Dip and Aerosoliz.e + 
Chlorhexidine 1.44 0.14 0.43 I.II 1.77 Yes 
Spray and Dip 1.75 0.30 0.91 1.05 2.45 Yes 
Spray and Dip + 
Chlorhexidine 1.05 0.07 0.21 0.89 1.21 Yes 
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Figure 38: Data shown are the mean insertion forces+ SEMfor each coating method. Each 
number corresponds to the spider silk coating type on the project overview and the addition of 
"C" represents coatings containing chlorhexidine. Different letters indicate groups are 
statistically different (p < 0.05) according to ANO VA with Tukey HSD post-hoc tests (GraphPad 
Prism). 
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Figure 39: Data shown are the max insertion forces + SEMfor each coating method. Each 
number corresponds to the spider silk coating type on the project overview and the addition of 
"C " represents coatings containing chlorhexidine. Different letters indicate groups are 
statistically different (p < 0.05) according to ANOVA with Tukey HSD post-hoc tests (GraphPad 
Prism). 
Conclusions 
The results obtained from the third friction test method indicated the addition of all coatings to 
the Foley catheters decreased the force needed for insertion. Uncoated Foley catheters required 
approximately 4 N of force during insertion through the 9-mm diameter silicon hole, while 
coated catheters required less than 2 N forces. Several coating methods displayed statistical 
difference between insertion force values (Figure 38 and 39). A summary of all decisions made 
to design the friction test is shown in Figure 40. 
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vi. Bend/ Bunch Testing 
Catheter insertion is an uncomfortable experience for all patients, but is especially uncomfortable 
for male patients. Due to the longer male urethra and the presence of a prostate, catheters must 
be flexible during insertion. It is critical that the coating on a catheter does not tear off when it is 
bent. Ideally, catheter coatings would stay consistent and would not crack during bending, but 
this is not critical to catheter function. Should a catheter coating crack and flake off of the 
catheter, this could contaminate any urine samples drawn from the catheter. However, cracking 
would not affect samples and would not compromise the function of the catheters. Furthermore, 
most elderly male patients have enlarged prostates which cause catheters to bunch at the end. 
The characteristics of the coating must be tested when the catheters are bunched at the end. To 
test the coating characteristics under bend/ bunch conditions, a testing fixture was 3D printed to 
hold catheters in a bent position while they were imaged. 
Materials 
• AmScope Light Microscope 
• Onshape.com Online CAD program 
• 3D printer 
• Coated catheters 
Methods 
First, a bunch test fixture was designed using Solid Works. The idea of the first iteration of the 
part was to place catheters inside a curved tunnel for 3 hours and image after removal using light 
microscopy. The design drawing is shown in Figure 41. The first part iteration was designed with 
holes in arcs with 1, 2, 4, 8, and 16-inch diameters. 
With this experimental design, however, the catheters were imaged in a straightened position, 
minimizing the ability to view cracking and flaking. Because coating visualization was far easier 
when catheters were bent, a new fixture design was necessary. Furthermore, the I-inch and 2-
inch diameter holes were removed after examining catheter usage in clinical settings. Catheters 
will never be bent to that angle without becoming bunched. Therefore, the bunching portion of 
the test would cover these diameters. The drawing of the final iteration of the testing fixture is 
shown in Figure 42. 
The second testing fixture allowed images to be taken while the catheters were held in a bent 
position. Catheters were placed in each arch and imaged using the AmScope light microscope at 
5X magnification, starting with the 16-inch arc. 
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Figure 41: The CAD drawing of the fir st iteration of the bend test fixture . Five different diameter 
hollows were designed for coated catheters to be inserted through. The smallest two diameter 
hollows were deemed unnecessary because urinary catheters are not exposed to such extreme 
bending in actual practice . 
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Figure 42: Drawing of final bend test fixture . The top surface was removed in this design to 
allow easier placement of catheters within the three hollows. Width of the hollows was increased 
so the coating of the catheters was not removed upon placement. Overall dimensions were 
minimized to decrease printing expenses. 
60 
Results 
The results of the 50.4 mm diameter arc and bunch tests are shown in Figures 43 and 44. All 
images are available in Appendix c. Note the cracking visible in most coatings when bunched. 
Though the coatings did crack, none flaked off the catheter. A summary of all results is given in 
Table 10. 
Figure 43: Catheters placed in the 8-inch diameter arc. All images on the left are without 
chlorhexidine. (I) Spin (2) Dip (3) Aerosolized (4) Dip and aerosolized , (5) Spin and dip. Note 
the cracking visible in images (2), (4), and (5). 
. . " '°-:·'·:. .· .. ,_· 
. . ·.,, . 
.. _ . ~· 
.. '. ,. 
· . .. 
,C..,.-\ 
1ii . ; . \ ·, 
r(3) ,, ,,, ...... ·~ f / I 
_,,,,,,,r ti~ 
_,.... '--
(4) i .... • (Su)· .. ··,_ .. •···. .. :., •~ . . ·I•,:,,,•:· 
~ ,r , ' ' 
f, . .· ./ 
·~ ,.~· • .. · . . '""" 
Figure 44: Catheters bunched at tip. All images on the left are without chlorhexidine. (I) Spin 
(2) Dip (3) Aerosolized (4) Dip and aerosolized, (5) Spin and dip. Note the cracking visible in 
images (1), (2), (4), (5). 
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Table I 0: Summar,r_ o[ Bend/Bun ch test results. 
Coating Type 
8 inch arc Bllllch 
Crack? Flake? Crack? Flake? 
Spin No No Yes No 
Spin+ Chlorhexidine No No No No 
Dip Yes No Yes No 
Dip + Chlorhexidine Yes No Yes No 
Aerosolized No No No No 
Aerosolized + Chlorhexidine No No No No 
Dip and Aerosolized Yes No Yes No 
Dip and Aerosolized + Chlorhexidine Yes No Yes No 
Spin and Dip Yes No Yes No 
S_ein and D!e + Chlorhexidine No No Yes No 
Conclusions 
As shown in the figures above, all coating methods except for the aerosolized coating cracked 
during bunch testing. Because the catheters only cracked and did not flake off, the coatings 
would not affect any diagnostic samples taken from the catheter in clinical use. Each of the 
coating methods was determined to be a viable method based on the bend/bunch testing 
parameters. 
vii. AFM Imaging 
Materials 
• Atomic Force Microscope (AFM) 
• Glass Microscope Slides 
• Double Sided Tape 
• Coated and uncoated catheters 
Methods 
A section of catheter was cut into a 10-cm strip. The bottom of the strip was uniform to avoid 
any bumps or inconsistencies that would prevent the AFM from obtaining a clear image. The 
strip was then secured to a glass microscope slide using double sided tape and placed under the 
cantilever of the AFM. The AFM was set to tapping mode and the cantilever was lowered onto 
the sample until contact was made . The AFM measured the topography of an area between 2500 
and 10000 µm2 and a 2D image was created. Three images of each catheter were taken. Once the 
image was taken, the mean roughness of each catheter was measured using the AFM software 
and 3D images were created for several of the catheters. 
Results 
All 2D AFM images can be found in Appendix e. A 3D image of an uncoated catheter is shown 
in Figure 45 . A 3D image of a dip and aerosolize coated catheter with chlorhexidine is shown in 
Figure 46. A 3D image of a dip coated catheter with chlorhexidine is shown in Figure 47. These 
images are shown for their high quality and the consistency across coating types. The mean 
roughness measurements of the catheter images are shown in Table 11. There are large 
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differences between images of the same catheter due to micro-imperfections in the coatings such 
as cracks. 
Figure 45: 3D image of the topography of an uncoated catheter . The scan size in the horizontal 
directions is 50 µm and the data scale in the vertical direction is 3 µm . 
Figure 46: 3D image of the topography of a dip and aerosolize coated spider silk and 
chlorhexidine catheter. The scan size in the horizontal directions is 50 µm and the data scale in 
the vertical direction is 3 µm . 
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Figure 47: 3D image of the topography of a dip coated spider silk and chlorhexidin e catheter. 
The scan size in the horizontal directions is 50 µm and the data scale in the vertical direction is 
3µm. 
Table 11: The mean roughness of catheters calculated.from AFM images. 
Coating Image 1 (nm} Image 2 (nm) Image 3 (nm) Average(nm) 
Uncoated 73.005 61.453 63.65 66.036 
Dip 131.74 244.22 88.15 154.703 
Dip with Chlorhexidine 88.332 45.316 68.841 67.496 
Aerosolized 146.76 76.845 375.52 199.708 
Aerosolized with Chlorhexidine 102.62 107.8 550.7 253.706 
Spray 192.71 221.95 315.36 243.34 
Spray with Chlorhexidine 248.18 86.586 99.953 144.906 
Dip &Aerosolize 29.053 26.633 46.694 34.127 
Dip &Aerosolize with 
73.208 191.04 163.53 142.593 
Chlorhexidine 
Dip & Spray 76.279 113.78 44.097 78.052 
Dip & Spray with Chlorhexidine 73.164 168.95 271.59 171.235 
Conclusions 
Several divots can be seen in the image of the uncoated catheter. Divots are an optimal location 
for bacterial colonization , increasing the risk of CAUTis. Both 3D images of spider silk coated 
catheters show smooth surfaces with no divots. Though several bumps can be seen on the 
surfaces, they are not optimal locations for bacterial colonization due to their smoothness. The 
crack seen in Figure 4 7 is similar to cracks seen in many other images and is likely a gap 
between different drops of spider silk. This could be a possible attachment point for bacteria , 
though the antimicrobial properties of the coating would inhibit bacterial growth in these areas . 
These images show the relative smoothness of coated catheters. 
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viii. SEM Imaging 
Materials 
• Scanning Electron Microscope (SEM) 
• SEM sample mount 
• Coated catheters 
Methods 
Catheter samples of each coating method were cut transversely to an approximate thickness of 1 
cm, secured to an SEM sample mount, and placed in the machine . Imaging was carried out in the 
SEM under vacuum. FenAnn Shen operated the instrument with all group members present to 
help direct the process. 
Results 
Several representative SEM images displaying the measured thickness of the synthetic spider silk 
coating are shown in Figures 48 through 55. Appendix e contains all SEM images taken. The bar 
at the bottom of each image shows the conditions used during imaging including the 
magnification. A scale bar is also shown for reference. 
Figure 48: SEM image of a spray coated catheter. The SEM software was used to measure the 
thickness of the coating (1.133 µm) . 
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Figure 49: SEM image of dip coated catheter. The SEM software was used to measure the 
thickness of the coating (1. 759) and the distance from the catheter to the top of the flake (4.049 
µm) that was caused by cutting with a razor blade. 
Figure 50: SEM image of a dip coated catheter + chlorhexidine. The SEM software was used to 
measure the thickness of the coating (1.511 µm). 
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Figure 51: SEM image of aerosolize coated catheter. The SEM software was used to measure 
the thickness of the coating (1.027 µm) . 
Figure 52: SEM image of dip and aerosolize coated catheter. The SEM software was used to 
measure the thickness of the coating (1. 512 µm). 
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Figure 53: SEM image of spray and dip coated catheter. The SEM software was used to measure 
the thickness of the coating (2.952 µm) . 
~ ii', ,r,1,1111 
:rJpm----. 
fff P, 11111, ·1, 11.il111q 
Figure 54: SEM image of aerosolize inside catheter coating. The SEM software was used to 
measure the thickness of three different coating beads. From left to right : 20.25 µm , 14.84 µm, 
and 12.14 µm. 
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Figure 55: SEM image of dip inside catheter coating. The SEM software was used to measure 
the thickness of a coating bead (I. 769 µm). 
Conclusions 
The SEM images that were obtained provided qualitative results to whether the applied coatings 
were smooth. Dip, dip and aerosolize, and spray and dip all showed very smooth surfaces. The 
spray and aerosolize methods appeared much rougher. The catheters were difficult to cut due to 
the latex material that they are made of. This resulted in the appearance of flaking in some of the 
SEM images. 
SEM images is very time consuming so all of the catheter samples that were imaged were 
synthetic spider silk coating without chlorhexidine. FenAnn Shen assured the group that the 
addition of chlorhexidine would not change the SEM pictures in any way. However, in order to 
be sure of this, the team decided to image a dip coated catheter and a dip coated catheter with 
chlorhexidine in order to ensure that the coatings were similar (Figures 49 and 50 respectively). 
The resulting thicknesses were 1.759 µm and 1.511 µm respectively however, no other 
differences were noted. This confirmed that imaging only the synthetic spider silk coated 
catheters was sufficient. 
Industry leaders expressed interest in a catheter that is coated on the inside as well. As 
mentioned in the coating protocols above, the team developed an aerosolized inside coating 
method and dip inside coating method to meet this interest. However, the SEM images revealed 
that neither method created an even coating (Figures 54 and 55) since there was no way to 
control the flow of spider silk through the catheter in either method. Due to time constraints, the 
team decided to stop investigating methods to create an inner coating. 
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7. Final Design Review 
A summary table (Table 12) was created evaluating the various catheter coating methods based 
on the design criteria: antimicrobial activity, insertion friction, surface roughness, coating 
flexibility, and production feasibility. For antimicrobial activity, coatings that had statistically 
significant zones of inhibition when compared to uncoated catheters were given one point for 
each bacteria species (total of three). Coating methods that significantly reduced friction when 
compared to an uncoated catheter were given a score of one. Roughness was given a qualitative 
score based on SEM imaging: a smooth appearance received a one while a rough appearance 
received a zero. The coating flexibility was based on the bend bunch test. Coating methods that 
did not crack received a one, and coatings that did crack scored zero. The feasibility scores were 
based on the team's opinion on ease of manufacturing. A score of two is ease of manufacturing 
compared to the current process of creating urinary catheters; a score of one is harder to 
manufacture than the current process, and a score of zero is a non-feasible coating for 
manufacturing. Based on this scoring process, the best coating methods were dip with 
chlorhexidine, spray and dip with chlorhexidine, and dip and aerosolized with chlorhexidine. 
Table 12: Summary of Evaluation Criteria 
Dip with Spray with 
Aerosolized 
Spray and 
Spray and Dip 
Dip and 
Dip and 
Uncoated Dip Chlorhexidine Spray Chlorhexidine 
Aerosolized with Dip 
with Aerosolized Aerosolize~ ~Ith 
Chlorhexidine Chlorhexidine Chlorhex,dine 
Antimicrobial: 0 0 3 0 0 0 0 0 3 0 3 
Friction : 0 1 1 1 1 1 1 1 1 1 1 
Roughness: 0 0 0 0 0 0 0 1 1 1 1 
Bend/Bunch: 1 0 0 0 1 1 1 0 0 0 0 
Ease: 2 2 2 0 0 1 1 0 0 1 1 
Total : 3 3 6 1 2 3 3 2 5 3 6 
8. Conclusions 
Multiple methods for coating of urinary catheters using synthetic spider silk were developed. 
However, results showed that only three coating methods exhibited significant antimicrobial 
properties. All methods were scored on their antimicrobial properties, insertion force 
requirements, surface roughness, ability to resist flaking when bent and bunched, and mass 
manufacturing feasibility. Two coating methods tied for the highest score: the dip with 
chlorhexidine and dip and aerosolized with chlorhexidine. However, because the feasibility score 
is based on qualitative results, the team recommends the dip and aerosolized with chlorhexidine 
coating as the best catheter coating to reduce the risk of CAUTis. 
Catheters coated using this method met all of our design objectives and, in particular, showed 
statistically significant larger bacterial zones of inhibition against three UTI-causing bacterial 
strains. This was the most important objective for the product because significant antimicrobial 
properties will reduce the possibility of CAUTis. It was further determined that this coating 
requires a smaller force to insert through a synthetic urethra analog which means that the coating 
is smoother than uncoated Foley catheters. The coating did not flake off when the catheter was 
bent or bunched at the tip which is critical. Flaking of the coating would cause the catheter to 
lose antimicrobial properties. This coating would require additional work to upscale to mass 
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manufacturing levels when compared to the process of manufacturing uncoated catheters. Based 
on the antimicrobial and mechanical success of this coating the team recommend the dip and 
aerosolized with chlorhexidine coated catheter as the final product. 
9. Recommendations for future work 
Though the design of an antimicrobial Foley catheter was successful , there are many 
recommendations for future work. Testing with biological fluids such as urine is important to 
determine if there is any effect on the coating. It would also be important to compare the 
antimicrobial and mechanical results of the final product with those of silver-coated catheters . A 
cost analysis comparing the two products would also be beneficial to determine if the synthetic 
spider silk coated catheter would be successful in the current market. 
An additional test for surface fouling due to the adsorption of proteins such as fibrinogen should 
also be performed . Fibrinogen is involved in blood coagulation which is a concern during 
catheter use. Additionally , cytotoxicity assays should be completed to determine host cell 
response to the presence of the coated catheters . 
There are several changes that could be made to the coating protocols outlined in this design 
report. Inner surface catheter coatings were examined but were not successful. However , 
industry leaders remain interested in inner coatings of catheters. Therefore , new methods could 
be developed based on the design completed in this project to successfully coat the inside of 
urinary catheters. The effect of nanoparticles on antimicrobial properties when included in the 
synthetic spider silk solutions before coating could be investigated as well. 
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11. Appendices 
a. Additional Protocols 
i. Protocol for Making 6% Synthetic Spider Silk Solution 
Materials 
• Glass scintillation vial 
• Pipette 
• Pipette tips 
• Analytical Balance 
• M4 synthetic spider silk protein 
• M5 synthetic spider silk protein 
• Distilled water 
• Sonicator equipped with a microtip 
• Microwave 
• Fluke 561 IR thermometer gun 
• 1.5 mL microcentrifuge tubes 
• Centrifuge 
Methods 
1. Using an analytical balance weigh 0.144g of M4 synthetic spider silk protein and 0.036g 
of M5 synthetic spider silk protein and put in a glass scintillation vial. 
2. Add 3 mL of distilled water. 
3. Sonicate using the microtip for 2 minutes , pausing every 20 seconds. 
4. Seal the vial and microwave in five second intervals. Take the vial out of the microwave 
in between intervals and gently shake before measuring the vial with the digital 
thermometer gun . Continue this procedure until the temperature of the vial reads 270° C. 
5. Allow the vial to cool and periodically measure the temperature until it reaches 100° C. If 
adding chlorhexidine , pipette 250 µL of 20% chlorhexidine to make a 1.5% solution in 
synthetic spider silk. 
6. Transfer the solution into 1.5 mL microcentrifuge tubes. 
7. Centrifuge at top speed for 15 seconds. The supernatant can be used for any of the 
coating methods. 
ii. Protocol for making solid LB media with 2% agar 
Materials 
• 1000 mL glass bottle 
• Stir plate 
• Autoclave 
• Distilled water 
• Tryptone 
• Yeast extract 
• Bacteriological agar 
• Petri dishes 
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Method: 
1. Add 500 mL of distilled water to the glass bottle, place on a stir plate with a stir bar and 
begin stirring . 
2. Weigh out 1 % tryptone (1 g/100 mL) and 0.5% yeast extract (0.5 g/ 100 mL). Add to 
glass bottle. Mix completely. 
3. Weigh out 2% bacteriological agar (2 g/100 mL) and add to mixture in glass bottle. Mix 
completely. 
4. Cover the opening of the glass bottle with a piece of aluminum foil. Autoclave at 121 ° C 
for 15 minutes on a liquid cycle. 
5. Remove bottle from autoclave to a benchtop and let cool until it reaches 5 3 ° C. 
6. Remove lids from petri dishes and pour enough agar to cover the bottom of the dish. 
Replace lids and allow for agar to solidify. 
iii. Protocol for making liquid LB media 
Materials 
• 1000 mL glass bottle 
• Stir plate 
• Autoclave 
• Distilled water 
• Tryptone 
• Yeast extract 
Method: 
1. Add 500 mL of distilled water to the glass bottle, place on a stir plate with a stir bar and 
begin stirring. 
2. Weigh out 1 % tryptone (1 g/100 mL) and 0.5% yeast extract (0.5 g/100 mL) . Add to 
glass bottle. Mix completely. 
3. Cover the opening of the glass bottle with a piece of aluminum foil. Autoclave at 121 ° C 
for 15 minutes on a liquid cycle. 
4. Remove bottle from autoclave to a benchtop and let cool until it reaches 53 ° C. 
5. Refrigerate until needed . 
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b. Antimicrobial Pictures and Data 
Trial 2/Day 1 - S. aureus 
Trial 2/Day 1 - E. coli 
81 
Trial 2/Day 2 - S. aureus 
Trial 2/Day 2 - E. coli 
Trial 2/Day 2 - S. marcescens 
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Trial 2/Day 3 - E. coli 
Trial 2/Day 3 - S. marcescens 
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Trial 2/Day 4 - E. coli 
Trial 2/Day 4 - S. marcescens 
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Trial 2/Day 5 - S. aureus 
Trial 2/Day 5 - E. coli 
Trial 2/Day 5 - S. marcescens 
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Trial 2/Day 6 - S. aureus 
Trial 2/Day 6 - E. coli 
Trial 2/Day 6 - S. marcescens 
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Trial 2/Day 7 - E. coli 
Trial 2/Day 7 - S. aureus 
Trial 2/Day 7 - S. marcescens 
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Trial 4/Day 2 - E. coli 
Trial 4/Day 1 - S. aureus 
Trial 4/Day 1 - S. marcescens 
Trial 4/Day 2 - S. aureus 
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Trial 4/Day 3 - E. coli Trial 4/Day 3 - S. marcescens 
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Trial 4/Day 4 - S. marcescens 
Trial 4/Day 4 - S. aureus Trial 4/Day 5 - E. coli 
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Trial 4/Day 6 - E. coli 
Trial 4/Day 5 - S. aureus 
Trial 4/Day 6 - S. aureus 
Trial 4/Day 5 - S. marcescens 
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Table 1: ZOis (mm) for E. coli all days [Trial 2] 
Coattne. Method: Dav 1 Coattne. Method: Dav2 Coadn2 Method: DavJ 
Plate 1 Plate 2 Averaae Plate 1 Plate 2 Averaae Plate 1 Plate 2 Averaae 
l:ncoated 10 10 10 l:ncoated 10 10 10 l:ncoated 10 10 10 
Spider Silk 11 12 11.5 Spider Silk 12 13 12.5 Spider Silk 12 13 12.5 
Spider Silk + Spider Silk + Spider Silk + 
Cblorhexldlne 17 16 16.5 Cblorhexldlne 17 17 17 Cblorhexldlne 18 18 18 
Cblorhexldlne 15 16 15.5 Cblorhexldlne 15 16 15.5 Cblorhexldlne 16 18 17 
Coatln2 Method: Dav4 Coatln2 Method: Dav5 Coatln2 Method: Dav6 Coatln2 Method: Day7 
Plate 1 Plate 2 Avera11e Plate 1 Plate 2 Avera11e Plate 1 Plate 2 Avera11e Plate 1 Plate 2 Avera11e 
L"ncoated 10 10 10 L"ncoated 10 10 10 L"ncoated 10 10 10 L"ncoated 10 10 10 
Spider Silk 12 13.5 12.75 Spider Silk 12 13.5 12.75 Spider Silk 12 13.5 12.75 Spider Silk 12 13.5 12.75 
Spider Silk + Spider Silk+ Spider Silk + Spider Silk + 
Chlorhexidine 18 18 18 Chlorhexidine 18 18 18 Chlorhexidine 18 18 18 Chlorhexidine 18 18 18 
Chlorhexidine 17 18 17.5 Chlorhexidine 17 19 18 Chlorhexidine 17 19 18 Chlorhexidine 17 18 17.5 
Table 2: ZOis (mm) for S. aureus all days [Trial 2] 
Coadn Method: Da 1 Coattn Method: Da 2 Coadn Method: Da J 
Plate 1 Plate 2 Averaae Plate 1 Plate 2 Averaae Plate 1 Plate 2 Avgeraae 
l:ncoated 10 10 10 l"ncoated 10 10 10 l:ncoated 10 10 10 
Spider Silk 11 12 11.5 Spider Silk I I 12 11.5 Spider Silk 11 12 .. 5 11.75 
Spider Silk + Spider Silk + Spider Silk + 
Cblorhexldlne 18 19 18.5 Cblorhexldlne 19 20 19.5 Cblorhexldlne 19 20 19.5 
Cblorhexldlne 16 23 19.5 Cblorhexldlne 17 24 20.5 Cblorhexldlne 17 26 21.5 
I coating Method: Dai:4 Coating Method: Dai:5 Coating Method: Dai:6 Coating Method: oai:1 
Plate I Plate 2 Anra11e Plate I Plate 2 Avera11e Plate I Plate 2 A\•era11e Plate I Plate 2 Avera11e 
L"ncoated 10 10 10 L"ncoated 10 10 10 L"ncoated 10 10 10 L"ncoated 10 10 10 
Spider Silk II 13 12 Spider Silk II 13 12 Spider Silk II 13 12 Spider Silk II 13 12 
Spider Silk + Spider Silk+ Spider Silk + Spider Silk + 
Chlorhexidine 19 20 19.5 Chlorhexidine 19 2 1 20 Chlorhexidine 19 2 1 20 Chlorhexidine 19 21 20 
Chlorhexidine 17 26 21.5 Chlorhexidine 17 26 21.5 Chlorhexidine 17 26 21.5 Chlorhexidine 17 26 21.5 
Table 3: ZOis (mm) for S. marcescens all days [Trial 2] 
Coattna Method: Dav 1 Coadn2 Method: Dav2 Coadn2 Method: DavJ 
Plate 1 Plate 2 A,0era1e Plate 1 Plate 2 A,•eraae Plate 1 Plate 2 Averaae 
l:ncoated 10 10 10 l"ncoated 10 10 10 l:ncoated 10 10 10 
Spider Silk 12 14 13 Spider Silk 12 14 13 Spider Silk 14 14 14 
Spider Silk + Spider Silk + Spider Silk + 
Cblorhexldlne 22 32 27 Cblorhexldlne 22 33 27.5 Cblorhexldlne 23 33 28 
Cblorhexldlne 25 34 29.5 Cblorhexldlne 25 35 30 Cblorhexldlne 26 36 31 
Coadn2 Method: Day4 Coadnl! Method: Dav5 Coatln11 Method: Dav6 Coadn11 Method: Dav7 
Plate 1 Plate 2 Avera11e Plate I Plate 2 Avera11e Plate I Plate 2 Aver■ 11e Plate 1 Plate 2 Avera11e 
L"ncoated 10 10 10 L"ncoated 10 10 10 L"ncoated 10 10 10 L"ncoated 10 10 10 
Spider Silk 14 15 14.5 Spider Silk 14 15 14.5 Spider Sllk 14 15 14.5 Spider Silk 14 15 14.5 
Spider Silk + Spider Silk + Spider Silk + Spider Sllk + 
Chlorhexidine 23 33 28 Chlorhexidine 23 34 28.5 Chlorhexidine 23 34 28.5 Chlorhexidine 23 34 28.5 
Chlorhexidine 26 36 31 Chlorhex.ldine 26 36 31 Chlorhexidine 26 36 31 Chlorhexidine 26 38 32 
104 
Table 4: ZOis (mm) for E. coli all days [Trial 3] 
Coatln Method: Da 1 Coatln Method: Da 2 
Plate 2 Plate 3 Plate 4 Plate !5 Plate 6 Plate 7 Average Plate 2 Plate 3 Plate 4 Plate !5 Plate 6 Plate 7 Average 
6% DlpSS 8 8 8 6% DlpSS 8 8 8 
6% DlpSS+ 6% Dip SS+ 
Chlor. 12 14 13 Chlor. 13 14 13.5 
6% Spray + Dip 6% Spray + Dip 
ss 8 8 8 ss 8 8 8 
6% Spray + Dip 6% Spray + Dip 
SS+Chlor. 12 12 12 SS +Chlor. 12 14 13 
3% Aerosollud 3% Aerosollud 
ss 8 8 8 ss 8 8 8 
3 % Aerosollud 3 % Aerosollud 
SS +Chlor. 8 8 8 SS +Chlor. 8 8 8 
6%SpnySS 8 8 8 6%SpraySS 9 8 8.5 
6% SpraySS+ 6%SpraySS+ 
Chlor. 9 9 9 Chlor. 9 9 9 
6% Aerosollud 6% Aerosollud 
ss 8 8 8 ss 8 8 8 
6% Aerosollud 6% Aerosollud 
SS+Chlor. 11 8 9 .5 SS +Chlor. 12 8 10 
l:nc:oated 8 8 8 l:ncoated 8 8 8 
Coatln2 Method: DavJ Coatln2 Method: Dav4 
Plate 2 Plate 3 Plate 4 Plate !5 Plate 6 Plate 7 Average Plate 2 Plate 3 Plate 4 Plate !5 Plate 6 Plate 7 Average 
6% Dip SS 8 8 8 6% Dip SS 8 8 8 
6°1. Dlp SS+ 6% DlpSS+ 
Chlor. 13 14 13.5 Chlor. 13 14 13.5 
6%Spray+Dlp 6% Spray+Dlp 
ss 8 8 8 ss 8 8 8 
6%Spray+Dfp 6% Spray+Dip 
SS +Chlor. 12 14 13 SS +Chlor. 12 14 13 
3% Aerosollud 3% Aerosollud 
ss 8 8 8 ss 8 8 8 
3% Aerosollud 3 % Aerosollud 
SS +Chlor. 8 8 8 SS +Chlor. 8 8 8 
6%SpraySS 9 8 8.5 6%SpraySS 9 8 8.5 
6%SpraySS+ 6%SpraySS+ 
Chlor. 9 9 9 Chlor. 9 9 9 
6% AerosoHud 6% Aerosollud 
ss 8 8 8 ss 8 8 8 
6% AerosoHud 6% Aerosollud 
SS +Chlor . 12 8 10 SS +Chlor. 12 8 10 
l:nc:oattd 8 8 8 l:nc:oated 8 8 8 
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Table 4: ZOis (mm) for E. coli all days [Trial 3] 
Coatln Method: Da 5 Coatln Method: Da 6 
Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 A,•era11e Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Avera11e 
6% Olp SS 8 8 8 6% DlpSS 8 8 8 
6% DlpSS+ 6% Olp SS+ 
Chlor. 13 14 13.5 Chlor. 13 14 13.5 
6% Spny + Dip 6%Spny+Dlp 
ss 8 8 8 ss 8 8 8 
6% Spray + Dip 6% Spray + Dip 
SS+Cblor. 12 14 13 SS +Chlor. 12 14 13 
3% Aero10llzed J % Aero10llzed 
ss 8 8 8 ss 
I 3% Aero10llzed 3% Aerosolized 
SS +Cblor. 8 8 8 SS +Chlor. 
8 8 8 
8 8 8 
6% Spray SS 9 8 8.5 6% Spray SS 9 8 8.5 
6% SpraySS+ 6% SpraySS+ 
Chlor. 9 9 9 Chlor. 9 9 9 
6% Aerosolized 6% Aerosolized 
ss 8 8 8 ss 8 8 8 
6% Aerosolized 6% Aero10llzed 
SS+Chlor. 12 8 10 SS +Chlor. 12 8 10 
C.:ncoated 8 8 8 l"ncoated 8 8 8 
ICoadng Metbod: Dal: 7 
Plate 2 Plate J Plate 4 Plate 5 Plate 6 Plate 7 Avera~e 
6% Olp SS 8 8 8 
6% Olp SS+ 
Chlor. 13 14 13 .5 
16% Spra)' + Dip 
8 8 8 ss 
16% Spra)' + Dip 
SS+Chlor. 12 14 13 
3 % Aerosolized 
ss 8 8 8 
3 % Aerosolized 
SS+Chlor. 8 8 8 
6% Spra)'SS 9 8 8.5 
6% SpraySS+ 
Chlor. 9 9 9 
6% Aerosolized 
ss 8 ll ll 
6% Aerosolized 
SS+Chlor. 12 ll 10 
t:ncoated ll ll ll 
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Table 5: ZOis mm for S. aureus all da s Trial 3 
Coadn Method: Da I Coadn Method: Da 2 
Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Avera11e Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Avera11e 
6% DlpSS II II II 6% Dip SS II II II 
6% DlpSS+ 6% DlpSS+ 
Cblor. 15 14 14.5 Cblor. 15 14 14.5 
6% Spray + Dip 6% Spray + Dip 
ss II II II ss II II II 
6% Spray + Dip 6% Spray + Dip 
SS +Cblor. 13 14 13.5 SS +Cblor. 13 14 13.5 
3 % Aerosolized 3 % Aerosolized 
ss II II II ss II II II 
3 % Aerosolized 3 % Aerowllzed 
SS+Cblor. II II II SS +Cblor. II II II 
6% SpraySS II 9 11.5 6% Spray SS II 10 9 
6% SpraySS+ 6% Spray SS+ 
Cblor. 9 11 10 Cblor. 9 11 10 
6% Aerosolized 6% Aerosolized 
ss II 9 11.5 ss II 9 11.5 
6% AeroiOJlzed 6% AeroiOllzed 
SS +Cblor. II II II SS +Cblor. II II II 
l"nc:oated II II II l"nc:oated II II II 
Coadn Method: Da 3 Coadn Method: Da 4 
Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Avera11e Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Avera11e 
6% DlpSS II II II 6% DlpSS II 8 II 
6% DlpSS+ 6% DlpSS+ 
Cblor. 15 14 14.5 Cblor. 15 14 14.5 
6% Spray + Dip 6% Spray + Dip 
ss II II II ss II II II 
6% Spray + Dip 6% Spray + Dip 
SS+Cblor. 13 15 14 SS +Cblor. 13 15 14 
3 % AeroiOllzed 3% AeroM1llzed 
ss II II II ss II II 8 
3 % Aerosolized 3% AeroM1Jlzed 
SS +Cblor. II II II SS +Cblor. II II 8 
6% SpraySS II 10 9 6% Spray SS II 10 9 
6%SpraySS+ 6%SpraySS+ 
Cblor. 9 12 10.5 Cblor. 9 12 10.5 
6% Aerosolized 6% Aerosolized 
ss II 9 11.5 ss II 9 11.5 
6% AeroiOllzed 6% Aerosolized 
SS +Cblor. II II II SS +Cblor. II 8 II 
l"nc:oated II II II l"nc:oated II II II 
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Table 5: ZOis (mm) for S. aureus all days [Trial 3] 
Coadn Metbod: Da 5 Coadn Metbod: Da 6 
Plate 2 Plate 3 Plate 4 Plate S Plate 6 Plate 7 Avera11e Plate 2 Plate 3 Plate 4 Plate S Plate 6 Plate 7 Avera11e 
6% DtpSS 8 8 8 6% Olp SS 8 8 8 
6% Dtp SS+ 6% Dtp SS+ 
Chlor. 15 14 14 .5 Chlo:r. 15 14 14 .5 
6% Spray -t Dip 6% Spray + Dip 
I ss 8 8 8 ss 8 8 8 6% Spray -t Dip 6% Spray -t Dip 
SS +Chlor. 13 15 14 SS+Chlor. 14 15 14.5 
J¾ AeroM>llzed J¾ AeroM>llzed 
I ss 8 8 8 ss 8 8 8 J % AeroM>llzed J % Aero10llzed 
SS+Chlor. 8 8 8 SS+Chlor. 8 8 8 
6% SpraySS 8 10 9 6%SpraySS 8 10 9 
6% SpraySS+ 6%SpraySS+ 
Chlor. 9 12 10.5 Chlor. 9 12 10.5 
6% Aero10llzed 6% AerolOllzed 
I ss 8 9 8.5 ss 8 9 8.5 
6% Aero10llzed 6% Aero10llzed 
I SS+Chlor. 8 8 8 SS+Chlor. 8 8 8 
C.:ncoated 8 8 8 C.:ncoated 8 8 8 
!Coating Method: Dal: 7 
Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 A,•erage 
6% Dip ss !I !I !I 
6% Dlp SS+ 
Cblor. 15 14 14 .5 
6% Spray + Dip 
ss !I !I !I 
6% Spray + Dip 
SS+Cblor. 14 15 14 .5 
J % Aerosolized 
ss !I !I !I 
J % Aerosolized 
SS+Cblor. !I !I !I 
6% SpraySS !I 10 9 
6% SpraySS+ 
Cblor. 9 12 10 .5 
6% Aerosolized 
ss !I 9 S.5 
6% Aerosolized 
SS +Cblor. !I !I !I 
l'ncoated !I !I !I 
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Table 6: ZOis (mm) for S. marcescens all days [Trial 3] 
Coadn Metllod: Da 1 Coadn Method: Da 2 
Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Avera11e Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Avera11e 
6% DlpSS 8 8 8 6% DlpSS 8 8 8 
6% Olp SS+ 6% Dip SS+ 
Chlor. 11 10 10.5 Chlor. 11 11 I I 
6% Spray + Dip 6% Spray + Dip 
ss 8 8 8 ss 8 8 8 
6% Spray + Dip 6% Spray + Dip 
SS +Chlor. 11 13 12 SS +Chlor . 12 14 13 
3% Aerosoll:r.ed 3 % Aerosolized 
ss 8 8 8 ss 8 8 II 
3 % Aerosoll:r.ed 3 % Aerosolized 
SS+Chlor. II II II SS +Chlor . II II II 
6%SpnySS II II II 6%SpnySS 8 II II 
6%SpnySS+ 6% SpnySS+ 
Chlor. II II II Chlor. 8 II II 
6% Aerosolized 6% Aerosolized 
ss II II II ss II II II 
6% Aerosolized 6% Aerosoll:r.ed 
SS +Chlor. II II II SS +Chlor. II II II 
l:nc:oated II II II l:nc:oated II II II I 
Coadn2 Method: DayJ Coadn2 Method: Dav4 
Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Avera11e Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 PJate 7 Avera11e 
6% DlpSS II II II 6% DlpSS II II II 
6% DlpSS+ 6% DlpSS+ 
Chlor. I I 11 I I Chlor. I I I I 11 
6% Spny+Dfp 6% Spny + Dfp 
ss 8 II II ss II 8 II 
6%Spny + Dfp 6% Spny+Dfp 
SS+Chlor. 12 14 13 SS +Chlor . 12 14 13 
3 % Aerosoll:r.ed 3 % Aerosolized 
ss 8 II II ss II II II 
3 % Aerosoll:r.ed 3% Aerosolized 
SS +Chlor . II II II SS +Chlor. II II II 
6%SpnySS II II II 6%SpnySS II II II 
6%SpnySS+ 6%SpnySS+ 
Chlor. II II II Chlor. II II II 
6% Aerosolized 6% Aerosolized 
ss II II II ss II II II 
6% Aerosolized 6% Aerosolized 
SS +Chlor. II II II SS +Chlor. II II II 
l:nc:oated II II II l:nc:oated II II II 
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Table 6: ZOis (mm) for S. marcesc ens all days [Trial 3] 
Coadnl!. Method: Day5 Coadne. Method: Dav6 
Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Averaiie Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Averaiie 
6% DlpSS 11 11 11 6% DlpSS 11 11 11 
6% Dip SS+ 6% Dip SS+ 
Chlor. I I I I I I Chlor. II I I I I 
6% Spray + Dip 6% Spray + Dip 
ss 11 11 11 ss 11 11 8 
6% Spra) ' + Dip 6% Spray + Dip 
SS +Chlor . 12 14 13 SS +Chlor. 12 14 13 
3 % Aerosolized 3 % Aerosolized 
ss 8 8 8 ss 8 8 8 
3 % Aerosolized 3% Aerosolized 
SS +Chlor. 11 11 11 SS +Chlor. 8 8 8 
6% Spray SS 8 8 8 6% SpraySS 8 8 8 
6% SpraySS+ 6% Spray SS+ 
Chlor. 11 8 11 Chlor. 8 8 8 
6% Aerosolized 6% Aerosolized 
ss 11 8 11 ss 8 8 8 
6% Aerosolized 6% Aerosolized 
I 
SS +Chlor . 11 8 11 SS+Chlor. 8 8 8 
C:ncoated 8 11 11 C:ncoated 11 8 8 
Coadne. Method: Dav7 
Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 A,•eraiie 
6% Dip SS 8 8 8 
6% DlpSS+ 
Chlor. 11 11 11 
6% Spray + D1p 
ss 8 8 8 
6% Spray + D1p 
SS +Chlor . 12 14 13 
3 % Aerosolized 
ss II II II 
3 9/a Aerosolized 
SS +Chlor. II II II 
6% SpraySS II II II 
6% Spray SS+ 
Chlor. II 8 II 
6% Aerosolized 
ss 8 II II 
6% Aerosolized 
SS+Chlor . 8 II II 
l"nc:oated 8 II II 
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Table 7: ZOis (mm) for E. coli all days [Trial 4] 
Coattn Method: Da I Coattn Method: Da 2 
Plate 2 Plate 3 Plate 4 Avera1e Plate 2 Plate 3 Plate 4 
TblckSpny 
Tlllck Spray + 
Chis 
Dip + Aerosolized 
Dip + Aerosolized 
+Chill 
Aerosolized + 
Chis I 
Aerosolized + 
Chls2 
Spny + Dip+ 
Chb 
Coadn1. Method: 
ThlckSpny 
ThlckSpny+ 
Chis 
Dip + Aero1ollzed 
Dip + Aero1ollzed 
+Cblll 
Aerosolized + 
Chill I 
Aerosolized + 
Chlll2 
Spny+Dlp+ 
Chill 
8 
9 
13 
Coadn Method: 
TblckSpny 
TblckSpny+ 
Chl:I 
Dip + Aerosolized 
Dip + Aerosolized 
+Cbl:I: 
Aerosolized + 
Chis 1 
Aerosolized + 
Chls2 
Spny+ Dip+ 
Chis 
8 8 Thick Spny 9 
TblckSpny+ 
8 8.5 Chlx 9 
II 9.5 Dip + Aerosolized 8 
Dip + Aerosolized 
13 13 +Cbls 13 
Aerosolized + 
8 8 Chis I 
Aerosolized + 
8 8 Chlx 2 
Spny+ Dip+ 
8 8 Chis 
Dav4 Coadnl! Method: 
Plate 2 Plate 3 Plate 4 Avera1e 
9 8 8 ThlckSpny 
ThlckSpny+ 
9 8 8.5 Chill 
8 II 9.5 Dip + Aero1ollzed 
Dip + Aero1ollzed 
13 13 13 +Cblll 
Aerosolized + 
8 8 Chill I 
Aerosolized + 
8 8 Chlll2 
Spray+ Dip+ 
8 8 Chill 
Da 7 
Plate 2 Plate 3 Plate 4 Averai=e 
9 
9 
8 
13 
8 
8 
11 
13 
8 
8 
8 
8 
8.5 
9.5 
13 
8 
I! 
8 
8 
8 
11 
13 
8 
8 
Dav! 
Plate 2 Plate 3 Plate 4 
9 8 
9 8 
8 II 
13 13 
8 
8 
8 
Coadn Method: Da 3 
Averqe Plate 2 Plate 3 Plate 4 Avera1e 
8.5 TllkkSpny 9 8 8 
Thick Spny + 
8.5 Chis 9 8.5 
9.5 Dip + Aerosolized II 9.5 
Dip + Aerosolized 
13 +Cbls 13 13 13 
Aerosolized + 
8 Chis I 8 8 
Aerosolized + 
8 Chls2 
Spny+Dlp+ 
8 Chis 
Coadno Method: Dav6 
Avera1e Plate 2 Plate 3 Plate 4 Avera1e 
8 ThlckSpny 9 8 8 
Thick Spray + 
8.5 Chill 9 8 8.5 
9 .5 Dip + Aerosolized 8 11 9.5 
Dip + Aero1ollzed 
13 +Cblll 13 13 13 
Aerosolized + 
8 Chill I 8 8 
Aerosolized + 
8 Chlll2 8 8 
Spray+ Dip+ 
8 Chill 8 8 
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Table 8: ZOis (mm) for S. aureus all days [Trial 4] 
Coadn Method: Da 1 Coadn Method: Da 2 Coadn Method: Da 3 
Plate 2 Plate 3 Averai:e Plate 2 Plate 3 Averai:e Plate 2 Plate 3 Averai:e 
Thick Spra) ' 9 8 8.5 Thick Spray 9 8 8.5 Thick Spray 9 8 8.5 
Thick Spray + Thick Spray + Tblck Spray + 
Chl1 9 8 8.5 Chl1 9 8 8.5 Chl1 9 8 8.5 
Dlp + ~eb 8 8 8 Dlp + ~eb 8 8 8 Dlp + ~eb 8 8 8 
Dlp + ~eb+ 
Dl + ~eb + Chl1 15 12 13.5 Dl +~eb+Chl1 15 13 14 Chl1 15 13 14 
Coadnl! Method: Dav4 Coadn11 Method: Day5 Coadna Method: Davfi 
I Plate 2 Plate J A,•erai:e Plate 2 Plate J Averai:e Plate 2 Plate J Averai:e 
Thick Spray 9 8 8.5 Thick Spray 9 8 8.5 Thick Spray • 8 8 
Thick Spray + Thick Spray + Thick Spray + 
I Chll 9 8 8.5 Chll 9 8 8.5 Chll 9 8 8.5 
Dlp + ~eb 8 8 8 Dip+ ~eb 8 8 8 Dlp + :'.'lleb 8 8 8 
DID + :'.'lleb + Chl:1 15 13 14 DID + :'.'lleb + Chll 15 13 14 Dip + :'.'lleb + Chll 15 13 14 
Coadn11 Method: Da}' 7 
Plate 2 Plate J A\·erai:e 
Thick Spray • 8 8 
Thick Spray + 
I Chll 9 8 8.5 
Dip+ :'.'lleb 8 8 8 
Imp+ :'.'lleb + Chll 15 13 14 
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Table 9: ZOis (mm) for S. marcescens all days [Trial 4] 
Coalln1 Metllod: 
TlllckSpny 
Thick Spray+ 
Chb: 
Dip + Ae1"090llzed 
Dip + Ae1"090llzed 
+Chb: 
Aerosollud 
Spray+ Dip+ 
Chli: 
Coadn Method: 
Plate 2 Plate 3 
8 8 
8 8 
8 8 
13 13 
Day 1 
Plate 4 
8 
8 
D■ 4 
Coating Metllod: 
Avera11e Plate 2 Plate 3 
8 Thick Spray 8 8 
TlllckSpny + 
8 Chli: 
8 Dip + Aerosolized 
Dip + Aero1ollzed 
13 +Chb: 13 13 
8 Aerosollud 
Spny+Dfp+ 
8 Chb: 
Coatln Method: 
Day2 
Plate 4 
8 
8 
Da !! 
Plate 2 Plate 3 Plate 4 Avera1:e Plate 2 Plate 3 Plate 4 
Thick Spray 
Thick Spray+ 
Chli: 
Dip + Ael"Ololized 
Dip + Aero■olized 
+Chh: 
Aeroaollted 
Spray+Dlp+ 
Chli: 
Coadn Method: 
8 
8 
8 
13 
8 8 
8 8 
8 8 
13 13 
8 8 
8 8 
Da 7 
PJate 2 PJate 3 PJate 4 Averai:e 
TblckSpny 
Thick Spn1y -t 
8 8 8 
Chis 8 
Dip -t Aerosollzed 8 
Dip -t Aerosollzed 
+Cblx 13 
AerosolizM 
Spn1y -t Dip + 
Chill 
8 
8 
13 
8 
8 
8 
8 
13 
8 
8 
Thick Spray 8 8 
Thick Spray+ 
Chli: 8 8 
Dip + Aerosolized 8 8 
Dip + Aerosolized 
+Chllt 13 13 
Aerosollted 8 
Spray +Dip+ 
Chli: 8 
Coadn& Method: 
Averqe Plate 2 
8 TblckSpny 8 
TblckSpny + 
8 Chli: 8 
8 Dip + Aero1ollzed 8 
Dip + Aero1ollzed 
13 +Cbli: 13 
8 Aerosollud 
Spny+Dip+ 
8 Chli: 
Coadn Method: 
Avera1:e 
8 Thick Spray 
Thick Spray + 
8 Chli: 
8 Dip + Aerosolized 
Dip + Ael"Ololized 
13 +Chll[ 
8 Aerosolized 
Spray+ Dip+ 
8 Chli: 
Day3 
Plate 3 
8 
8 
8 
13 
Plate 4 Avera1 
8 
8 
8 
13 
8 
Da 6 
Plate 2 Plate 3 Plate 4 Avera1:, 
8 8 8 
8 8 8 
8 8 8 
13 13 13 
8 8 
8 8 
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Table 10: ZOis (mm) for E. coli all days [Trial 5] 
Da I 
Aerosolized S.S. + Spny + Dip S.S. Dip + Aerosolized Dip + Aerosolized 
Coadng Method: Dip S.S. Dip S.S. + Cblll Spny S.S. Spny S.S. + Cblll Aerotallzed S.S. Chill Spny + Dip S.S. +Cblx S.S. S.S. +Chlx 
Dllk I 8 12 8 8 8 8 8 14 8 13 
Dllk 2 8 13 8 8 8 8 8 13 8 13 
Dllk 3 8 12 8 8 8 8 8 14 8 14 
Dllk4 8 12 8 8 8 8 8 14 8 I I 
Average: 8 12 .25 8 8 8 8 8 13.75 8 12.75 
Da•l 
Aerosolized S.S. + Spny + Dip S.S. Dip + Ael"Olollzed Dip + Aerosolized 
Coadng Method: Dip S.S. Dip S.S. + Cblll Spny S.S. Spny S.S. + Cblll Aerosolized S.S. Chill Spn) ' + Dip S.S. + Cblll S.S. S.S. + Chill 
Dllk I 8 12 8 8 8 
Dllk 2 8 13 8 8 8 
Dllk 3 8 12 8 8 8 
Dllk 4 8 12 8 8 8 
Average: 12.25 
Coadng Method: Dip S.S. Dip S.S.+ Cblll Spny S.S. Spny S.S.+ Cbl:t Aerosolized S.S. 
Dllk I 8 12 8 8 8 
Dllk 2 12 8 8 8 
Dllk 3 
Dllk4 
A\•erai:e: 
12 
II 
11.75 
Coadng Method: Dip S.S. Dip S.S. + Cblll Spny S.S. Spny S.S. + Cblll Aerotallzed S.S. 
Dllk l 8 12 8 8 8 
Dllk 2 8 12 8 8 8 
Dllk 3 8 12 8 8 8 
Dllk4 
Average: 
I I 
11.75 
8 8 14 8 13 
8 
8 
Aerosolized S.S. + 
Chill Spny + Dip S.S. 
8 8 
8 8 
Da 4 
Aerosolized S.S. + 
Chlx Spny + Dip S.S. 
8 8 
8 8 
8 8 
8 8 
8 8 
Da•5 
13 
14 
14 
13.75 
Spray + Dip S.S. 
+Cblll 
14 
13 
14 
14 
13.75 
Spny + Dip S.S. 
+Cblll 
14 
13 
14 
14 
13.75 
Dip + Aerosolized 
S.S. 
8 
8 
8 
8 
8 
Dip + Aerosolized 
S.S. 
8 
8 
8 
8 
8 
13 
14 
I I 
12.75 
Dip + Aerosolized 
S.S.+Chlll 
13 
13 
14 
12 
13 
Dip + Aerosolized 
S.S. +Chill 
13 
13 
14 
12 
13 
Aerosolized S.S. + Spray + Dip S.S. Dip + Aerosolized Dip + Aerosolized 
Coadng Method: Dip S.S. Dip S.S.+ Cblll Spray S.S. Spray S.S. + Cblll Aero1ollzed S.S. Chlx Spra)' + Dip S.S. + Cblll S.S. S.S. +Chill 
Dllk I 8 12 8 8 8 8 8 14 
Dllk 2 8 12 8 8 8 8 8 13 
Dlsk3 8 12 8 8 8 8 8 14 
Dllk4 8 II 8 8 8 8 8 14 
A\•erage: 8 11.75 8 8 8 8 8 13.75 
Da 6 
Aerosolized S.S. + 
Coadng Method: Dip S.S. Dip S.S. + Cblll Spray S.S. Spray S.S. + Cblll Aerosolized S.S. Chill Spray + Dip S.S. 
Spra) ' + Dip S.S. 
+Cblll 
Disk l 8 12 8 8 8 8 8 14 
Disk 2 8 13 9 8 8 8 8 13 
Dlsk3 8 12 8 8 8 8 8 14 
Dlsk4 8 12 8 8 8 8 8 14 
A\•erage: 8 12 .25 8.25 8 8 8 8 13.75 
Da 7 
8 13 
8 13 
8 14 
8 12 
8 13 
Dip + Ael"OIOllzed Dip + Aerosolized 
S.S. S.S. +Chlx 
8 13 
8 13 
8 14 
8 12 
8 13 
Aero101ized S.S. + Spny + Dip S.S. Dip + Aerosolized Dip + Aerosolized 
Coadng Method: Dip S.S. Dip S.S. + Cblll Spray S.S. Spray S.S. + Cblll Aero101ized S.S. Chill Spray + Dip S.S. +Cblll S.S. S.S.+Chlll 
Disk l 8 12 8 8 8 8 8 14 8 13 
Disk 2 8 13 8 8 8 8 8 12 8 13 
Disk 3 8 12 8 8 8 8 8 13 8 14 
Dlsk4 8 12 8 8 8 8 8 14 8 12 
Average: 8 12 .25 8 8 8 8 8 13.25 8 13 
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Table 11: ZOis (mm) for S. aureus all days [Trial 5] 
DI 1 
Aerosolized S.S. + Spny + Dip S.S. 
Co1dn1J Method : Dip S.S. Dip S.S.+ Chill Spny S.S. Spny S.S. + Chill Aerosolized S.S. Chill Spny + Dip S.S. + Chill 
Dllk 1 8 14 9 8 9 8 8 II 
Dllk 2 
Dllk 3 
Dllk4 
Avenge: 
13 
12 
12 
12.75 
8 
I I 
9 
9.l!i 
8 
8 
8 
8 
8 
8 
8 
8.25 
D1 2 
8 
9 
8 
8.25 
Aerosolized S.S. + 
Co1dng Method: Dip S.S. Dip S.S. + Chill Spny S.S. Spny S.S. + Chill Aerosolized S.S. Chb Spny + Dip S.S. 
Dllk 1 8 14 9 8 9 8 8 
Dllk 2 8 13 8 8 8 8 8 
Dllk 3 8 12 II 8 8 9 8 
Dllk 4 8 12 9 8 8 8 8 
Avenge: 8 12.75 9.25 8 8.25 8.25 
D1 3 
Aerosolized S.S. + 
Co1dng Method: Dip S.S. Dip S.S.+ Chill Spny S.S. Spny S.S.+ Chill Aerosolized S.S. Chill 
8 Dllk 1 8 14 9 8 9 
Disk 2 8 13 8 8 
Dllk 3 
Dllk4 
Average: 
12 
12 
12.75 
II 
8 
9 
8 
8.25 
8 
9 
8 
8.25 
DI 4 
Spny + Dip S.S. 
8 
8 
8 
8 
8 
13 
12 
12 
12 
Spny + Dip S.S. 
+Chill 
12 
15 
13 
13 
13.25 
Spny + Dip S.S. 
+Chill 
13 
15 
13 
13 
13.5 
Aerosolized S.S. + Spny + Dip S.S. 
Coadng Method: Dip S.S. Dip S.S. + Chill Spny S.S. Spny S.S. + Chill Aerosolized S.S. Chill Spny + Dip S.S. + Chill 
Dllk 1 8 14 9 8 9 8 8 13 
Dllk 2 8 13 8 8 8 8 8 15 
Dllk 3 8 12 II 8 8 
Dllk4 
Avenge: 
8 
8 
12 
12.75 
8 
9 
8 
8 
8 
8.25 
D1 5 
9 
8 
8.25 
Aerosolized S.S. + 
Co1dng Method: Dip S.S. Dip S.S.+ Chill Spny S.S. Spny S.S. + Chill Aerosolized S.S. Chill Spny + Dip S.S. 
Dllk 1 8 14 9 8 9 8 8 
Dllk 2 8 14 8 8 8 8 8 
Disk 3 8 12 11 8 8 9 8 
Dllk4 
Avenge: 
8 
8 
12 
13 
8 
9 
8 
8 
8 
8.25 
DI 6 
8 
8.25 
13 
13 
13.5 
Spny + Dip S.S. 
+Chill 
13 
15 
13 
13 
13.5 
Dip + Aerosolized Dip + Aerosolized 
S.S. S.S.+Chb 
8 13 
8 13 
8 16 
8 13 
8 13.75 
Dip + Aerosolized Dip + Aerosolized 
S.S. S.S.+Chlll 
8 14 
8 13.5 
8 16 
8 13 
8 14.125 
Dip + Aerosolized Dip + Aerosolized 
S.S. S.S.+Chb 
8 14 
8 14 
8 16 
8 13 
8 14.25 
Dip + Aerosolized Dip + Aerosolized 
S.S. S.S.+Chlll 
8 14 
8 14 
8 16 
8 13 
8 14.25 
Dip + Aerosolized Dip + Aerosolized 
S.S. S.S. +Chill 
8 14 
8 14 
8 16 
8 13 
8 14.25 
Aerosolized S.S. + Spny + Dip S.S. Dip + Aerosolized Dip + Aerosolize 
Co1dng Method: Dip S.S. Dip S.S. + Chill Spny S.S. Spny S.S. + Chill Aerosolized S.S. Chb Spny + Dip S.S. + Chill S.S. S.S.+Chlll 
Dllk 1 8 14 9 8 9 8 8 13 8 14 
Dllk2 8 14 8 8 8 8 8 16 8 14 
DlskJ 8.5 12 I I 8 8 9 8 13 8 16 
Dllk4 8 12 8 8 8 8 8 13 8 13 
Avera1e: 8.125 13 9 8 8.25 8.25 8 13.75 8 14.25 
D1 7 
Aerosolized S.S. + Spny + Dip S.S. Dip + Aerosolized Dip + Aero1olize1 
Co1dng Method : Dip S.S. Dip S.S . + Chli: Spny S.S. Spny S.S.+ Chill Aerosolized S.S. Chill Spny + Dip S.S. +Chill S.S. S.S. +Chill 
Dllk 1 8 14 9 8 9 8 8 13 8 14 
Dlsk2 8 14 8 8 8 8 8 16 8 14 
DlskJ 9 13 I I 8 8 9 8 13 8 16 
Dllk4 8 12 8 8 8 8 8 13 8 13 
Aver11e: 8.l!i 13.l!i 9 8 8.25 8.25 8 13.75 8 14.25 
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Table 12: ZOis (mm) for S. marcescens all days [Trial 5] 
Da I 
Aerosolized S.S. + Spray + Dip S.S. Dip + Aerosolized Dip + Aerosolized 
Coadnc Method: Dip S.S. Dip S.S. + Cblll Spny S.S. Spny S.S. + Cbh Aerosolized S.S. Chb Spny -t Dip S.S. +Cbh S.S. S.S. +Chill 
Dllkl 8 9 8 8 8 8 14 8 10 
Dllk 2 8 10 8 8 8 8 14 I I 
Dllk 3 8 10 8 8 9 8 8 10 8 10 
Dllk4 8 10 8 8 8 8 13 8 10 
Avera1ie: 8 9.75 8 8 8.25 12.75 8 10.25 
Da 2 
Aerosolized S.S. + Spny -t Dip S.S. Dip + Aerosolized Dip T Aerosolized 
Coadnc Method: Dip S.S. Dip S.S. + Cbh Spny S.S. Spny S.S. + Cblll Aerosolized S.S. 
Dllk I 8 10 8 8 8 
Dllk 2 8 I I 8 8 8 
Dllk 3 8 10 8 8 9 
Dllk 4 8 10 8 8 8 
Average: 8 10.25 8 8 8.25 
Da 3 
Chill 
8 
8 
8 
8 
8 
Spny -t Dip S.S. 
8 
8 
8 
8 
8 
Aerosolized S.S. + 
Coadng Method: Dip S.S. Dip S.S.+ Cblll Spny S.S. Spny S.S.+ Cbh Aerosolized S.S. Chb Spny -t Dip S.S. 
Dllk l 8 10 8 8 8 8 8 
Dllk 2 8 II 8 8 8 8 8 
Dilkl 
Dllk4 
Average: 
8 
8 
8 
10 
10 
10.25 
8 
8 
8 
9 
8 
8.25 
Da 4 
Aerosolized S.S. + 
Coadnc Method: Dip S.S . Dip S.S. + Cblll Spny S.S. Spny S.S.+ Cblll Aerosolized S.S . Chill 
Dllk I 8 10 8 8 8 
Dllk2 8 I I 8 8 8 
Dllk3 8 10 8 8 9 
Dllk4 8 10 8 8 8 
Average: 8 10.25 8 8 8.25 
Da 5 
8 
8 
8 
8 
8 
8 
Spny + Dip S.S. 
8 
8 
8 
8 
8 
+Cbh 
15 
14 
10 
13 
13 
Spny + Dip S.S. 
+Cblll 
15 
14 
10 
13 
13 
Spny + Dip S.S. 
+Cblll 
15 
14 
10 
13 
13 
S.S. 
8 
8 
8 
8 
Dip + Aerosollzed 
S.S. 
8 
8 
8 
8 
8 
Dip + Aerosolized 
S.S. 
8 
8 
8 
8 
8 
S.S.+Chb 
10 
I I 
10 
10 
10.25 
Dip -t Aerosolized 
S.S.-+-Chlll 
10 
II 
II 
10 
10 .5 
Dip + Aerosolized 
S.S. +Chill 
10 
II 
II 
10 
10.5 
Aerosolized S.S. + Spray -t Dip S.S. Dip + Aerosolized Dip + Aerosolized 
Co■dng Method: Dip S.S. Dip S.S.+ Cb)][ Spray S.S. Spray S.S.+ Chill Aerosolized S.S. 
Dllk I 8 10 8 8 8 
Dilk 2 8 I I 8 8 8 
Dllk 3 8 10 8 8 9 
Dilk 4 8 10 8 8 8 
Average: 8 10 .25 8 8 8.25 
D■ 6 
Chb Spra)' + Dip S.S. + Cblll 
8 8 15 
8 8 14 
8 8 10 
13 
13 
S.S. S.S. +Chill 
8 10 
8 I I 
8 I I 
8 10 
8 10.5 
Aerosolized S.S. + Spray + Dip S.S. Dip + Aerosolized Dlp -t Aerosollzed 
Coadng Method: Dip S.S. Dip S.S.+ Cblll Spray S.S. Spray S.S.+ Cblll Aerosolized S.S. 
Dilk I 8 10 8 8 8 
Dllk 2 8 II 8 8 8 
Dilk 3 8 10 8 8 9 
Dllk4 
Average: 
8 
8 
10 
10.25 
8 
8 
8 
8.25 
Chb Spray -t Dip S.S. 
8 8 
8 8 
8 8 
Da•7 
Coadng Method: Dip S.S. Dip S.S.+ Cbh Spra)' S.S . Spray S.S . + Cblll Aerosolized S.S. 
Dilk I 8 10 8 8 8 
Dllk 2 
Dllk 3 
Dllk4 
A,·erage: 
8 
8 
8 
8 
II 
10 
10 
10.25 
8 
8 
8 
8 
Aerosolized S.S . + 
Chb Spray + Dip S.S. 
8 8 
+ Cblll S.S. S.S. -+-Chill 
15 8 10 
14 
10 
13 
13 
8 
8 
8 
8 
II 
I I 
10 
10 .5 
Spray + Dip S.S. Dip + Aerosollzed Dip + Aerosolized 
+ Cblll S.S. S.S. -+-Chill 
14 8 10 
14 
10 
12 
12.5 
116 
II 
II 
12 
II 
c. Bend and Bunch Test Pictures 
All images for the bend and bunch test are shown below . The order of all images from left to 
right is tip, middle, and base. From top to bottom, images are in order of decreasing diameter (16 
in, 8 in, 4 in). The bottom image is the bunched image. The image collages are in the order of 
spin , spin with chlorhexidine , dip , dip with chlorhexidine , aerosolized , aerosolized with 
chlorhexidine , dip and aerosolized , dip and aerosolized with chlorhexidine , spin and dip , spin 
and dip with chlorhexidine . The scale bar in the first image applies to all images. 
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119 
120 
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124 
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d. Instron Friction Data 
Data for the friction test was taken at 120 Hz. As such, only a small sample of each trial is shown 
below. 
Uncoated 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
3.8939 3.7468 3.7541 3.7434 3.7179 3.7189 3.3762 3.3551 3.3835 
3.9112 3.7580 3.7838 3.7573 3.7246 3.7217 3.3801 3.3881 3.4301 
3.9296 3.7663 3.8098 3.7731 3.7342 3.7320 3.4011 3.4078 3.4800 
3.9448 3.7693 3.8327 3.7834 3.7404 3.7373 3.4225 3.4314 3.5157 
3.9631 3.7789 3.8568 3.7932 3.7488 3.7456 3.4358 3.4544 3.5463 
3.9769 3.7845 3.8780 3.8030 3.7553 3.7531 3.4461 3.4838 3.5794 
3.9905 3.7933 3.9030 3.8110 3.7596 3.7574 3.4582 3.5054 3.6030 
4.0031 3.8053 3.9202 3.8178 3.7655 3.7643 3.4679 3.5284 3.6261 
4.0149 3.8118 3.9435 3.8234 3.7722 3.7704 3.4813 3.5462 3.6409 
4.0298 3.8143 3.9623 3.8295 3.7779 3.7740 3.4964 3.5566 3.6592 
4.0413 3.8218 3.9788 3.8349 3.7811 3.7781 3.5091 3.5779 3.6792 
4.0516 3.8269 3.9946 3.8396 3.7861 3.7821 3.5191 3.5928 3.6976 
4.0640 3.8351 4.0084 3.8445 3.7894 3.7869 3.5310 3.6081 3.7074 
4.0725 3.8417 4.0185 3.8479 3.7941 3.7912 3.5400 3.6203 3.7063 
4.0849 3.8460 4.0229 3.8515 3.7976 3.7952 3.5519 3.6319 3.7000 
4.0923 3.8538 4.0230 3.8550 3.8005 3.7982 3.5636 3.6449 3.6964 
4.1049 3.8584 4.0229 3.8570 3.8041 3.8010 3.5735 3.6525 3.6953 
4.1174 3.8658 4.0245 3.8589 3.8070 3.8035 3.5805 3.6629 3.6953 
4.1243 3.8725 4.0292 3.8607 3.8096 3.8074 3.5889 3.6726 3.6974 
4.1372 3.8768 4.0345 3.8619 3.8124 3.8102 3.5965 3.6791 3.7019 
4.1446 3.8828 4.0412 3.8630 3.8141 3.8111 3.6065 3.6903 3.7068 
4.1549 3.8897 4.0458 3.8644 3.8187 3.8146 3.6149 3.6964 3.7094 
4.1629 3.8966 4.0476 3.8655 3.8206 3.8163 3.6217 3.7085 3.7140 
4.1728 3.9008 4.0508 3.8685 3.8234 3.8195 3.6275 3.7196 3.7189 
4.1793 3.9073 4.0572 3.8711 3.8258 3.8226 3.6345 3.7263 3.7255 
4.1854 3.9116 4.0644 3.8749 3.8286 3.8240 3.6407 3.7342 3.7313 
4.1918 3.9183 4.0716 3.8790 3.8307 3.8265 3.6493 3.7382 3.7334 
4.1983 3.9240 4.0791 3.8848 3.8327 3.8286 3.6553 3.7386 3.7361 
4.2052 3.9288 4.0842 3.8896 3.8344 3.8301 3.6573 3.7361 3.7389 
4.2124 3.9361 4.0874 3.8966 3.8363 3.8319 3.6647 3.7331 3.7409 
4.2192 3.9417 4.0900 3.9042 3.8380 3.8343 3.6688 3.7291 3.7425 
4.2256 3.9464 4.0936 3.9121 3.8399 3.8359 3.6754 3.7271 3.7441 
4.2288 3.9516 4.0943 3.9233 3.8413 3.8376 3.6811 3.7253 3.7444 
4.2315 3.9564 4.0934 3.9336 3.8425 3.8391 3.6845 3.7249 3.7430 
4.2331 3.9631 4.0923 3.9434 3.8434 3.8401 3.6890 3.7246 3.7413 
4.2339 3.9684 4.0899 3.9529 3.8442 3.8427 3.6947 3.7239 3.7378 
127 
4.2344 3.9701 4.0846 3.9627 3.8450 3.8445 3.6976 3.7244 3.7344 
4.2344 3.9763 4.0744 3.9718 3.8465 3.8453 3.7034 3.7250 3.7347 
4.2356 3.9817 4.0644 3.9823 3.8470 3.8466 3.7086 3.7270 3.7369 
4.2371 3.9851 4.0615 3.9934 3.8475 3.8477 3.7123 3.7281 3.7391 
4.2397 3.9932 4.0632 4.0007 3.8482 3.8487 3.7171 3.7300 3.7407 
4.2423 3.9979 4.0659 4.0109 3.8485 3.8495 3.7205 3.7325 3.7415 
4.2453 3.9995 4.0685 4.0254 3.8504 3.8502 3.7264 3.7342 3.7394 
4.2492 4.0047 4.0689 4.0326 3.8505 3.8522 3.7318 3.7366 3.7347 
4.2504 4.0097 4.0674 4.0400 3.8512 3.8535 3.7361 3.7388 3.7291 
4.2502 4.0127 4.0652 4.0494 3.8522 3.8542 3.7427 3.7411 3.7230 
4.2489 4.0179 4.0578 4.0566 3.8532 3.8563 3.7477 3.7424 3.7176 
4.2457 4.0204 4.0526 4.0625 3.8544 3.8581 3.7515 3.7455 3.7090 
4.2449 4.0252 4.0459 4.0664 3.8561 3.8597 3.7561 3.7479 3.6977 
4.2434 4.0299 4.0413 4.0679 3.8569 3.8622 3.7600 3.7505 3.6896 
4.2446 4.0330 4.0369 4.0647 3.8583 3.8639 3.7623 3.7539 3.6819 
4.2471 4.0375 4.0339 4.0604 3.8599 3.8673 3.7641 3.7566 3.6769 
4.2510 4.0414 4.0328 4.0538 3.8621 3.8704 3.7646 3.7595 3.6763 
4.2574 4.0440 4.0331 4.0497 3.8638 3.8728 3.7649 3.7609 3.6769 
4.2616 4.0477 4.0349 4.0452 3.8672 3.8769 3.7643 3.7620 3.6769 
4.2686 4.0523 4.0381 4.0430 3.8690 3.8804 3.7628 3.7626 3.6798 
4.2722 4.0550 4.0440 4.0413 3.8721 3.8835 3.7606 3.7645 3.6834 
4.2764 4.0594 4.0509 4.0394 3.8751 3.8905 3.7582 3.7650 3.6880 
4.2806 4.0626 4.0596 4.0394 3.8782 3.8978 3.7563 3.7661 3.6920 
4.2855 4.0649 4.0677 4.0389 3.8815 3.9039 3.7538 3.7674 3.6956 
4.2884 4.0676 4.0716 4.0384 3.8837 3.9128 3.7522 3.7679 3.6996 
4.2913 4.0697 4.0699 4.0374 3.8887 3.9186 3.7515 3.7696 3.7045 
4.2938 4.0710 4.0570 4.0369 3.8933 3.9259 3.7505 3.7702 3.7082 
4.2966 4.0721 4.0371 4.0368 3.8986 3.9330 3.7497 3.7708 3.7097 
4.2995 4.0731 4.0021 4.0364 3.9023 3.9402 3.7494 3.7716 3.7079 
4.3014 4.0742 3.9512 4.0349 3.9075 3.9466 3.7489 3.7724 3.7023 
4.3035 4 .0744 3.9138 4.0344 3.9118 3.9522 3.7479 3.7724 3.6900 
4.3061 4.0749 3.8914 4.0339 3.9176 3.9557 3.7475 3.7719 3.6762 
4.3076 4.0752 3.8831 4.0339 3.9224 3.9614 3.7476 3.7713 3.6575 
4.3081 4.0754 3.8756 4.0324 3.9244 3.9668 3.7469 3.7703 3.6293 
4.3079 4.0755 3.8687 4.0319 3.9306 3.9709 3.7469 3.7693 3.6048 
4.3078 4.0759 3.8618 4.0319 3.9339 3.9772 3.7469 3.7678 3.5773 
4.3072 4.0760 3.8583 4.0328 3.9401 3.9822 3.7469 3.7658 3.5708 
4.3062 4.0764 3.8559 4.0339 3.9480 3.9863 3.7470 3.7649 3.5653 
4.3054 4.0769 3.8549 4.0354 3.9534 3.9919 3.7491 3.7629 3.5618 
4.3034 4.0774 3.8524 4.0365 3.9593 3.9967 3.7498 3.7624 3.5609 
4.3024 4.0780 3.8513 4.0390 3.9632 4.0010 3.7509 3.7619 3.5599 
4.2998 4.0785 3.8502 4.0404 3.9677 4.0054 3.7513 3.7631 3.5594 
4.2962 4.0796 3.8488 4.0427 3.9711 4.0071 3.7523 3.7641 3.5594 
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4.2913 4.0812 3.8442 4.0463 3.9772 4.0127 3.7534 3.7651 3.5589 
4.2864 4.0826 3.8408 4.0492 3.9832 4.0172 3.7543 3.7660 3.5574 
4.2824 4.0837 3.8368 4.0520 3.9882 4.0195 3.7553 3.7669 3.5564 
4.2803 4.0858 3.8330 4.0544 3.9920 4.0237 3.7571 3.7674 3.5559 
4.2783 4.0876 3.8289 4.0565 3.9965 4.0296 3.7578 3.7681 3.5544 
4.2779 4.0888 3.8259 4.0569 4.0006 4 .0362 3.7588 3.7679 3.5538 
4.2786 4.0902 3.8233 4.0574 4.0057 4.0419 3.7594 3.7674 3.5519 
4.2808 4.0913 3.8214 4.0573 4.0099 4.0476 3.7599 3.7674 3.5509 
4.2827 4.0924 3.8197 4.0576 4.0140 4.0528 3.7609 3.7654 3.5489 
4.2830 4.0941 3.8179 4.0592 4.0192 4.0576 3.7619 3.7639 3.5478 
4.2839 4.0955 3.8149 4.0600 4.0263 4.0595 3.7634 3.7613 3.5469 
4.2848 4.0960 3.8134 4.0615 4.0294 4.0598 3.7647 3.7583 3.5447 
4.2845 4.0965 3.8119 4.0631 4.0343 4.0587 3.7650 3.7553 3.5434 
4.2849 4.0969 3.8104 4.0656 4.0380 4.0579 3.7660 3.7517 3.5424 
4.2854 4.0971 3.8089 4.0680 4.0426 4.0547 3.7682 3.7481 3.5419 
4.2839 4.0974 3.8089 4.0696 4.0460 4.0517 3.7694 3.7453 3.5415 
4.2839 4.0976 3.8087 4.0713 4.0507 4.0473 3.7699 3.7424 3.5409 
4.2823 4.0979 3.8089 4.0729 4.0531 4.0449 3.7720 3.7386 3.5394 
4.2787 4.0982 3.8088 4.0734 4.0564 4.0434 3.7738 3.7309 3.5392 
4.2765 4.0987 3.8079 4.0739 4.0595 4.0408 3.7750 3.7262 3.5394 
4.2739 4.0994 3.8079 4.0744 4.0604 4.0388 3.7763 3.7212 3.5409 
Spin Coated 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
0.3648 0.4500 0.4294 0.6119 0.6195 0.6296 0.5531 0.5054 0.5158 
0.3666 0.4531 0.4478 0.6173 0.6219 0.6452 0.5554 0.5134 0.5289 
0.3704 0.4572 0.4607 0.6216 0.6252 0.6579 0.5588 0.5192 0.5389 
0.3743 0.4595 0.4752 0.6252 0.6278 0.6645 0.5616 0.5247 0.5502 
0.3766 0.4633 0.4885 0.6276 0.6290 0.6693 0.5636 0.5309 0.5636 
0.3787 0.4675 0.5019 0.6316 0.6309 0.6735 0.5671 0.5361 0.5784 
0.3817 0.4701 0.5163 0.6349 0.6329 0.6780 0.5704 0.5401 0.5970 
0.3841 0.4742 0.5336 0.6379 0.6341 0.6849 0.5732 0.5444 0.6135 
0.3876 0.4775 0.5511 0.6410 0.6355 0.6959 0.5773 0.5521 0.6337 
0.3907 0.4793 0.5719 0.6432 0.6365 0.7079 0.5796 0.5581 0.6557 
0.3931 0.4827 0.5984 0.6443 0.6370 0.7303 0.5831 0.5655 0.6850 
0.3968 0.4869 0.6237 0.6462 0.6387 0.7521 0.5876 0.5727 0.7233 
0.4004 0.4908 0.6710 0.6478 0.6395 0.7796 0.5913 0.5822 0.7557 
0.4025 0.4932 0.6986 0.6491 0.6400 0.8106 0.5951 0.5906 0.7953 
0.4055 0.4971 0.7334 0.6503 0.6411 0.8466 0.6001 0.5978 0.8316 
0.4078 0.5000 0.7701 0.6520 0.6421 0.8779 0.6026 0.6074 0.8604 
0.4117 0.5039 0.8038 0.6526 0.6431 0.9174 0.6054 0.6164 0.8947 
0.4159 0.5085 0.8428 0.6537 0.6438 0.9526 0.6104 0.6260 0.9096 
129 
0.4200 0.5112 0.8667 0.6548 0.6451 0.9885 0.6140 0.6379 0.9136 
0.4225 0.5162 0.8834 0.6561 0.6461 1.0324 0.6199 0.6505 0.9156 
0.4269 0.5209 0.8927 0.6568 0.6469 1.0721 0.6241 0.6625 0.9198 
0.4310 0.5243 0.9012 0.6579 0.6492 1.1107 0.6277 0.6747 0.9264 
0.4337 0.5280 0.9055 0.6593 0.6516 1.1338 0.6329 0.6906 0.9359 
0.4385 0.5313 0.8984 0.6609 0.6527 1.1485 0.6361 0.7023 0.9456 
0.4431 0.5368 0.8887 0.6620 0.6547 1.1599 0.6410 0.7312 0.9595 
0.4463 0.5411 0.8834 0.6625 0.6569 1.1662 0.6471 0.7551 0.9685 
0.4503 0.5451 0.8810 0.6657 0.6600 1.1802 0.6525 0.7709 0.9798 
0.4542 0.5511 0.8800 0.6672 0.6627 1.1933 0.6572 0.7880 0.9925 
0.4597 0.5541 0.8801 0.6681 0.6657 1.2078 0.6625 0.8044 1.0069 
0.4640 0.5595 0.8806 0.6711 0.6698 1.2234 0.6671 0.8240 1.0197 
0.4687 0.5656 0.8827 0.6728 0.6731 1.2328 0.6747 0.8415 1.0303 
0.4726 0.5708 0.8835 0.6757 0.6765 1.2420 0.6813 0.8519 1.0385 
0.4775 0.5756 0.8833 0.6775 0.6817 1.2479 0.6870 0.8677 1.0340 
0.4819 0.5829 0.8867 0.6827 0.6859 1.2525 0.6955 0.8889 1.0316 
0.4889 0.5866 0.8896 0.6851 0.6902 1.2536 0.7023 0.9027 1.0245 
0.4942 0.5906 0.8925 0.6901 0.6970 1.2544 0.7090 0.9125 1.0235 
0.4988 0.5980 0.8920 0.6926 0.7020 1.2541 0.7136 0.9152 1.0231 
0.5064 0.6061 0.8915 0.6984 0.7036 1.2433 0.7210 0.9155 1.0228 
0.5123 0.6102 0.8922 0.7017 0.7127 1.2338 0.7306 0.9172 1.0208 
0.5182 0.6180 0.8913 0.7084 0.7152 1.2319 0.7396 0.9185 1.0179 
0.5221 0.6231 0.8913 0.7140 0.7219 1.2258 0.7566 0.9187 1.0175 
0.5264 0.6329 0.8900 0.7182 0.7284 1.2215 0.7672 0.9215 1.0147 
0.5370 0.6416 0.8886 0.7251 0.7383 1.2168 0.7758 0.9236 1.0108 
0.5457 0.6562 0.8874 0.7313 0.7416 1.2175 0.7866 0.9259 1.0145 
0.5531 0.6657 0.8855 0.7357 0.7512 1.2154 0.7980 0.9285 1.0150 
0.5592 0.6723 0.8845 0.7414 0.7625 1.2147 0.8076 0.9339 1.0156 
0.5631 0.6807 0.8828 0.7452 0.7710 1.2228 0.8143 0.9372 1.0135 
0.5683 0.6876 0.8807 0.7523 0.7781 1.2305 0.8246 0.9384 1.0085 
0.5899 0.6974 0.8810 0.7593 0.7844 1.2330 0.8334 0.9423 0.9909 
0.6017 0.7053 0.8799 0.7713 0.7914 1.2332 0.8426 0.9476 0.9855 
0.6066 0.7130 0.8800 0.7774 0.7979 1.2333 0.8491 0.9515 0.9860 
0.6116 0.7181 0.8770 0.7815 0.8079 1.2420 0.8600 0.9561 0.9885 
0.6214 0.7237 0.8735 0.7909 0.8151 1.2428 0.8698 0.9619 1.0019 
0.6257 0.7351 0.8708 0.8076 0.8219 1.2342 0.8764 0.9665 1.0179 
0.6356 0.7457 0.8668 0.8133 0.8264 1.2204 0.8855 0.9721 1.0305 
0.6460 0.7511 0.8635 0.8221 0.8358 1.2021 0.8902 0.9774 1.0205 
0.6519 0.7675 0.8614 0.8283 0.8446 1.1890 0.9002 0.9831 1.0171 
0.6619 0.7731 0.8579 0.8370 0.8544 1.1910 0.9117 0.9912 1.0197 
0.6713 0.7787 0.8547 0.8515 0.8626 1.2012 0.9227 0.9960 1.0143 
0.6785 0.7906 0.8508 0.8566 0.8707 1.2125 0.9288 1.0057 1.0013 
0.6881 0.8013 0.8488 0.8621 0.8759 1.2217 0.9373 1.0127 0.9907 
130 
0.6957 0.8079 0.8475 0.8726 0.8859 1.2253 0.9413 1.0182 0.9792 
0.7068 0.8187 0.8457 0.8827 0.8917 1.2158 0.9473 1.0230 0.9719 
0.7159 0.8299 0.8438 0.8886 0.9011 1.2075 0.9516 1.0270 0.9664 
0.7240 0.8372 0.8405 0.9032 0.9082 1.2056 0.9525 1.0317 0.9604 
0.7321 0.8484 0.8380 0.9086 0.9192 1.2014 0.9524 1.0342 0.9546 
0.7349 0.8561 0.8375 0.9151 0.9292 1.1973 0.9521 1.0328 0.9510 
0.7482 0.8671 0.8359 0.9257 0.9377 1.1944 0.9525 1.0305 0.9471 
0.7553 0.8740 0.8326 0.9368 0.9480 1.1892 0.9528 1.0305 0.9443 
0.7606 0.8774 0.8283 0.9432 0.9559 1.1830 0.9541 1.0284 0.9437 
0.7641 0.8840 0.8280 0.9592 0.9675 1.1764 0.9545 1.0243 0.9443 
0.7678 0.8890 0.8289 0.9656 0.9774 1.1700 0.9545 1.0205 0.9480 
0.7692 0.8918 0.8376 0.9723 0.9849 1.1610 0.9547 1.0205 0.9486 
0.7732 0.8973 0.8440 0.9857 0.9965 1.1526 0.9552 1.0203 0.9483 
0.7785 0.9014 0.8459 0.9973 1.0060 1.1464 0.9559 1.0190 0.9435 
0.7824 0.9036 0.8439 1.0042 1.0093 1.1407 0.9568 1.0193 0.9350 
0.7852 0.9091 0.8419 1.0153 1.0223 1.1352 0.9579 1.0200 0.9199 
0.7880 0.9127 0.8382 1.0225 1.0334 1.1307 0.9587 1.0190 0.9016 
0.7892 0.9145 0.8325 1.0354 1.0465 1.1279 0.9595 1.0183 0.8807 
0.7943 0.9166 0.8231 1.0465 1.0578 1.1285 0.9610 1.0170 0.8543 
0.7989 0.9193 0.8079 1.0557 1.0647 1.1310 0.9620 1.0159 0.8313 
0.8011 0.9222 0.7880 1.0656 1.0666 1.1337 0.9632 1.0147 0.8265 
0.8046 0.9236 0.7743 1.0747 1.0722 1.1333 0.9675 1.0133 0.8250 
0.8078 0.9263 0.7609 1.0850 1.0779 1.1346 0.9690 1.0134 0.8235 
0.8087 0.9291 0.7589 1.0928 1.0843 1.1265 0.9700 1.0130 0.8262 
0.8128 0.9293 0.7575 1.0992 1.0900 1.1145 0.9705 1.0130 0.8259 
0.8162 0.9285 0.7543 1.1028 1.0942 1.0898 0.9712 1.0130 0.8248 
0.8177 0.9281 0.7488 1.1084 1.0956 1.0594 0.9722 1.0114 0.8235 
0.8196 0.9264 0.7435 1.1132 1.1017 1.0420 0.9734 1.0103 0.8230 
0.8206 0.9245 0.7393 1.1155 1.1049 1.0168 0.9754 1.0084 0.8185 
0.8214 0.9220 0.7365 1.1183 1.1119 0.9955 0.9780 1.0079 0.8170 
0.8209 0.9185 0.7329 1.1230 1.1163 0.9833 0.9799 1.0075 0.8125 
0.8199 0.9160 0.7288 1.1278 1.1192 0.9778 0.9825 1.0080 0.8072 
0.8184 0.9142 0.7255 1.1301 1.1201 0.9757 0.9847 1.0085 0.8018 
0.8151 0.9126 0.7234 1.1333 1.1241 0.9734 0.9869 1.0085 0.7977 
0.8126 0.9118 0.7201 1.1353 1.1262 0.9730 0.9902 1.0110 0.7934 
0.8094 0.9107 0.7156 1.1381 1.1289 0.9725 0.9942 1.0115 0.7905 
0.8077 0.9086 0.7120 1.1410 1.1318 0.9719 0.9972 1.0122 0.7883 
0.8066 0.9069 0.7088 1.1420 1.1338 0.9705 0.9989 1.0130 0.7858 
0.8049 0.9064 0.7055 1.1431 1.1372 0.9660 1.0013 1.0130 0.7843 
Spin Coated with Chlorhexidine 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
131 
0.3648 0.4500 0.4294 0.6379 0.6109 0.6296 0.5531 0.5054 0.5158 
0.3666 0.4531 0.4478 0.6410 0.6159 0.6452 0.5554 0.5134 0.5289 
0.3704 0.4572 0.4607 0.6432 0.6195 0.6579 0.5588 0.5192 0.5389 
0.3743 0.4595 0.4752 0.6443 0.6219 0.6645 0.5616 0.5247 0.5502 
0.3766 0.4633 0.4885 0.6462 0.6252 0.6693 0.5636 0.5309 0.5636 
0.3787 0.4675 0.5019 0.6478 0.6278 0.6735 0.5671 0.5361 0.5784 
0.3817 0.4701 0.5163 0.6491 0.6290 0.6780 0.5704 0.5401 0.5970 
0.3841 0.4742 0.5336 0.6503 0.6309 0.6849 0.5732 0.5444 0.6135 
0.3876 0.4775 0.5511 0.6520 0.6329 0.6959 0.5773 0.5521 0.6337 
0.3907 0.4793 0.5719 0.6526 0.6341 0.7079 0.5796 0.5581 0.6557 
0.3931 0.4827 0.5984 0.6537 0.6355 0.7303 0.5831 0.5655 0.6850 
0.3968 0.4869 0.6237 0.6548 0.6365 0.7521 0.5876 0.5727 0.7233 
0.4004 0.4908 0.6710 0.6561 0.6370 0.7796 0.5913 0.5822 0.7557 
0.4025 0.4932 0.6986 0.6568 0.6387 0.8106 0.5951 0.5906 0.7953 
0.4055 0.4971 0.7334 0.6579 0.6395 0.8466 0.6001 0.5978 0.8316 
0.4078 0.5000 0.7701 0.6593 0.6400 0.8779 0.6026 0.6074 0.8604 
0.4117 0.5039 0.8038 0.6609 0.6411 0.9174 0.6054 0.6164 0.8947 
0.4159 0.5085 0.8428 0.6620 0.6421 0.9526 0.6104 0.6260 0.9096 
0.4200 0.5112 0.8667 0.6625 0.6431 0.9885 0.6140 0.6379 0.9136 
0.4225 0.5162 0.8834 0.6657 0.6438 1.0324 0.6199 0.6505 0.9156 
0.4269 0.5209 0.8927 0.6672 0.6451 1.0721 0.6241 0.6625 0.9198 
0.4310 0.5243 0.9012 0.6681 0.6461 1.1107 0.6277 0.6747 0.9264 
0.4337 0.5280 0.9055 0.6711 0.6469 1.1338 0.6329 0.6906 0.9359 
0.4385 0.5313 0.8984 0.6728 0.6492 1.1485 0.6361 0.7023 0.9456 
0.4431 0.5368 0.8887 0.6757 0.6516 1.1599 0.6410 0.7312 0.9595 
0.4463 0.5411 0.8834 0.6775 0.6527 1.1662 0.6471 0.7551 0.9685 
0.4503 0.5451 0.8810 0.6827 0.6547 1.1802 0.6525 0.7709 0.9798 
0.4542 0.5511 0.8800 0.6851 0.6569 1.1933 0.6572 0.7880 0.9925 
0.4597 0.5541 0.8801 0.6901 0.6600 1.2078 0.6625 0.8044 1.0069 
0.4640 0.5595 0.8806 0.6926 0.6627 1.2234 0.6671 0.8240 1.0197 
0.4687 0.5656 0.8827 0.6984 0.6657 1.2328 0.6747 0.8415 1.0303 
0.4726 0.5708 0.8835 0.7017 0.6698 1.2420 0.6813 0.8519 1.0385 
0.4775 0.5756 0.8833 0.7084 0.6731 1.2479 0.6870 0.8677 1.0340 
0.4819 0.5829 0.8867 0.7140 0.6765 1.2525 0.6955 0.8889 1.0316 
0.4889 0.5866 0.8896 0.7182 0.6817 1.2536 0.7023 0.9027 1.0245 
0.4942 0.5906 0.8925 0.7251 0.6859 1.2544 0.7090 0.9125 1.0235 
0.4988 0.5980 0.8920 0.7313 0.6902 1.2541 0.7136 0.9152 1.0231 
0.5064 0.6061 0.8915 0.7357 0.6970 1.2433 0.7210 0.9155 1.0228 
0.5123 0.6102 0.8922 0.7414 0.7020 1.2338 0.7306 0.9172 1.0208 
0.5182 0.6180 0.8913 0.7452 0.7036 1.2319 0.7396 0.9185 1.0179 
0.5221 0.6231 0.8913 0.7523 0.7127 1.2258 0.7566 0.9187 1.0175 
0.5264 0.6329 0.8900 0.7593 0.7152 1.2215 0.7672 0.9215 1.0147 
0.5370 0.6416 0.8886 0.7713 0.7219 1.2168 0.7758 0.9236 1.0108 
132 
0.5457 0.6562 0.8874 0.7774 0.7284 1.2175 0.7866 0.9259 1.0145 
0.5531 0.6657 0.8855 0.7815 0.7383 1.2154 0.7980 0.9285 1.0150 
0.5592 0.6723 0.8845 0.7909 0.7416 1.2147 0.8076 0.9339 1.0156 
0.5631 0.6807 0.8828 0.8076 0.7512 1.2228 0.8143 0.9372 1.0135 
0.5683 0.6876 0.8807 0.8133 0.7625 1.2305 0.8246 0.9384 1.0085 
0.5899 0.6974 0.8810 0.8221 0.7710 1.2330 0.8334 0.9423 0.9909 
0.6017 0.7053 0.8799 0.8283 0.7781 1.2332 0.8426 0.9476 0.9855 
0.6066 0.7130 0.8800 0.8370 0.7844 1.2333 0.8491 0.9515 0.9860 
0.6116 0.7181 0.8770 0.8515 0.7914 1.2420 0.8600 0.9561 0.9885 
0.6214 0.7237 0.8735 0.8566 0.7979 1.2428 0.8698 0.9619 1.0019 
0.6257 0.7351 0.8708 0.8621 0.8079 1.2342 0.8764 0.9665 1.0179 
0.6356 0.7457 0.8668 0.8726 0.8151 1.2204 0.8855 0.9721 1.0305 
0.6460 0.7511 0.8635 0.8827 0.8219 1.2021 0.8902 0.9774 1.0205 
0.6519 0.7675 0.8614 0.8886 0.8264 1.1890 0.9002 0.9831 1.0171 
0.6619 0.7731 0.8579 0.9032 0.8358 1.1910 0.9117 0.9912 1.0197 
0.6713 0.7787 0.8547 0.9086 0.8446 1.2012 0.9227 0.9960 1.0143 
0.6785 0.7906 0.8508 0.9151 0.8544 1.2125 0.9288 1.0057 1.0013 
0.6881 0.8013 0.8488 0.9257 0.8626 1.2217 0.9373 1.0127 0.9907 
0.6957 0.8079 0.8475 0.9368 0.8707 1.2253 0.9413 1.0182 0.9792 
0.7068 0.8187 0.8457 0.9432 0.8759 1.2158 0.9473 1.0230 0.9719 
0.7159 0.8299 0.8438 0.9592 0.8859 1.2075 0.9516 1.0270 0.9664 
0.7240 0.8372 0.8405 0.9656 0.8917 1.2056 0.9525 1.0317 0.9604 
0.7321 0.8484 0.8380 0.9723 0.9011 1.2014 0.9524 1.0342 0.9546 
0.7349 0.8561 0.8375 0.9857 0.9082 1.1973 0.9521 1.0328 0.9510 
0.7482 0.8671 0.8359 0.9973 0.9192 1.1944 0.9525 1.0305 0.9471 
0.7553 0.8740 0.8326 1.0042 0.9292 1.1892 0.9528 1.0305 0.9443 
0.7606 0.8774 0.8283 1.0153 0.9377 1.1830 0.9541 1.0284 0.9437 
0.7641 0.8840 0.8280 1.0225 0.9480 1.1764 0.9545 1.0243 0.9443 
0.7678 0.8890 0.8289 1.0354 0.9559 1.1700 0.9545 1.0205 0.9480 
0.7692 0.8918 0.8376 1.0465 0.9675 1.1610 0.9547 1.0205 0.9486 
0.7732 0.8973 0.8440 1.0557 0.9774 1.1526 0.9552 1.0203 0.9483 
0.7785 0.9014 0.8459 1.0656 0.9849 1.1464 0.9559 1.0190 0.9435 
0.7824 0.9036 0.8439 1.0747 0.9965 1.1407 0.9568 1.0193 0.9350 
0.7852 0.9091 0.8419 1.0850 1.0060 1.1352 0.9579 1.0200 0.9199 
0.7880 0.9127 0.8382 1.0928 1.0093 1.1307 0.9587 1.0190 0.9016 
0.7892 0.9145 0.8325 1.0992 1.0223 1.1279 0.9595 1.0183 0.8807 
0.7943 0.9166 0.8231 1.1028 1.0334 1.1285 0.9610 1.0170 0.8543 
0.7989 0.9193 0.8079 1.1084 1.0465 1.1310 0.9620 1.0159 0.8313 
0.8011 0.9222 0.7880 1.1132 1.0578 1.1337 0.9632 1.0147 0.8265 
0.8046 0.9236 0.7743 1.1155 1.0647 1.1333 0.9675 1.0133 0.8250 
0.8078 0.9263 0.7609 1.1183 1.0666 1.1346 0.9690 1.0134 0.8235 
0.8087 0.9291 0.7589 1.1230 1.0722 1.1265 0.9700 1.0130 0.8262 
0.8128 0.9293 0.7575 1.1278 1.0779 1.1145 0.9705 1.0130 0.8259 
133 
0.8162 0.9285 0.7543 1.1301 1.0843 1.0898 0.9712 1.0130 0.8248 
0.8177 0.9281 0.7488 1.1333 1.0900 1.0594 0.9722 1.0114 0.8235 
0.8196 0.9264 0.7435 1.1353 1.0942 1.0420 0.9734 1.0103 0.8230 
0.8206 0.9245 0.7393 1.1381 1.0956 1.0168 0.9754 1.0084 0.8185 
0.8214 0.9220 0.7365 1.1410 1.1017 0.9955 0.9780 1.0079 0.8170 
0.8209 0.9185 0.7329 1.1420 1.1049 0.9833 0.9799 1.0075 0.8125 
0.8199 0.9160 0.7288 1.1431 1.1119 0.9778 0.9825 1.0080 0.8072 
0.8184 0.9142 0.7255 1.1452 1.1163 0.9757 0.9847 1.0085 0.8018 
0.8151 0.9126 0.7234 1.1472 1.1192 0.9734 0.9869 1.0085 0.7977 
0.8126 0.9118 0.7201 1.1491 1.1201 0.9730 0.9902 1.0110 0.7934 
0.8094 0.9107 0.7156 1.1526 1.1241 0.9725 0.9942 1.0115 0.7905 
0.8077 0.9086 0.7120 1.1560 1.1262 0.9719 0.9972 1.0122 0.7883 
0.8066 0.9069 0.7088 1.1588 1.1289 0.9705 0.9989 1.0130 0.7858 
0.8049 0.9064 0.7055 1.1634 1.1318 0.9660 1.0013 1.0130 0.7843 
Dip Coated 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
2.0899 2.1238 2.1753 0.5258 0.5116 0.4937 0.8571 0.8354 0.8235 
2.1016 2.1339 2.2042 0.5325 0.5158 0.5101 0.8667 0.8391 0.8388 
2.1163 2.1405 2.2505 0.5378 0.5178 0.5217 0.8715 0.8443 0.8597 
2.1251 2.1512 2.2925 0.5436 0.5214 0.5319 0.8731 0.8485 0.8824 
2.1340 2.1611 2.3421 0.5489 0.5243 0.5421 0.8817 0.8534 0.9112 
2.1397 2.1679 2.3914 0.5529 0.5265 0.5527 0.8890 0.8583 0.9370 
2.1464 2.1771 2.4237 0.5589 0.5289 0.5655 0.8957 0.8602 0.9663 
2.1585 2.1879 2.4480 0.5648 0.5309 0.5794 0.9010 0.8666 0.9945 
2.1705 2.1995 2.4579 0.5687 0.5339 0.5990 0.9067 0.8733 1.0265 
2.1783 2.2063 2.4651 0.5766 0.5364 0.6187 0.9091 0.8786 1.0566 
2.1900 2.2170 2.4785 0.5843 0.5384 0.6409 0.9253 0.8851 1.0915 
2.2021 2.2245 2.4887 0.5899 0.5415 0.6725 0.9390 0.8906 1.1316 
2.2108 2.2365 2.4978 0.5983 0.5441 0.7014 0.9475 0.8928 1.1662 
2.2232 2.2470 2.5066 0.6097 0.5465 0.7447 0.9533 0.9002 1.2030 
2.2325 2.2590 2.5233 0.6192 0.5492 0.7751 0.9619 0.9079 1.2350 
2.2456 2.2670 2.5425 0.6290 0.5518 0.8081 0.9676 0.9201 1.2551 
2.2630 2.2790 2.5668 0.6414 0.5555 0.8421 0.9775 0.9325 1.2694 
2.2703 2.2871 2.5871 0.6517 0.5586 0.8770 0.9875 0.9392 1.2861 
2.2780 2.3001 2.5953 0.6636 0.5620 0.9166 0.9944 0.9476 1.3009 
2.2915 2.3121 2.6157 0.6748 0.5641 0.9455 1.0053 0.9533 1.3142 
2.3035 2.3212 2.6338 0.6968 0.5686 0.9609 1.0145 0.9618 1.3265 
2.3101 2.3373 2.6491 0.7058 0.5710 0.9756 1.0208 0.9705 1.3352 
2.3233 2.3510 2.6639 0.7310 0.5761 0.9857 1.0292 0.9762 1.3394 
2.3333 2.3608 2.6779 0.7461 0.5819 0.9901 1.0402 0.9860 1.3422 
2.3409 2.3729 2.6789 0.7608 0.5860 0.9926 1.0511 0.9921 1.3517 
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2.3466 2.3810 2.6693 0.7798 0.5891 0.9941 1.0582 1.0013 1.3595 
2.3545 2.3915 2.6530 0.7960 0.5952 0.9999 1.0691 1.0093 1.3627 
2.3601 2.4027 2.6458 0.8166 0.5986 1.0082 1.0768 1.0149 1.3583 
2.3650 2.4106 2.6390 0.8334 0.6039 1.0127 1.0889 1.0250 1.3555 
2.3711 2.4160 2.6382 0.8501 0.6073 1.0221 1.0984 1.0340 1.3551 
2.3759 2.4226 2.6359 0.8670 0.6137 1.0310 1.1066 1.0404 1.3508 
2.3795 2.4286 2.6359 0.8858 0.6200 1.0443 1.1164 1.0481 1.3485 
2.3815 2.4347 2.6444 0.9052 0.6241 1.0617 1.1259 1.0558 1.3514 
2.3825 2.4378 2.6508 0.9174 0.6305 1.0747 1.1400 1.0664 1.3550 
2.3838 2.4395 2.6537 0.9357 0.6364 1.0915 1.1499 1.0746 1.3524 
2.3878 2.4421 2.6514 0.9627 0.6407 1.1026 1.1577 1.0828 1.3529 
2.3897 2.4445 2.6430 0.9715 0.6468 1.1153 1.1705 1.0945 1.3437 
2.3910 2.4455 2.6373 0.9807 0.6545 1.1150 1.1839 1.1001 1.3444 
2.3921 2.4480 2.6325 0.9913 0.6590 1.1153 1.1950 1.1067 1.3453 
2.3953 2.4492 2.6313 0.9984 0.6746 1.1151 1.2044 1.1185 1.3431 
2.4000 2.4523 2.6248 1.0045 0.6799 1.1102 1.2161 1.1302 1.3455 
2.4044 2.4573 2.6159 1.0107 0.6874 1.1049 1.2246 1.1446 1.3480 
2.4066 2.4612 2.6062 1.0152 0.6976 1.0975 1.2360 1.1525 1.3521 
2.4076 2.4625 2.5946 1.0180 0.7070 1.0910 1.2514 1.1623 1.3556 
2.4091 2.4660 2.5743 1.0200 0.7151 1.0925 1.2643 1.1708 1.3570 
2.4108 2.4666 2.5766 1.0212 0.7227 1.0903 1.2730 1.1831 1.3600 
2.4145 2.4677 2.5854 1.0217 0.7308 1.0856 1.2864 1.1924 1.3594 
2.4168 2.4705 2.6015 1.0214 0.7375 1.0855 1.2969 1.2001 1.3534 
2.4198 2.4719 2.6219 1.0247 0.7466 1.0906 1.3019 1.2130 1.3455 
2.4225 2.4757 2.6330 1.0265 0.7573 1.0954 1.3106 1.2230 1.3335 
2.4271 2.4771 2.6355 1.0297 0.7659 1.1040 1.3176 1.2318 1.3346 
2.4297 2.4788 2.6300 1.0339 0.7734 1.1095 1.3221 1.2430 1.3367 
2.4326 2.4818 2.6210 1.0375 0.7820 1.1017 1.3291 1.2481 1.3418 
2.4337 2.4839 2.6154 1.0419 0.7899 1.0990 1.3346 1.2528 1.3502 
2.4359 2.4855 2.6080 1.0434 0.7997 1.0924 1.3387 1.2615 1.3569 
2.4397 2.4860 2.5973 1.0455 0.8095 1.0900 1.3436 1.2662 1.3550 
2.4429 2.4891 2.5820 1.0501 0.8184 1.0858 1.3498 1.2714 1.3537 
2.4483 2.4915 2.5668 1.0549 0.8259 1.0826 1.3552 1.2787 1.3560 
2.4528 2.4970 2.5645 1.0605 0.8343 1.0773 1.3578 1.2820 1.3526 
2.4558 2.5026 2.5603 1.0680 0.8422 1.0709 1.3630 1.2843 1.3455 
2.4608 2.5059 2.5513 1.0760 0.8477 1.0675 1.3661 1.2896 1.3360 
2.4653 2.5102 2.5456 1.0831 0.8620 1.0784 1.3714 1.2935 1.3283 
2.4686 2.5158 2.5424 1.0931 0.8712 1.0847 1.3760 1.2958 1.3262 
2.4741 2.5195 2.5417 1.1017 0.8796 1.0854 1.3800 1.3008 1.3213 
2.4800 2.5211 2.5419 1.1097 0.8887 1.0780 1.3816 1.3043 1.3195 
2.4860 2.5276 2.5407 1.1191 0.8980 1.0743 1.3868 1.3098 1.3178 
2.4928 2.5335 2.5403 1.1266 0.9042 1.0750 1.3916 1.3139 1.3172 
2.4982 2.5411 2.5374 1.1326 0.9158 1.0770 1.3934 1.3161 1.3182 
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2.5016 2.5484 2.5277 1.1384 0.9270 1.0764 1.3983 1.3213 1.3215 
2.5110 2.5537 2.5133 1.1451 0.9322 1.0694 1.4023 1.3257 1.3268 
2.5173 2.5556 2.4958 1.1495 0.9418 1.0646 1.4049 1.3281 1.3293 
2.5218 2.5637 2.4673 1.1500 0.9466 1.0625 1.4065 1.3320 1.3300 
2.5256 2.5674 2.4455 1.1499 0.9523 1.0609 1.4087 1.3348 1.3305 
2.5282 2.5720 2.4313 1.1495 0.9552 1.0587 1.4101 1.3368 1.3309 
2.5300 2.5750 2.4245 1.1492 0.9610 1.0505 1.4108 1.3402 1.3303 
2.5353 2.5762 2.4197 1.1473 0.9631 1.0420 1.4125 1.3441 1.3254 
2.5413 2.5793 2.4150 1.1453 0.9681 1.0340 1.4143 1.3460 1.3175 
2.5458 2.5847 2.4100 1.1427 0.9704 1.0244 1.4153 1.3494 1.3024 
2.5503 2.5893 2.4089 1.1376 0.9742 1.0087 1.4164 1.3517 1.2813 
2.5545 2.5945 2.4017 1.1344 0.9760 1.0008 1.4170 1.3530 1.2429 
2.5571 2.5974 2.3962 1.1310 0.9786 0.9940 1.4170 1.3551 1.2235 
2.5641 2.6029 2.3999 1.1281 0.9812 0.9896 1.4172 1.3572 1.2069 
2.5674 2.6084 2.3957 1.1250 0.9830 0.9880 1.4185 1.3584 1.1970 
2.5712 2.6121 2.3908 1.1212 0.9858 0.9877 1.4204 1.3598 1.1882 
2.5728 2.6157 2.3971 1.1179 0.9874 0.9890 1.4220 1.3610 1.1879 
2.5770 2.6165 2.4071 1.1171 0.9890 0.9908 1.4225 1.3622 1.1865 
2.5816 2.6211 2.4129 1.1175 0.9902 0.9844 1.4240 1.3625 1.1871 
2.5868 2.6251 2.4171 1.1173 0.9905 0.9825 1.4251 1.3627 1.1805 
2.5904 2.6270 2.4095 1.1155 0.9911 0.9818 1.4260 1.3653 1.1776 
2.5940 2.6332 2.3850 1.1144 0.9925 0.9707 1.4280 1.3679 1.1801 
2.5987 2.6387 2.3859 1.1118 0.9929 0.9552 1.4285 1.3703 1.1792 
2.6043 2.6421 2.3870 1.1109 0.9933 0.9390 1.4291 1.3728 1.1815 
2.6075 2.6470 2.3872 1.1105 0.9930 0.9198 1.4295 1.3771 1.1778 
2.6128 2.6554 2.3885 1.1109 0.9932 0.8986 1.4295 1.3799 1.1762 
2.6159 2.6581 2.3862 1.1147 0.9944 0.8845 1.4293 1.3839 1.1760 
2.6179 2.6602 2.3898 1.1175 0.9957 0.8750 1.4284 1.3851 1.1793 
2.6201 2.6610 2.3845 1.1198 0.9960 0.8734 1.4279 1.3851 1.1795 
2.6205 2.6644 2.3804 1.1232 0.9970 0.8712 1.4276 1.3847 1.1805 
2.6200 2.6660 2.3780 1.1261 0.9982 0.8652 1.4278 1.3852 1.1765 
2.6187 2.6662 2.3768 1.1315 1.0003 0.8612 1.4271 1.3859 1.1742 
Dip Coated with Chlorhexidine 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
0.4521 0.4410 0.4338 1.6219 1.5959 1.6378 0.8513 0.8063 0.8152 
0.4553 0.4446 0.4522 1.6299 1.6027 1.6733 0.8540 0.8102 0.8286 
0.4571 0.4502 0.4686 1.6360 1.6051 1.7130 0.8589 0.8141 0.8464 
0.4605 0.4547 0.4805 1.6433 1.6174 1.7401 0.8635 0.8168 0.8663 
0.4632 0.4580 0.4907 1.6493 1.6240 1.7547 0.8675 0.8198 0.8840 
0.4649 0.4617 0.5018 1.6578 1.6261 1.7648 0.8724 0.8229 0.9063 
0.4679 0.4649 0.5148 1.6643 1.6345 1.7709 0.8766 0.8269 0.9310 
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0.4702 0.4693 0.5293 1.6702 1.6431 1.7822 0.8830 0.8308 0.9681 
0.4733 0.4722 0.5459 1.6790 1.6552 1.7946 0.8877 0.8351 0.9997 
0.4756 0.4745 0.5665 1.6870 1.6653 1.8057 0.8919 0.8383 1.0322 
0.4787 0.4776 0.5880 1.6973 1.6776 1.8225 0.8969 0.8429 1.0665 
0.4809 0.4800 0.6127 1.7026 1.6837 1.8410 0.8991 0.8468 1.1026 
0.4847 0.4811 0.6402 1.7114 1.6935 1.8586 0.9056 0.8524 1.1331 
0.4889 0.4841 0.6800 1.7252 1.7017 1.8774 0.9121 0.8573 1.1670 
0.4912 0.4859 0.7126 1.7302 1.7073 1.8959 0.9165 0.8616 1.1796 
0.4942 0.4894 0.7414 1.7411 1.7175 1.9121 0.9226 0.8658 1.1961 
0.4992 0.4921 0.7727 1. 7515 1.7260 1.9274 0.9278 0.8673 1.2080 
0.5016 0.4939 0.8071 1. 7576 1.7321 1.9371 0.9344 0.8740 1.2211 
0.5068 0.4975 0.8430 1.7677 1.7401 1.9416 0.9400 0.8804 1.2333 
0.5115 0.5009 0.8734 1.7762 1.7471 1.9371 0.9482 0.8839 1.2449 
0.5146 0.5033 0.8937 1.7807 1.7518 1.9344 0.9549 0.8895 1.2558 
0.5186 0.5064 0.9102 1.7900 1.7589 1.9345 0.9619 0.8978 1.2640 
0.5217 0.5086 0.9272 1.7989 1.7649 1.9345 0.9666 0.8998 1.2747 
0.5279 0.5124 0.9416 1.8035 1.7686 1.9346 0.9742 0.9066 1.2841 
0.5329 0.5167 0.9591 1.8099 1.7723 1.9306 0.9837 0.9140 1.2898 
0.5370 0.5214 0.9728 1.8125 1.7746 1.9269 1.0014 0.9187 1.2940 
0.5434 0.5241 0.9825 1.8180 1.7775 1.9275 1.0092 0.9258 1.2965 
0.5490 0.5288 0.9945 1.8212 1.7800 1.9252 1.0142 0.9306 1.3011 
0.5536 0.5327 1.0038 1.8246 1.7819 1.9275 1.0216 0.9395 1.3023 
0.5597 0.5384 1.0118 1.8263 1.7847 1.9310 1.0312 0.9468 1.2966 
0.5660 0.5432 1.0192 1.8288 1.7866 1.9347 1.0475 0.9519 1.2903 
0.5712 0.5474 1.0230 1.8309 1.7879 1.9350 1.0598 0.9666 1.2869 
0.5795 0.5519 1.0212 1.8326 1.7897 1.9385 1.0699 0.9737 1.2823 
0.5864 0.5564 1.0175 1.8331 1.7920 1.9422 1.0765 0.9874 1.2815 
0.5916 0.5592 1.0201 1.8344 1.7944 1.9475 1.0869 0.9995 1.2815 
0.5979 0.5653 1.0185 1.8383 1.7979 1.9492 1.0969 1.0041 1.2835 
0.6059 0.5713 1.0173 1.8411 1.8010 1.9535 1.1040 1.0096 1.2818 
0.6139 0.5776 1.0191 1.8437 1.8021 1.9537 1.1151 1.0190 1.2783 
0.6199 0.5832 1.0178 1.8468 1.8061 1.9561 1.1232 1.0246 1.2738 
0.6283 0.5889 1.0171 1.8493 1.8080 1.9568 1.1345 1.0371 1.2698 
0.6347 0.5928 1.0195 1.8539 1.8119 1.9564 1.1431 1.0467 1.2654 
0.6434 0.5999 1.0173 1.8579 1.8166 1.9581 1.1490 1.0516 1.2528 
0.6503 0.6049 1.0143 1.8609 1.8195 1.9564 1.1615 1.0576 1.2464 
0.6662 0.6128 1.0125 1.8632 1.8201 1.9529 1.1725 1.0680 1.2465 
0.6767 0.6203 1.0120 1.8661 1.8236 1.9513 1.1805 1.0736 1.2453 
0.6860 0.6248 1.0120 1.8685 1.8256 1.9462 1.1928 1.0866 1.2527 
0.6924 0.6394 1.0135 1.8726 1.8307 1.9416 1.2021 1.0965 1.2592 
0.7008 0.6490 1.0141 1.8765 1.8352 1.9369 1.2070 1.1011 1.2706 
0.7075 0.6572 1.0189 1.8782 1.8386 1.9343 1.2200 1.1071 1.2778 
0.7184 0.6677 1.0225 1.8832 1.8439 1.9325 1.2325 1.1176 1.2785 
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0.7271 0.6747 1.0222 1.8867 1.8490 1.9300 1.2438 1.1246 1.2719 
0.7343 0.6838 1.0188 1.8923 1.8521 1.9239 1.2498 1.1359 1.2626 
0.7422 0.6890 1.0169 1.8974 1.8562 1.9223 1.2575 1.1461 1.2558 
0.7452 0.6995 1.0133 1.9004 1.8595 1.9195 1.2621 1.1524 1.2512 
0.7578 0.7092 1.0120 1.9044 1.8646 1.9200 1.2678 1.1621 1.2452 
0.7671 0.7182 1.0078 1.9097 1.8693 1.9189 1.2721 1.1710 1.2423 
0.7764 0.7232 0.9998 1.9138 1.8733 1.9173 1.2754 1.1766 1.2410 
0.7835 0.7328 0.9921 1.9187 1.8788 1.9162 1.2806 1.1839 1.2326 
0.7946 0.7380 0.9874 1.9227 1.8830 1.9155 1.2851 1.1886 1.2275 
0.8038 0.7479 0.9839 1.9289 1.8868 1.9173 1.2891 1.1918 1.2213 
0.8117 0.7568 0.9792 1.9333 1.8907 1.9124 1.2928 1.1961 1.2168 
0.8230 0.7619 0.9788 1.9373 1.8939 1.9070 1.2952 1.1993 1.2118 
0.8328 0.7707 0.9762 1.9428 1.8991 1.9038 1.3002 1.2043 1.2099 
0.8410 0.7813 0.9730 1.9472 1.9045 1.8998 1.3022 1.2079 1.2071 
0.8495 0.7871 0.9693 1.9517 1.9094 1.8969 1.3054 1.2107 1.2019 
0.8522 0.7980 0.9654 1.9562 1.9144 1.8964 1.3075 1.2142 1.1959 
0.8615 0.8081 0.9645 1.9594 1.9192 1.8940 1.3109 1.2171 1.1983 
0.8693 0.8154 0.9618 1.9651 1.9206 1.8948 1.3139 1.2195 1.1960 
0.8726 0.8262 0.9595 1.9713 1.9283 1.8935 1.3173 1.2229 1.1924 
0.8788 0.8366 0.9569 1.9759 1.9322 1.8917 1.3197 1.2256 1.1860 
0.8841 0.8440 0.9528 1.9805 1.9336 1.8880 1.3230 1.2284 1.1828 
0.8866 0.8540 0.9509 1.9847 1.9388 1.8818 1.3255 1.2315 1.1840 
0.8928 0.8610 0.9454 1.9861 1.9437 1.8674 1.3290 1.2351 1.1834 
0.8982 0.8703 0.9438 1.9908 1.9460 1.8470 1.3316 1.2378 1.1831 
0.9008 0.8764 0.9467 1.9957 1.9497 1.8191 1.3336 1.2417 1.1806 
0.9054 0.8796 0.9490 1.9984 1.9526 1.7941 1.3376 1.2441 1.1783 
0.9114 0.8859 0.9528 2.0012 1.9543 1.7783 1.3404 1.2479 1.1739 
0.9154 0.8911 0.9560 2.0033 1.9568 1.7727 1.3425 1.2506 1.1694 
0.9210 0.8943 0.9613 2.0066 1.9589 1.7688 1.3463 1.2548 1.1640 
0.9244 0.8996 0.9664 2.0087 1.9609 1.7669 1.3494 1.2577 1.1553 
0.9282 0.9040 0.9695 2.0102 1.9620 1.7650 1.3509 1.2607 1.1455 
0.9335 0.9064 0.9665 2.0127 1.9620 1.7629 1.3531 1.2630 1.1290 
0.9380 0.9137 0.9616 2.0139 1.9613 1.7604 1.3547 1.2659 1.1027 
0.9396 0.9203 0.9494 2.0131 1.9592 1.7575 1.3558 1.2684 1.0835 
0.9453 0.9255 0.9317 2.0115 1.9581 1.7565 1.3577 1.2719 1.0611 
0.9501 0.9284 0.9123 2.0098 1.9573 1.7529 1.3602 1.2745 1.0523 
0.9522 0.9320 0.8840 2.0080 1.9563 1.7498 1.3620 1.2766 1.0485 
0.9591 0.9348 0.8648 2.0070 1.9549 1.7475 1.3657 1.2789 1.0453 
0.9632 0.9394 0.8424 2.0064 1.9537 1.7445 1.3672 1.2804 1.0443 
0.9668 0.9454 0.8320 2.0049 1.9530 1.7397 1.3683 1.2830 1.0426 
0.9700 0.9509 0.8215 2.0039 1.9528 1.7390 1.3697 1.2845 1.0415 
0.9737 0.9535 0.8145 2.0035 1.9525 1.7375 1.3712 1.2860 1.0390 
0.9751 0.9577 0.8129 2.0035 1.9525 1.7361 1.3725 1.2896 1.0370 
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0.9797 0.9609 0.8092 2.0036 1.9525 1.7352 1.3751 1.2922 1.0370 
0.9855 0.9652 0.8075 2.0040 1.9525 1.7335 1.3769 1.2945 1.0370 
0.9888 0.9685 0.8058 2.0036 1.9523 1.7328 1.3783 1.2964 1.0370 
0.9910 0.9712 0.8028 2.0030 1.9520 1.7303 1.3797 1.2984 1.0360 
0.9921 0.9754 0.8021 2.0030 1.9520 1.7307 1.3805 1.3001 1.0358 
0.9935 0.9788 0.8020 2.0028 1.9520 1.7280 1.3810 1.3025 1.0345 
0.9970 0.9820 0.7996 2.0026 1.9525 1.7276 1.3815 1.3044 1.0345 
Aerosol Coated 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
0.2949 0.3631 0.3416 0.4650 0.4212 0.4142 1.0768 1.0157 1.0200 
0.2995 0.3699 0.3649 0.4662 0.4254 0.4286 1.0820 1.0200 1.0401 
0.3054 0.3753 0.3840 0.4701 0.4306 0.4452 1.0879 1.0270 1.0632 
0.3104 0.3792 0.3985 0.4721 0.4340 0.4581 1.0916 1.0319 1.0949 
0.3139 0.3838 0.4130 0.4766 0.4352 0.4682 1.0977 1.0355 1.1306 
0.3191 0.3873 0.4257 0.4797 0.4397 0.4789 1.1021 1.0410 1.1607 
0.3232 0.3927 0.4404 0.4809 0.4424 0.4893 1.1092 1.0461 1.1867 
0.3263 0.3955 0.4548 0.4845 0.4461 0.5053 1.1154 1.0505 1.2260 
0.3301 0.3982 0.4706 0.4873 0.4493 0.5187 1.1195 1.0556 1.2604 
0.3332 0.4018 0.4855 0.4894 0.4514 0.5355 1.1267 1.0607 1.2983 
0.3368 0.4047 0.5051 0.4931 0.4544 0.5550 1.1331 1.0641 1.3159 
0.3396 0.4092 0.5251 0.4964 0.4561 0.5751 1.1376 1.0702 1.3083 
0.3419 0.4131 0.5508 0.4990 0.4613 0.6015 1.1504 1.0738 1.3055 
0.3461 0.4159 0.5816 0.5024 0.4622 0.6381 1.1564 1.0815 1.3050 
0.3494 0.4193 0.6210 0.5050 0.4661 0.6753 1.1682 1.0958 1.3057 
0.3524 0.4222 0.6601 0.5097 0.4679 0.7084 1.1792 1.1060 1.3070 
0.3563 0.4263 0.7013 0.5133 0.4711 0.7344 1.1836 1.1126 1.3070 
0.3581 0.4295 0.7391 0.5166 0.4742 0.7675 1.1885 1.1191 1.3050 
0.3624 0.4316 0.7826 0.5200 0.4776 0.8037 1.1975 1.1231 1.3085 
0.3671 0.4364 0.8220 0.5229 0.4817 0.8180 1.2032 1.1298 1.3137 
0.3696 0.4397 0.8444 0.5279 0.4857 0.8373 1.2120 1.1385 1.3207 
0.3718 0.4427 0.8711 0.5326 0.4885 0.8610 1.2210 1.1477 1.3282 
0.3758 0.4471 0.8873 0.5367 0.4897 0.8760 1.2269 1.1546 1.3401 
0.3787 0.4505 0.9072 0.5400 0.4946 0.8950 1.2369 1.1617 1.3517 
0.3832 0.4529 0.8653 0.5451 0.4983 0.9175 1.2461 1.1661 1.3658 
0.3868 0.4572 0.8661 0.5492 0.5027 0.9426 1.2523 1.1706 1.3772 
0.3897 0.4623 0.8756 0.5515 0.5071 0.9684 1.2614 1.1825 1.3907 
0.3939 0.4666 0.8917 0.5572 0.5108 0.9931 1.2711 1.1921 1.4011 
0.3981 0.4697 0.9013 0.5629 0.5140 1.0121 1.2778 1.1999 1.4167 
0.4014 0.4735 0.9158 0.5681 0.5191 1.0340 1.2870 1.2072 1.4326 
0.4052 0.4774 0.9264 0.5722 0.5228 1.0566 1.2942 1.2117 1.4496 
0.4077 0.4827 0.9337 0.5783 0.5254 1.0635 1.3051 1.2173 1.4643 
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0.4128 0.4896 0.9416 0.5815 0.5306 1.0607 1.3135 1.2276 1.4717 
0.4181 0.4940 0.9489 0.5884 0.5355 1.0585 1.3204 1.2367 1.4736 
0.4232 0.4999 0.9551 0.5957 0.5396 1.0601 1.3304 1.2424 1.4760 
0.4269 0.5067 0.9597 0.6023 0.5459 1.0661 1.3382 1.2532 1.4809 
0.4321 0.5114 0.9642 0.6074 0.5506 1.0716 1.3450 1.2629 1.4861 
0.4372 0.5218 0.9714 0.6143 0.5522 1.0776 1.3526 1.2697 1.4946 
0.4406 0.5272 0.9786 0.6202 0.5601 1.0826 1.3554 1.2790 1.5034 
0.4476 0.5361 0.9847 0.6286 0.5656 1.0854 1.3657 1.2834 1.5163 
0.4532 0.5437 0.9967 0.6362 0.5711 1.0845 1.3766 1.2942 1.5282 
0.4584 0.5496 1.0072 0.6420 0.5786 1.0848 1.3788 1.3110 1.5397 
0.4641 0.5522 1.0142 0.6514 0.5846 1.0835 1.3858 1.3167 1.5512 
0.4697 0.5601 1.0230 0.6600 0.5868 1.0860 1.3896 1.3223 1.5588 
0.4736 0.5655 1.0282 0.6740 0.5946 1.0880 1.3904 1.3325 1.5676 
0.4803 0.5740 1.0347 0.6767 0.6037 1.0900 1.3898 1.3400 1.5741 
0.4892 0.5802 1.0375 0.6861 0.6083 1.0945 1.3892 1.3454 1.5772 
0.4980 0.5895 1.0374 0.6954 0.6171 1.1002 1.3900 1.3472 1.5802 
0.5053 0.5974 1.0364 0.7024 0.6327 1.1056 1.3900 1.3469 1.5820 
0.5132 0.6034 1.0341 0.7138 0.6414 1.1116 1.3902 1.3454 1.5823 
0.5186 0.6136 1.0310 0.7253 0.6475 1.1164 1.3907 1.3438 1.5801 
0.5274 0.6235 1.0268 0.7319 0.6659 1.1196 1.3912 1.3424 1.5749 
0.5366 0.6379 1.0212 0.7418 0.6712 1.1225 1.3915 1.3419 1.5656 
0.5467 0.6426 1.0157 0.7492 0.6810 1.1226 1.3915 1.3400 1.5550 
0.5548 0.6557 1.0090 0.7551 0.6894 1.1235 1.3919 1.3395 1.5600 
0.5611 0.6695 1.0053 0.7644 0.6950 1.1230 1.3904 1.3395 1.5683 
0.5725 0.6804 0.9998 0.7752 0.7034 1.1209 1.3893 1.3395 1.5788 
0.5848 0.6891 0.9969 0.7844 0.7134 1.1195 1.3877 1.3395 1.5872 
0.5919 0.6967 0.9933 0.7924 0.7197 1.1207 1.3870 1.3395 1.5880 
0.6013 0.7073 0.9845 0.8019 0.7297 1.1175 1.3865 1.3395 1.5833 
0.6106 0.7182 0.9784 0.8091 0.7389 1.1131 1.3865 1.3396 1.5753 
0.6169 0.7280 0.9746 0.8181 0.7458 1.1041 1.3875 1.3400 1.5719 
0.6289 0.7361 0.9685 0.8289 0.7550 1.0973 1.3882 1.3400 1.5693 
0.6402 0.7455 0.9577 0.8385 0.7639 1.0842 1.3896 1.3400 1.5649 
0.6460 0.7549 0.9469 0.8449 0.7704 1.0753 1.3900 1.3400 1.5618 
0.6591 0.7672 0.9350 0.8527 0.7818 1.0660 1.3901 1.3400 1.5465 
0.6719 0.7788 0.9267 0.8565 0.7919 1.0589 1.3904 1.3401 1.5384 
0.6800 0.7902 0.9195 0.8581 0.7979 1.0518 1.3900 1.3407 1.5301 
0.6923 0.7994 0.9140 0.8621 0.8059 1.0484 1.3900 1.3415 1.5183 
0.7020 0.8102 0.9075 0.8669 0.8143 1.0463 1.3900 1.3415 1.5061 
0.7100 0.8195 0.9090 0.8729 0.8200 1.0436 1.3899 1.3411 1.4927 
0.7161 0.8297 0.9090 0.8771 0.8205 1.0507 1.3890 1.3405 1.4810 
0.7214 0.8335 0.9052 0.8841 0.8220 1.0590 1.3890 1.3403 1.4712 
0.7242 0.8378 0.8960 0.8882 0.8226 1.0643 1.3895 1.3399 1.4614 
0.7286 0.8430 0.8858 0.8971 0.8242 1.0660 1.3903 1.3394 1.4560 
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0.7360 0.8477 0.8692 0.9042 0.8316 1.0614 1.3923 1.3388 1.4516 
0.7403 0.8518 0.8455 0.9090 0.8368 1.0575 1.3936 1.3391 1.4384 
0.7508 0.8577 0.8151 0.9106 0.8388 1.0543 1.3942 1.3407 1.4344 
0.7581 0.8611 0.7851 0.9162 0.8468 1.0391 1.3951 1.3418 1.4245 
0.7617 0.8654 0.7485 0.9219 0.8514 1.0093 1.3958 1.3435 1.4129 
0.7661 0.8755 0.7116 0.9271 0.8590 0.9740 1.3975 1.3447 1.3986 
0.7730 0.8785 0.6953 0.9354 0.8646 0.9286 1.3994 1.3456 1.3772 
0.7777 0.8819 0.6843 0.9422 0.8704 0.8885 1.4012 1.3469 1.3507 
0.7851 0.8884 0.6774 0.9447 0.8732 0.8517 1.4025 1.3477 1.3196 
0.7924 0.8925 0.6718 0.9530 0.8793 0.8300 1.4053 1.3480 1.2979 
0.7967 0.8995 0.6675 0.9604 0.8838 0.8120 1.4082 1.3505 1.2817 
0.8042 0.9092 0.6634 0.9650 0.8912 0.8030 1.4095 1.3524 1.2745 
0.8099 0.9130 0.6613 0.9769 0.8978 0.7935 1.4106 1.3552 1.2694 
0.8141 0.9164 0.6580 0.9817 0.9029 0.7847 1.4137 1.3579 1.2645 
0.8188 0.9222 0.6555 0.9871 0.9097 0.7801 1.4166 1.3600 1.2612 
0.8217 0.9244 0.6526 0.9941 0.9150 0.7773 1.4181 1.3610 1.2575 
0.8273 0.9272 0.6506 0.9985 0.9222 0.7750 1.4217 1.3640 1.2549 
0.8326 0.9280 0.6527 1.0054 0.9287 0.7723 1.4230 1.3660 1.2524 
0.8377 0.9278 0.6490 1.0115 0.9359 0.7715 1.4246 1.3689 1.2478 
0.8412 0.9267 0.6360 1.0165 0.9411 0.7690 1.4283 1.3721 1.2459 
0.8443 0.9255 0.6371 1.0240 0.9468 0.7685 1.4323 1.3750 1.2420 
0.8460 0.9263 0.6365 1.0304 0.9507 0.7674 1.4352 1.3772 1.2399 
0.8498 0.9270 0.6380 1.0398 0.9576 0.7644 1.4393 1.3797 1.2395 
0.8509 0.9273 0.6365 1.0445 0.9631 0.7592 1.4415 1.3825 1.2380 
0.8484 0.9284 0.6350 1.0493 0.9673 0.7546 1.4456 1.3869 1.2370 
Aerosol Coated with Chlorhexidine 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1.0006 1.0847 1.0708 1.6285 1.5783 1.5943 0.7061 0.6262 0.5814 
1.0037 1.0875 1.0877 1.6351 1.5838 1.6419 0.7095 0.6301 0.5942 
1.0087 1.0898 1.1052 1.6400 1.5921 1.6842 0.7125 0.6329 0.6065 
1.0123 1.0955 1.1283 1.6461 1.5985 1.7287 0.7161 0.6369 0.6193 
1.0185 1.1010 1.1517 1.6509 1.6041 1.7779 0.7183 0.6407 0.6346 
1.0221 1.1039 1.1848 1.6568 1.6128 1.8245 0.7225 0.6444 0.6486 
1.0299 1.1102 1.2226 1.6632 1.6213 1.8755 0.7268 0.6472 0.6669 
1.0371 1.1163 1.2605 1.6720 1.6286 1.9309 0.7314 0.6511 0.6863 
1.0411 1.1197 1.2979 1.6804 1.6378 1.9821 0.7340 0.6539 0.7080 
1.0504 1.1259 1.3345 1.6853 1.6540 2.0180 0.7377 0.6576 0.7318 
1.0543 1.1305 1.3794 1.6938 1.6650 2.0318 0.7410 0.6607 0.7623 
1.0608 1.1369 1.4210 1.6992 1.6771 2.0490 0.7456 0.6647 0.8007 
1.0655 1.1438 1.4690 1.7072 1.6865 2.0685 0.7499 0.6671 0.8290 
1.0737 1.1486 1.5216 1.7180 1.6957 2.0897 0.7538 0.6717 0.8621 
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1.0789 1.1568 1.5736 1.7347 1.7057 2.1093 0.7594 0.6756 0.8967 
1.0876 1.1641 1.6209 1.7456 1.7092 2.1171 0.7635 0.6788 0.9247 
1.0979 1.1750 1.6501 1.7530 1.7223 2.1185 0.7670 0.6832 0.9386 
1.1145 1.1814 1.6635 1.7644 1.7293 2.1210 0.7716 0.6860 0.9508 
1.1204 1.1943 1.6763 1.7757 1.7429 2.1222 0.7763 0.6910 0.9736 
1.1314 1.2025 1.6895 1.7841 1.7553 2.1219 0.7810 0.6959 0.9946 
1.1378 1.2092 1.6834 1.7984 1.7642 2.1239 0.7845 0.6996 1.0169 
1.1486 1.2199 1.6820 1.8112 1.7769 2.1220 0.7902 0.7045 1.0381 
1.1550 1.2280 1.7021 1.8209 1.7855 2.1236 0.7948 0.7088 1.0567 
1.1675 1.2341 1.7167 1.8326 1.8026 2.1257 0.8003 0.7124 1.0782 
1.1795 1.2453 1.7353 1.8421 1.8129 2.1255 0.8056 0.7174 1.0980 
1.1870 1.2553 1.7015 1.8566 1.8349 2.1296 0.8115 0.7221 1.1147 
1.1999 1.2635 1.7125 1.8687 1.8517 2.1340 0.8149 0.7268 1.1296 
1.2117 1.2760 1.7042 1.8795 1.8680 2.1431 0.8222 0.7321 1.1362 
1.2189 1.2854 1.7349 1.8954 1.8893 2.1538 0.8288 0.7337 1.1390 
1.2307 1.2935 1.7693 1.9076 1.9169 2.1697 0.8336 0.7399 1.1400 
1.2404 1.3058 1.7955 1.9120 1.9348 2.1818 0.8397 0.7468 1.1449 
1.2475 1.3152 1.8146 1.9311 1.9479 2.1928 0.8432 0.7521 1.1492 
1.2565 1.3245 1.8345 1.9481 1.9665 2.1979 0.8525 0.7593 1.1592 
1.2652 1.3306 1.8535 1.9631 1.9890 2.2007 0.8614 0.7646 1.1671 
1.2772 1.3373 1.8685 1.9743 1.9992 2.1952 0.8695 0.7663 1.1752 
1.2891 1.3507 1.8771 1.9869 2.0140 2.1897 0.8759 0.7751 1.1765 
1.3022 1.3631 1.8823 1.9960 2.0237 2.1815 0.8840 0.7824 1.1796 
1.3125 1.3703 1.8867 2.0071 2.0363 2.1726 0.8883 0.7864 1.1840 
1.3253 1.3833 1.8895 2.0200 2.0428 2.1578 0.8982 0.7958 1.1853 
1.3357 1.3961 1.8927 2.0338 2.0443 2.1401 0.9180 0.8050 1.1925 
1.3495 1.4057 1.8965 2.0465 2.0474 2.1270 0.9244 0.8100 1.2006 
1.3625 1.4176 1.8992 2.0622 2.0511 2.1171 0.9328 0.8185 1.2075 
1.3778 1.4275 1.8996 2.0763 2.0550 2.1202 0.9378 0.8249 1.2125 
1.3877 1.4409 1.9005 2.0963 2.0614 2.1215 0.9485 0.8341 1.2176 
1.4034 1.4526 1.9021 2.1112 2.0662 2.1313 0.9594 0.8415 1.2169 
1.4158 1.4630 1.9071 2.1161 2.0704 2.1368 0.9657 0.8560 1.2223 
1.4273 1.4750 1.9105 2.1319 2.0759 2.1320 0.9733 0.8645 1.2214 
1.4423 1.4867 1.9099 2.1377 2.0822 2.1174 0.9801 0.8707 1.2205 
1.4548 1.5028 1.9036 2.1393 2.0903 2.1054 0.9903 0.8797 1.2201 
1.4738 1.5107 1.8925 2.1302 2.0957 2.1019 0.9981 0.8868 1.2191 
1.4899 1.5238 1.8781 2.1234 2.1056 2.0989 1.0009 0.8927 1.2146 
1.5028 1.5410 1.8650 2.1232 2.1102 2.0883 1.0114 0.9020 1.2080 
1.5192 1.5547 1.8595 2.1290 2.1175 2.0772 1.0202 0.9097 1.2052 
1.5292 1.5679 1.8620 2.1358 2.1271 2.0710 1.0303 0.9165 1.2011 
1.5321 1.5858 1.8654 2.1470 2.1333 2.0710 1.0414 0.9244 1.2015 
1.5396 1.5943 1.8657 2.1568 2.1373 2.0735 1.0507 0.9313 1.2019 
1.5429 1.6099 1.8682 2.1620 2.1416 2.0759 1.0586 0.9417 1.2020 
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1.5472 1.6248 1.8536 2.1700 2.1431 2.0817 1.0678 0.9471 1.2022 
1.5542 1.6317 1.8409 2.1757 2.1440 2.0865 1.0726 0.9531 1.2015 
1.5597 1.6388 1.8358 2.1798 2.1441 2.0885 1.0751 0.9636 1.1977 
1.5616 1.6490 1.8290 2.1848 2.1445 2.0900 1.0773 0.9699 1.1913 
1.5715 1.6538 1.8207 2.1888 2.1445 2.0848 1.0782 0.9804 1.1823 
1.5764 1.6618 1.8195 2.1943 2.1443 2.0725 1.0802 0.9895 1.1747 
1.5807 1.6675 1.8168 2.1985 2.1440 2.0547 1.0845 0.9947 1.1718 
1.5872 1.6697 1.8143 2.2015 2.1440 2.0280 1.0881 1.0000 1.1679 
1.5915 1.6723 1.8140 2.2065 2.1442 1.9990 1.0937 1.0019 1.1703 
1.5926 1.6755 1.8099 2.2102 2.1449 1.9674 1.0978 1.0041 1.1670 
1.5969 1.6796 1.8070 2.2130 2.1455 1.9390 1.1053 1.0094 1.1640 
1.5955 1.6827 1.8082 2.2157 2.1455 1.9104 1.1119 1.0140 1.1638 
1.5829 1.6862 1.8070 2.2170 2.1455 1.8982 1.1179 1.0170 1.1599 
1.5807 1.6890 1.8053 2.2173 2.1454 1.8915 1.1240 1.0204 1.1590 
1.5853 1.6913 1.8021 2.2181 2.1449 1.8873 1.1261 1.0263 1.1582 
1.5931 1.6975 1.7981 2.2183 2.1444 1.8835 1.1339 1.0299 1.1531 
1.5969 1.7029 1.7915 2.2176 2.1442 1.8804 1.1403 1.0399 1.1442 
1.5992 1.7063 1. 7853 2.2164 2.1451 1.8776 1.1445 1.0480 1.1334 
1.6026 1.7109 1.7714 2.2153 2.1455 1.8755 1.1511 1.0520 1.1171 
1.6072 1.7153 1.7427 2.2147 2.1455 1.8747 1.1557 1.0554 1.0991 
1.6120 1.7184 1.7013 2.2145 2.1460 1.8735 1.1631 1.0618 1.0840 
1.6213 1.7230 1.6543 2.2145 2.1464 1.8715 1.1682 1.0655 1.0575 
1.6268 1.7259 1.6146 2.2150 2.1460 1.8704 1.1711 1.0728 1.0233 
1.6286 1.7296 1.5589 2.2150 2.1458 1.8689 1.1763 1.0793 0.9869 
1.6316 1.7340 1.5272 2.2147 2.1452 1.8678 1.1811 1.0836 0.9534 
1.6388 1.7355 1.5047 2.2134 2.1438 1.8671 1.1861 1.0913 0.9313 
1.6439 1. 7377 1.4962 2.2129 2.1430 1.8659 1.1926 1.0976 0.9116 
1.6533 1.7412 1.4858 2.2125 2.1435 1.8641 1.1987 1.1010 0.9008 
1.6615 1.7435 1.4825 2.2124 2.1438 1.8635 1.2069 1.1057 0.8935 
1.6651 1.7436 1.4805 2.2116 2.1451 1.8620 1.2127 1.1087 0.8889 
1.6697 1.7421 1.4788 2.2103 2.1458 1.8610 1.2148 1.1144 0.8859 
1.6729 1.7430 1.4749 2.2100 2.1467 1.8595 1.2213 1.1213 0.8832 
1.6767 1.7433 1.4727 2.2100 2.1473 1.8585 1.2254 1.1278 0.8805 
1.6786 1.7448 1.4717 2.2100 2.1477 1.8576 1.2325 1.1324 0.8783 
1.6806 1.7471 1.4682 2.2100 2.1464 1.8555 1.2381 1.1386 0.8762 
1.6829 1.7517 1.4635 2.2096 2.1460 1.8544 1.2421 1.1429 0.8723 
1.6840 1.7567 1.4620 2.2088 2.1466 1.8532 1.2480 1.1488 0.8700 
1.6902 1.7613 1.4582 2.2080 2.1474 1.8512 1.2526 1.1550 0.8682 
1.6990 1.7663 1.4543 2.2075 2.1491 1.8490 1.2586 1.1602 0.8653 
1.7047 1.7695 1.4550 2.2075 2.1498 1.8489 1.2628 1.1642 0.8617 
1.7087 1.7731 1.4515 2.2080 2.1512 1.8478 1.2659 1.1701 0.8595 
1.7132 1.7772 1.4514 2.2092 2.1535 1.8467 1.2702 1.1742 0.8565 
1.7150 1.7807 1.4469 2.2102 2.1537 1.8475 1.2731 1.1794 0.8538 
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Dip and Aerosol Coated 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1.2349 1.1446 1.1829 0.3556 0.3034 0.2848 1.8419 1.8913 1.9670 
1.2387 1.1551 1.2099 0.3599 0.3086 0.3014 1.8495 1.9000 2.0111 
1.2437 1.1659 1.2362 0.3642 0.3122 0.3195 1.8572 1.9173 2.0517 
1.2527 1.1780 1.2755 0.3665 0.3167 0.3341 1.8626 1.9268 2.0837 
1.2617 1.1905 1.3232 0.3715 0.3203 0.3492 1.8802 1.9349 2.1258 
1.2674 1.2037 1.3620 0.3767 0.3257 0.3627 1.8918 1.9462 2.1582 
1.2755 1.2191 1.3959 0.3804 0.3296 0.3782 1.8992 1.9550 2.1806 
1.2807 1.2321 1.4360 0.3840 0.3325 0.3947 1.9118 1.9693 2.1964 
1.2915 1.2512 1.4717 0.3881 0.3372 0.4139 1.9234 1.9785 2.2109 
1.3004 1.2708 1.4887 0.3912 0.3410 0.4336 1.9322 1.9910 2.2252 
1.3075 1.2986 1.5021 0.3952 0.3446 0.4554 1.9428 2.0028 2.2309 
1.3185 1.3195 1.5031 0.4001 0.3482 0.4795 1.9519 2.0102 2.2402 
1.3277 1.3391 1.5052 0.4044 0.3496 0.5058 1.9647 2.0214 2.2527 
1.3450 1.3562 1.5086 0.4080 0.3558 0.5453 1.9776 2.0358 2.2572 
1.3586 1.3677 1.5187 0.4106 0.3602 0.5780 1.9898 2.0390 2.2581 
1.3666 1.3897 1.5225 0.4134 0.3636 0.6088 1.9981 2.0520 2.2641 
1.3766 1.4105 1.5283 0.4177 0.3666 0.6331 2.0126 2.0642 2.2675 
1.3850 1.4322 1.5326 0.4197 0.3697 0.6503 2.0249 2.0709 2.2718 
1.3962 1.4476 1.5350 0.4249 0.3706 0.6673 2.0339 2.0817 2.2777 
1.4068 1.4645 1.5335 0.4298 0.3757 0.6875 2.0468 2.0892 2.2789 
1.4180 1.4790 1.5366 0.4327 0.3808 0.7093 2.0582 2.1011 2.2770 
1.4259 1.4871 1.5375 0.4377 0.3846 0.7297 2.0670 2.1116 2.2801 
1.4366 1.4933 1.5373 0.4430 0.3877 0.7479 2.0781 2.1175 2.2834 
1.4454 1.5006 1.5419 0.4457 0.3927 0.7618 2.0869 2.1303 2.2879 
1.4579 1.5039 1.5477 0.4531 0.3965 0.7744 2.0999 2.1407 2.2930 
1.4673 1.5046 1.5495 0.4591 0.4002 0.7856 2.1097 2.1478 2.3077 
1.4753 1.5044 1.5561 0.4621 0.4053 0.7964 2.1190 2.1573 2.3203 
1.4868 1.5043 1.5627 0.4650 0.4097 0.8025 2.1332 2.1641 2.3341 
1.4959 1.5065 1.5645 0.4714 0.4133 0.8007 2.1438 2.1688 2.3500 
1.5042 1.5077 1.5670 0.4755 0.4191 0.7995 2.1537 2.1751 2.3627 
1.5091 1.5095 1.5720 0.4815 0.4237 0.8004 2.1671 2.1796 2.3756 
1.5135 1.5138 1.5750 0.4879 0.4282 0.8002 2.1775 2.1827 2.3883 
1.5244 1.5175 1.5740 0.4916 0.4328 0.8080 2.1847 2.1865 2.4013 
1.5281 1.5196 1.5720 0.4988 0.4372 0.8190 2.1972 2.1900 2.4058 
1.5315 1.5227 1.5735 0.5063 0.4437 0.8194 2.2072 2.1950 2.4095 
1.5377 1.5256 1.5720 0.5101 0.4485 0.8225 2.2142 2.1975 2.4072 
1.5430 1.5282 1.5720 0.5170 0.4501 0.8052 2.2226 2.2025 2.4090 
1.5467 1.5300 1.5668 0.5241 0.4575 0.8076 2.2272 2.2077 2.4096 
1.5520 1.5312 1.5697 0.5294 0.4649 0.8134 2.2303 2.2100 2.4109 
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1.5542 1.5321 1.5700 0.5385 0.4695 0.8195 2.2347 2.2122 2.4170 
1.5588 1.5317 1.5726 0.5471 0.4764 0.8312 2.2392 2.2162 2.4196 
1.5624 1.5315 1.5745 0.5530 0.4834 0.8370 2.2430 2.2185 2.4278 
1.5652 1.5315 1.5699 0.5601 0.4881 0.8384 2.2494 2.2221 2.4332 
1.5673 1.5331 1.5655 0.5641 0.4951 0.8280 2.2541 2.2246 2.4402 
1.5709 1.5350 1.5649 0.5817 0.4999 0.8199 2.2580 2.2257 2.4483 
1.5725 1.5351 1.5614 0.5906 0.5084 0.8238 2.2600 2.2274 2.4570 
1.5742 1.5349 1.5550 0.5964 0.5152 0.8234 2.2622 2.2298 2.4665 
1.5751 1.5339 1.5497 0.6053 0.5206 0.8216 2.2653 2.2315 2.4745 
1.5752 1.5342 1.5402 0.6126 0.5293 0.8185 2.2676 2.2334 2.4786 
1.5740 1.5366 1.5402 0.6217 0.5442 0.8123 2.2688 2.2357 2.4785 
1.5728 1.5402 1.5445 0.6342 0.5519 0.8074 2.2701 2.2402 2.4774 
1.5721 1.5435 1.5495 0.6434 0.5578 0.8074 2.2710 2.2442 2.4718 
1.5715 1.5460 1.5480 0.6513 0.5662 0.8091 2.2727 2.2474 2.4634 
1.5716 1.5464 1.5460 0.6592 0.5760 0.8115 2.2741 2.2514 2.4553 
1.5726 1.5482 1.5440 0.6646 0.5850 0.8132 2.2750 2.2539 2.4483 
1.5730 1.5524 1.5445 0.6726 0.5947 0.8115 2.2758 2.2552 2.4383 
1.5731 1.5551 1.5425 0.6817 0.6029 0.8077 2.2771 2.2568 2.4327 
1.5736 1.5591 1.5380 0.6861 0.6088 0.8107 2.2780 2.2587 2.4282 
1.5745 1.5616 1.5402 0.6905 0.6170 0.8155 2.2801 2.2596 2.4275 
1.5773 1.5625 1.5394 0.6982 0.6258 0.8095 2.2816 2.2602 2.4255 
1.5785 1.5627 1.5316 0.7049 0.6318 0.8101 2.2826 2.2610 2.4239 
1.5791 1.5650 1.5136 0.7079 0.6405 0.7956 2.2837 2.2613 2.4212 
1.5805 1.5656 1.5045 0.7180 0.6472 0.7854 2.2842 2.2629 2.4162 
1.5811 1.5678 1.4895 0.7215 0.6527 0.7779 2.2844 2.2658 2.4089 
1.5822 1.5705 1.4731 0.7243 0.6577 0.7719 2.2834 2.2672 2.4006 
1.5843 1.5720 1.4542 0.7301 0.6614 0.7662 2.2828 2.2691 2.3945 
1.5859 1.5719 1.4429 0.7356 0.6680 0.7616 2.2802 2.2704 2.3831 
1.5870 1.5707 1.4279 0.7402 0.6739 0.7547 2.2785 2.2710 2.3732 
1.5875 1.5705 1.4251 0.7472 0.6782 0.7484 2.2787 2.2710 2.3594 
1.5885 1.5691 1.4191 0.7532 0.6823 0.7424 2.2794 2.2712 2.3477 
1.5886 1.5685 1.4149 0.7584 0.6860 0.7396 2.2802 2.2717 2.3389 
1.5901 1.5695 1.4071 0.7635 0.6871 0.7365 2.2805 2.2720 2.3359 
1.5912 1.5700 1.3984 0.7671 0.6923 0.7344 2.2801 2.2725 2.3345 
1.5917 1.5704 1.3950 0.7715 0.6977 0.7307 2.2793 2.2736 2.3348 
1.5920 1.5678 1.3919 0.7797 0.7008 0.7345 2.2788 2.2750 2.3330 
1.5925 1.5675 1.3907 0.7866 0.7060 0.7328 2.2778 2.2758 2.3325 
1.5924 1.5680 1.3864 0.7910 0.7094 0.7218 2.2767 2.2776 2.3298 
1.5920 1.5665 1.3804 0.7988 0.7157 0.7163 2.2760 2.2791 2.3234 
1.5920 1.5640 1.3797 0.8061 0.7217 0.7083 2.2755 2.2802 2.3170 
1.5912 1.5668 1.3778 0.8115 0.7265 0.6963 2.2750 2.2816 2.3125 
1.5910 1.5687 1.3750 0.8187 0.7334 0.6827 2.2745 2.2821 2.3134 
1.5910 1.5700 1.3725 0.8221 0.7397 0.6624 2.2744 2.2829 2.3102 
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1.5916 1.5706 1.3718 0.8308 0.7448 0.6422 2.2741 2.2841 2.3019 
1.5925 1.5716 1.3679 0.8362 0.7504 0.6259 2.2746 2.2845 2.2866 
1.5930 1.5721 1.3700 0.8390 0.7552 0.6032 2.2751 2.2845 2.2694 
1.5930 1.5726 1.3663 0.8418 0.7623 0.5866 2.2756 2.2843 2.2489 
1.5929 1.5719 1.3643 0.8465 0.7689 0.5721 2.2760 2.2842 2.2319 
1.5925 1.5690 1.3607 0.8508 0.7726 0.5655 2.2757 2.2847 2.2247 
1.5923 1.5674 1.3609 0.8544 0.7772 0.5600 2.2745 2.2852 2.2198 
1.5914 1.5660 1.3578 0.8582 0.7803 0.5559 2.2731 2.2857 2.2159 
1.5907 1.5624 1.3541 0.8605 0.7837 0.5523 2.2723 2.2864 2.2077 
1.5897 1.5625 1.3517 0.8632 0.7880 0.5520 2.2717 2.2872 2.2050 
1.5890 1.5621 1.3490 0.8674 0.7916 0.5499 2.2715 2.2881 2.2036 
1.5900 1.5605 1.3470 0.8712 0.7951 0.5474 2.2709 2.2894 2.1987 
1.5906 1.5594 1.3445 0.8732 0.7977 0.5463 2.2700 2.2904 2.1942 
1.5917 1.5554 1.3400 0.8785 0.8006 0.5438 2.2700 2.2914 2.1904 
1.5931 1.5534 1.3439 0.8805 0.8030 0.5394 2.2700 2.2922 2.1880 
1.5939 1.5524 1.3404 0.8827 0.8063 0.5363 2.2695 2.2929 2.1838 
1.5958 1.5484 1.3367 0.8869 0.8089 0.5335 2.2695 2.2947 2.1796 
1.5971 1.5441 1.3348 0.8903 0.8113 0.5267 2.2695 2.2960 2.1754 
Dip and Aerosol Coated with Chlorhexidine 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
0.5312 0.3658 0.4786 0.5494 0.5439 0.5480 1.4946 1.3945 1.3784 
0.5355 0.3678 0.4995 0.5531 0.5476 0.5752 1.4993 1.4051 1.4044 
0.5395 0.3742 0.5129 0.5589 0.5516 0.5910 1.5059 1.4214 1.4307 
0.5443 0.3779 0.5245 0.5633 0.5587 0.6034 1.5111 1.4353 1.4671 
0.5492 0.3849 0.5330 0.5657 0.5641 0.6111 1.5198 1.4507 1.5170 
0.5535 0.3931 0.5420 0.5709 0.5670 0.6160 1.5277 1.4643 1.5630 
0.5600 0.3976 0.5514 0.5753 0.5736 0.6224 1.5339 1.4929 1.5920 
0.5653 0.3992 0.5662 0.5780 0.5778 0.6283 1.5436 1.5144 1.6312 
0.5737 0.4042 0.5851 0.5808 0.5804 0.6357 1.5532 1.5317 1.6641 
0.5803 0.4071 0.6036 0.5824 0.5844 0.6473 1.5684 1.5540 1.7015 
0.5909 0.4123 0.6221 0.5858 0.5861 0.6640 1.5764 1.5708 1.7246 
0.6007 0.4169 0.6469 0.5877 0.5898 0.6834 1.5851 1.5915 1.7360 
0.6096 0.4191 0.6730 0.5891 0.5933 0.7037 1.6009 1.6107 1.7468 
0.6217 0.4236 0.7133 0.5917 0.5957 0.7337 1.6170 1.6278 1.7541 
0.6314 0.4269 0.7558 0.5938 0.5970 0.7691 1.6264 1.6432 1.7629 
0.6420 0.4292 0.7905 0.5950 0.5992 0.8063 1.6345 1.6677 1.7747 
0.6531 0.4321 0.8244 0.5966 0.6004 0.8380 1.6427 1.6860 1.7864 
0.6644 0.4342 0.8654 0.5980 0.6021 0.8840 1.6507 1.7031 1.7999 
0.6783 0.4383 0.9047 0.5986 0.6033 0.9237 1.6625 1. 7209 1.8165 
0.6912 0.4401 0.9440 0.5999 0.6056 0.9657 1.6718 1.7311 1.8313 
0.7116 0.4431 0.9771 0.6014 0.6063 1.0143 1.6750 1.7423 1.8487 
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0.7399 0.4444 1.0017 0.6032 0.6077 1.0517 1.6875 1.7499 1.8642 
0.7579 0.4475 1.0253 0.6040 0.6089 1.0809 1.6997 1.7581 1.8791 
0.7813 0.4502 1.0515 0.6052 0.6106 1.0935 1.7072 1.7633 1.8893 
0.8000 0.4531 1.0721 0.6067 0.6121 1.1021 1.7183 1.7688 1.8968 
0.8155 0.4565 1.0949 0.6096 0.6129 1.1103 1.7261 1.7746 1.8984 
0.8400 0.4593 1.1141 0.6113 0.6147 1.1156 1.7353 1.7780 1.8934 
0.8583 0.4604 1.1306 0.6131 0.6164 1.1224 1.7442 1.7814 1.8875 
0.8789 0.4641 1.1495 0.6155 0.6178 1.1290 1.7570 1.7863 1.8867 
0.8969 0.4674 1.1648 0.6175 0.6194 1.1303 1.7631 1.7905 1.8825 
0.9156 0.4698 1.1717 0.6210 0.6205 1.1278 1.7690 1.7967 1.8790 
0.9398 0.4732 1.1698 0.6243 0.6230 1.1290 1.7840 1.8011 1.8797 
0.9608 0.4769 1.1613 0.6272 0.6263 1.1267 1.7962 1.8073 1.8792 
0.9803 0.4795 1.1464 0.6311 0.6287 1.1295 1.8066 1.8138 1.8807 
0.9954 0.4832 1.1310 0.6330 0.6314 1.1320 1.8138 1.8191 1.8852 
1.0092 0.4863 1.1260 0.6358 0.6346 1.1363 1.8257 1.8254 1.8925 
1.0227 0.4895 1.1237 0.6437 0.6376 1.1330 1.8349 1.8335 1.8998 
1.0304 0.4906 1.1285 0.6466 0.6419 1.1305 1.8403 1.8431 1.9066 
1.0407 0.4967 1.1359 0.6498 0.6456 1.1256 1.8485 1.8525 1.9115 
1.0569 0.5019 1.1410 0.6549 0.6495 1.1200 1.8556 1.8623 1.9188 
1.0681 0.5062 1.1447 0.6588 0.6521 1.1195 1.8600 1.8681 1.9244 
1.0805 0.5101 1.1490 0.6649 0.6577 1.1146 1.8657 1.8762 1.9310 
1.0955 0.5137 1.1540 0.6715 0.6609 1.1104 1.8710 1.8857 1.9411 
1.1064 0.5151 1.1606 0.6741 0.6680 1.1150 1.8739 1.8951 1.9486 
1.1178 0.5203 1.1726 0.6814 0.6738 1.1137 1.8766 1.9024 1.9546 
1.1261 0.5272 1.1819 0.6879 0.6788 1.1129 1.8797 1.9111 1.9560 
1.1360 0.5291 1.1921 0.6920 0.6837 1.1075 1.8822 1.9169 1.9550 
1.1450 0.5349 1.1997 0.6994 0.6891 1.1034 1.8839 1.9214 1.9501 
1.1530 0.5409 1.2016 0.7064 0.6945 1.1019 1.8863 1.9258 1.9413 
1.1639 0.5449 1.1955 0.7112 0.6981 1.0993 1.8881 1.9296 1.9333 
1.1726 0.5509 1.1922 0.7252 0.7075 1.0984 1.8905 1.9310 1.9248 
1.1818 0.5575 1.1772 0.7346 0.7140 1.0943 1.8937 1.9308 1.9175 
1.1911 0.5616 1.1607 0.7422 0.7190 1.0940 1.8955 1.9272 1.9095 
1.1971 0.5695 1.1594 0.7495 0.7330 1.0960 1.8961 1.9248 1.9012 
1.2012 0.5769 1.1560 0.7568 0.7376 1.0980 1.8981 1.9213 1.8925 
1.2010 0.5817 1.1418 0.7619 0.7469 1.1012 1.9001 1.9183 1.8898 
1.1997 0.5899 1.1459 0.7791 0.7570 1.1035 1.9013 1.9180 1.8895 
1.1974 0.5956 1.1568 0.7875 0.7679 1.1055 1.9049 1.9159 1.8906 
1.1910 0.6032 1.1631 0.8000 0.7785 1.1075 1.9075 1.9145 1.8912 
1.1823 0.6131 1.1620 0.8117 0.7883 1.1033 1.9086 1.9127 1.8877 
1.1719 0.6228 1.1540 0.8188 0.7946 1.0988 1.9123 1.9102 1.8828 
1.1638 0.6379 1.1544 0.8300 0.8035 1.0953 1.9158 1.9086 1.8761 
1.1555 0.6443 1.1636 0.8417 0.8148 1.0825 1.9185 1.9105 1.8708 
1.1508 0.6533 1.1612 0.8488 0.8215 1.0655 1.9217 1.9085 1.8650 
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1.1484 0.6656 1.1538 0.8592 0.8332 1.0425 1.9242 1.9080 1.8631 
1.1475 0.6788 1.1369 0.8672 0.8441 1.0212 1.9266 1.9077 1.8610 
1.1475 0.6881 1.1289 0.8806 0.8521 0.9941 1.9297 1.9050 1.8583 
1.1486 0.6949 1.1290 0.8912 0.8617 0.9702 1.9313 1.9061 1.8575 
1.1517 0.7026 1.1265 0.8977 0.8678 0.9484 1.9351 1.9086 1.8600 
1.1550 0.7083 1.1217 0.9116 0.8808 0.9381 1.9388 1.9096 1.8607 
1.1573 0.7225 1.1174 0.9234 0.8939 0.9311 1.9416 1.9113 1.8623 
1.1629 0.7285 1.1087 0.9322 0.9052 0.9230 1.9456 1.9152 1.8595 
1.1665 0.7385 1.1066 0.9459 0.9140 0.9184 1.9495 1.9186 1.8575 
1.1712 0.7453 1.1065 0.9578 0.9253 0.9114 1.9537 1.9221 1.8505 
1.1736 0.7560 1.1042 0.9677 0.9346 0.9085 1.9589 1.9250 1.8457 
1.1768 0.7651 1.0986 0.9796 0.9484 0.9025 1.9637 1.9285 1.8405 
1.1826 0.7745 1.0918 0.9906 0.9593 0.8980 1.9692 1.9308 1.8318 
1.1873 0.7802 1.0885 1.0060 0.9681 0.8913 1.9736 1.9334 1.8139 
1.1890 0.7922 1.0700 1.0136 0.9791 0.8875 1.9775 1.9373 1.7937 
1.1913 0.8037 1.0501 1.0219 0.9937 0.8859 1.9806 1.9412 1.7703 
1.1945 0.8113 1.0247 1.0366 1.0064 0.8819 1.9856 1.9439 1.7506 
1.2002 0.8229 0.9977 1.0432 1.0154 0.8762 1.9905 1.9460 1.7353 
1.2072 0.8330 0.9695 1.0561 1.0261 0.8741 1.9942 1.9482 1. 7319 
1.2106 0.8434 0.9413 1.0655 1.0333 0.8699 2.0001 1.9510 1.7302 
1.2163 0.8531 0.9232 1.0708 1.0421 0.8650 2.0058 1.9571 1.7269 
1.2239 0.8600 0.9146 1.0802 1.0520 0.8619 2.0105 1.9612 1.7241 
1.2313 0.8621 0.9089 1.0885 1.0611 0.8598 2.0135 1.9646 1.7214 
1.2360 0.8700 0.9052 1.0937 1.0666 0.8575 2.0168 1.9693 1.7181 
1.2417 0.8784 0.8991 1.0999 1.0744 0.8568 2.0217 1.9718 1. 7155 
1.2457 0.8852 0.8949 1.1042 1.0788 0.8542 2.0243 1.9746 1. 7124 
1.2495 0.8917 0.8933 1.1057 1.0834 0.8525 2.0282 1.9755 1. 7095 
1.2507 0.8967 0.8905 1.1076 1.0885 0.8510 2.0309 1.9755 1.7077 
1.2463 0.8986 0.8877 1.1087 1.0905 0.8494 2.0331 1.9763 1.7050 
1.2440 0.9060 0.8869 1.1110 1.0922 0.8443 2.0356 1.9763 1.7022 
1.2433 0.9143 0.8840 1.1128 1.0957 0.8425 2.0387 1.9754 1.6964 
1.2382 0.9206 0.8812 1.1137 1.0982 0.8399 2.0400 1.9742 1.6962 
1.2303 0.9284 0.8810 1.1148 1.0997 0.8349 2.0411 1.9709 1.6950 
1.2241 0.9342 0.8785 1.1158 1.1017 0.8317 2.0442 1.9665 1.6935 
1.2164 0.9361 0.8760 1.1167 1.1040 0.8280 2.0459 1.9613 1.6940 
1.2068 0.9437 0.8705 1.1174 1.1059 0.8255 2.0469 1.9567 1.6917 
Spin and Dip Coated 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
0.3667 0.3839 0.3704 0.6083 0.6346 0.6246 2.4397 2.4500 2.4665 
0.3695 0.3886 0.3927 0.6104 0.6364 0.6329 2.4565 2.4683 2.5127 
0.3741 0.3917 0.4085 0.6122 0.6384 0.6390 2.4871 2.4832 2.5483 
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0.3779 0.3962 0.4216 0.6133 0.6401 0.6463 2.5106 2.5069 2.5906 
0.3804 0.3989 0.4289 0.6154 0.6417 0.6556 2.5330 2.5217 2.6376 
0.3839 0.4023 0.4406 0.6173 0.6435 0.6693 2.5511 2.5924 2.6784 
0.3861 0.4062 0.4538 0.6186 0.6446 0.6842 2.5712 2.6312 2.7078 
0.3896 0.4098 0.4637 0.6207 0.6461 0.7006 2.5964 2.6527 2.7244 
0.3919 0.4111 0.4793 0.6232 0.6476 0.7208 2.6181 2.6742 2.7377 
0.3940 0.4152 0.4984 0.6249 0.6488 0.7449 2.6397 2.6891 2.7472 
0.3966 0.4178 0.5151 0.6276 0.6519 0.7825 2.6641 2.6997 2.7515 
0.3985 0.4196 0.5418 0.6303 0.6551 0.8263 2.6860 2.7078 2.7581 
0.4014 0.4225 0.5690 0.6320 0.6566 0.8657 2.7092 2.7160 2.7635 
0.4046 0.4247 0.6122 0.6353 0.6582 0.8997 2.7225 2.7231 2.7660 
0.4071 0.4268 0.6635 0.6390 0.6608 0.9424 2.7343 2.7289 2.7648 
0.4095 0.4291 0.6957 0.6417 0.6637 0.9818 2.7465 2.7337 2.7678 
0.4122 0.4324 0.7392 0.6452 0.6678 1.0269 2.7543 2.7375 2.7685 
0.4147 0.4354 0.7798 0.6480 0.6715 1.0711 2.7610 2.7395 2.7710 
0.4184 0.4375 0.8207 0.6523 0.6743 1.1169 2.7661 2.7401 2.7759 
0.4212 0.4409 0.8654 0.6564 0.6782 1.1429 2.7708 2.7417 2.7735 
0.4238 0.4441 0.8906 0.6597 0.6814 1.1614 2.7739 2.7483 2.7741 
0.4257 0.4465 0.9034 0.6652 0.6866 1.1745 2.7755 2.7523 2.7834 
0.4297 0.4494 0.9097 0.6703 0.6907 1.1945 2.7761 2.7547 2.7940 
0.4321 0.4529 0.9135 0.6739 0.6944 1.2099 2.7793 2.7550 2.7985 
0.4362 0.4573 0.9140 0.6791 0.7000 1.2307 2.7832 2.7545 2.8065 
0.4400 0.4603 0.9204 0.6833 0.7046 1.2430 2.7850 2.7545 2.8230 
0.4453 0.4627 0.9262 0.6869 0.7087 1.2611 2.7860 2.7540 2.8482 
0.4485 0.4668 0.9336 0.6927 0.7116 1.2779 2.7857 2.7559 2.8666 
0.4522 0.4704 0.9362 0.6978 0.7153 1.2909 2.7842 2.7582 2.8817 
0.4561 0.4741 0.9316 0.7023 0.7210 1.3047 2.7829 2.7596 2.8985 
0.4587 0.4793 0.9303 0.7095 0.7265 1.3111 2.7825 2.7598 2.9170 
0.4659 0.4832 0.9347 0.7144 0.7327 1.3272 2.7845 2.7599 2.9279 
0.4707 0.4846 0.9423 0.7199 0.7397 1.3278 2.7854 2.7626 2.9386 
0.4753 0.4922 0.9505 0.7246 0.7431 1.3254 2.7849 2.7655 2.9487 
0.4807 0.4970 0.9619 0.7290 0.7480 1.3164 2.7835 2.7662 2.9528 
0.4856 0.4986 0.9657 0.7380 0.7564 1.3078 2.7863 2.7656 2.9468 
0.4888 0.5047 0.9768 0.7472 0.7651 1.3131 2.7888 2.7672 2.9405 
0.4968 0.5087 0.9841 0.7534 0.7736 1.3141 2.7905 2.7681 2.9255 
0.5039 0.5160 0.9866 0.7628 0.7824 1.2998 2.7905 2.7703 2.9133 
0.5127 0.5227 0.9906 0.7859 0.7946 1.3016 2.7900 2.7744 2.9022 
0.5199 0.5279 0.9937 0.8010 0.8056 1.3012 2.7901 2.7772 2.9012 
0.5272 0.5357 0.9952 0.8067 0.8161 1.3055 2.7905 2.7795 2.8970 
0.5319 0.5416 0.9965 0.8129 0.8208 1.3049 2.7919 2.7836 2.8935 
0.5419 0.5507 0.9962 0.8236 0.8340 1.2946 2.7952 2.7880 2.8871 
0.5476 0.5583 0.9935 0.8360 0.8511 1.2896 2.8005 2.7887 2.8809 
0.5569 0.5647 0.9894 0.8491 0.8617 1.2850 2.8042 2.7944 2.8729 
149 
0.5679 0.5737 0.9814 0.8579 0.8694 1.2827 2.8062 2.8016 2.8727 
0.5740 0.5815 0.9777 0.8681 0.8818 1.2826 2.8079 2.8091 2.8713 
0.5908 0.5891 0.9651 0.8772 0.8917 1.2840 2.8060 2.8275 2.8647 
0.6022 0.5974 0.9517 0.8895 0.8982 1.2825 2.8117 2.8393 2.8667 
0.6122 0.6055 0.9416 0.8952 0.9108 1.2830 2.8254 2.8534 2.8707 
0.6202 0.6107 0.9335 0.9054 0.9222 1.2830 2.8302 2.8616 2.8791 
0.6299 0.6290 0.9228 0.9184 0.9299 1.2815 2.8406 2.8694 2.8851 
0.6371 0.6535 0.9153 0.9288 0.9426 1.2797 2.8554 2.8747 2.8952 
0.6512 0.6606 0.9057 0.9382 0.9520 1.2759 2.8649 2.8857 2.9025 
0.6673 0.6725 0.8956 0.9510 0.9578 1.2679 2.8725 2.8936 2.9129 
0.6761 0.6801 0.8863 0.9572 0.9709 1.2590 2.8793 2.9008 2.9199 
0.6894 0.6925 0.8790 0.9638 0.9827 1.2527 2.8878 2.9110 2.9302 
0.7001 0.7026 0.8758 0.9767 0.9901 1.2444 2.8967 2.9160 2.9361 
0.7082 0.7106 0.8710 0.9842 1.0022 1.2368 2.9039 2.9216 2.9427 
0.7187 0.7235 0.8692 0.9979 1.0124 1.2329 2.9115 2.9285 2.9462 
0.7297 0.7342 0.8695 1.0106 1.0199 1.2331 2.9180 2.9362 2.9475 
0.7381 0.7427 0.8711 1.0193 1.0332 1.2366 2.9226 2.9442 2.9405 
0.7504 0.7528 0.8725 1.0304 1.0450 1.2400 2.9286 2.9485 2.9370 
0.7609 0.7600 0.8764 1.0369 1.0554 1.2415 2.9341 2.9524 2.9253 
0.7700 0.7723 0.8810 1.0491 1.0678 1.2404 2.9438 2.9518 2.9186 
0.7801 0.7824 0.8840 1.0642 1.0794 1.2371 2.9496 2.9484 2.9067 
0.7908 0.7913 0.8850 1.0784 1.0942 1.2344 2.9546 2.9426 2.9013 
0.7981 0.8044 0.8858 1.0871 1.1047 1.2305 2.9553 2.9394 2.8980 
0.8115 0.8155 0.8840 1.0997 1.1132 1.2226 2.9520 2.9367 2.8983 
0.8231 0.8192 0.8805 1.1087 1.1243 1.2182 2.9471 2.9298 2.8895 
0.8365 0.8394 0.8848 1.1118 1.1308 1.2119 2.9428 2.9214 2.8860 
0.8461 0.8505 0.8673 1.1191 1.1351 1.2079 2.9424 2.9154 2.8839 
0.8537 0.8542 0.8367 1.1259 1.1411 1.2080 2.9351 2.9114 2.8787 
0.8583 0.8696 0.7979 1.1301 1.1441 1.2045 2.9259 2.9030 2.8749 
0.8653 0.8762 0.7610 1.1363 1.1491 1.2010 2.9189 2.8997 2.8752 
0.8689 0.8781 0.7329 1.1398 1.1550 1.1999 2.9139 2.9014 2.8737 
0.8721 0.8846 0.7252 1.1416 1.1591 1.1967 2.9073 2.8991 2.8770 
0.8746 0.8883 0.7209 1.1456 1.1622 1.1916 2.9010 2.8947 2.8810 
0.8762 0.8917 0.7194 1.1470 1.1650 1.1882 2.9015 2.8945 2.8810 
0.8777 0.8949 0.7156 1.1480 1.1661 1.1952 2.9016 2.8951 2.8851 
0.8789 0.8970 0.7149 1.1515 1.1699 1.1974 2.8980 2.8903 2.8945 
0.8809 0.8975 0.7110 1.1564 1.1751 1.1900 2.8956 2.8855 2.9023 
0.8825 0.9005 0.7080 1.1605 1.1803 1.1801 2.8980 2.8837 2.9023 
0.8830 0.9019 0.7077 1.1659 1.1839 1.1663 2.8943 2.8820 2.9030 
0.8832 0.9036 0.7060 1.1705 1.1878 1.1336 2.8885 2.8789 2.8943 
0.8835 0.9049 0.7039 1.1731 1.1895 1.1097 2.8874 2.8752 2.8780 
0.8837 0.9060 0.7014 1.1768 1.1908 1.0775 2.8849 2.8694 2.8574 
0.8837 0.9065 0.7038 1.1804 1.1953 1.0499 2.8801 2.8677 2.8243 
150 
0.8835 0.9060 0.7034 1.1860 1.2011 1.0321 2.8759 2.8691 2.7917 
0.8833 0.9060 0.6996 1.1911 1.2046 1.0188 2.8724 2.8703 2.7601 
0.8830 0.9064 0.6950 1.1967 1.2119 1.0132 2.8701 2.8666 2.7465 
0.8825 0.9060 0.6922 1.2005 1.2159 1.0110 2.8712 2.8632 2.7380 
0.8817 0.9055 0.6899 1.2038 1.2215 1.0087 2.8722 2.8609 2.7310 
0.8817 0.9062 0.6868 1.2110 1.2260 1.0047 2.8703 2.8585 2.7271 
0.8820 0.9077 0.6845 1.2130 1.2289 1.0010 2.8645 2.8599 2.7250 
0.8823 0.9091 0.6805 1.2148 1.2331 0.9979 2.8603 2.8627 2.7272 
0.8843 0.9111 0.6816 1.2196 1.2360 0.9935 2.8574 2.8650 2.7304 
0.8861 0.9115 0.6838 1.2249 1.2406 0.9916 2.8576 2.8705 2.7294 
0.8895 0.9127 0.6810 1.2286 1.2449 0.9907 2.8607 2.8746 2.7292 
Spin and Dip Coated with Chlorhexidine 
Catheter 1 Catheter 2 Catheter 3 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
0.3292 0.3480 0.3485 0.4491 0.4218 0.4217 0.5898 0.5882 0.6021 
0.3316 0.3562 0.3626 0.4538 0.4247 0.4341 0.5945 0.5938 0.6115 
0.3357 0.3621 0.3771 0.4556 0.4256 0.4456 0.6020 0.5990 0.6188 
0.3397 0.3697 0.3893 0.4578 0.4306 0.4549 0.6045 0.6024 0.6253 
0.3421 0.3779 0.4063 0.4617 0.4332 0.4696 0.6057 0.6068 0.6366 
0.3463 0.3826 0.4230 0.4636 0.4341 0.4854 0.6086 0.6099 0.6499 
0.3505 0.3905 0.4367 0.4672 0.4376 0.5029 0.6105 0.6136 0.6655 
0.3529 0.3995 0.4577 0.4723 0.4399 0.5204 0.6140 0.6188 0.6841 
0.3559 0.4069 0.4778 0.4741 0.4435 0.5418 0.6190 0.6228 0.6991 
0.3575 0.4136 0.4988 0.4764 0.4467 0.5643 0.6210 0.6289 0.7236 
0.3624 0.4226 0.5227 0.4808 0.4500 0.5983 0.6252 0.6336 0.7497 
0.3659 0.4310 0.5500 0.4837 0.4521 0.6252 0.6297 0.6408 0.7891 
0.3703 0.4397 0.5853 0.4883 0.4551 0.6542 0.6321 0.6489 0.8292 
0.3728 0.4486 0.6213 0.4923 0.4579 0.6820 0.6353 0.6542 0.8642 
0.3771 0.4577 0.6528 0.4952 0.4616 0.7131 0.6402 0.6658 0.9139 
0.3799 0.4696 0.6857 0.5005 0.4659 0.7432 0.6448 0.6727 0.9574 
0.3842 0.4790 0.7061 0.5058 0.4684 0.7637 0.6505 0.6815 0.9907 
0.3888 0.4911 0.7239 0.5088 0.4726 0.7756 0.6562 0.6910 1.0322 
0.3931 0.5027 0.7384 0.5141 0.4766 0.7900 0.6591 0.7007 1.0642 
0.3962 0.5142 0.7558 0.5192 0.4801 0.8055 0.6623 0.7133 1.0827 
0.4003 0.5277 0.7707 0.5229 0.4847 0.8200 0.6677 0.7255 1.0967 
0.4036 0.5430 0.7864 0.5281 0.4881 0.8382 0.6730 0.7417 1.1076 
0.4086 0.5578 0.8000 0.5316 0.4932 0.8546 0.6795 0.7644 1.1202 
0.4133 0.5748 0.8115 0.5384 0.4971 0.8731 0.6865 0.7812 1.1344 
0.4169 0.5876 0.8231 0.5438 0.5002 0.8882 0.6901 0.7958 1.1499 
0.4211 0.6021 0.8313 0.5479 0.5059 0.9055 0.6934 0.8254 1.1627 
0.4253 0.6142 0.8401 0.5546 0.5107 0.9161 0.7004 0.8445 1.1822 
0.4319 0.6317 0.8429 0.5602 0.5147 0.9270 0.7051 0.8674 1.1995 
151 
0.4362 0.6463 0.8368 0.5651 0.5187 0.9317 0.7127 0.8889 1.2175 
0.4398 0.6611 0.8325 0.5712 0.5231 0.9283 0.7195 0.9094 1.2365 
0.4461 0.6812 0.8279 0.5767 0.5262 0.9229 0.7247 0.9232 1.2520 
0.4534 0.6959 0.8236 0.5847 0.5334 0.9144 0.7338 0.9542 1.2705 
0.4596 0.7059 0.8208 0.5891 0.5386 0.9064 0.7427 0.9740 1.2826 
0.4646 0.7169 0.8173 0.5934 0.5423 0.9000 0.7497 0.9867 1.2958 
0.4725 0.7241 0.8134 0.6052 0.5497 0.9018 0.7584 1.0145 1.3016 
0.4782 0.7325 0.8125 0.6124 0.5534 0.9080 0.7654 1.0297 1.3080 
0.4820 0.7390 0.8120 0.6193 0.5605 0.9077 0.7766 1.0479 1.3111 
0.4892 0.7497 0.8125 0.6279 0.5642 0.9096 0.7847 1.0626 1.3130 
0.4962 0.7573 0.8156 0.6385 0.5724 0.9110 0.7906 1.0733 1.3092 
0.5016 0.7637 0.8203 0.6503 0.5797 0.9156 0.8019 1.0816 1.2980 
0.5095 0.7734 0.8255 0.6604 0.5853 0.9189 0.8217 1.0881 1.2925 
0.5152 0.7811 0.8327 0.6700 0.5941 0.9246 0.8344 1.0957 1.2845 
0.5193 0.7863 0.8396 0.6776 0.6019 0.9287 0.8448 1.1011 1.2781 
0.5275 0.7940 0.8434 0.6803 0.6079 0.9386 0.8516 1.1072 1.2780 
0.5342 0.8008 0.8490 0.6891 0.6156 0.9450 0.8630 1.1133 1.2846 
0.5398 0.8074 0.8534 0.7012 0.6239 0.9460 0.8808 1.1197 1.2851 
0.5473 0.8157 0.8596 0.7084 0.6367 0.9505 0.8894 1.1271 1.2745 
0.5590 0.8197 0.8658 0.7150 0.6430 0.9550 0.9033 1.1347 1.2774 
0.5689 0.8272 0.8633 0.7249 0.6515 0.9620 0.9148 1.1438 1.2825 
0.5787 0.8317 0.8597 0.7322 0.6573 0.9648 0.9232 1.1491 1.2842 
0.5871 0.8346 0.8574 0.7395 0.6690 0.9545 0.9335 1.1557 1.2843 
0.5929 0.8402 0.8575 0.7468 0.6807 0.9600 0.9471 1.1637 1.2775 
0.6009 0.8462 0.8575 0.7532 0.6832 0.9544 0.9598 1.1760 1.2763 
0.6063 0.8485 0.8574 0.7661 0.6923 0.9530 0.9675 1.1837 1.2729 
0.6186 0.8474 0.8542 0.7728 0.6974 0.9520 0.9788 1.1926 1.2665 
0.6290 0.8444 0.8502 0.7817 0.7062 0.9505 0.9865 1.2018 1.2536 
0.6374 0.8414 0.8460 0.7869 0.7153 0.9459 0.9980 1.2110 1.2383 
0.6404 0.8384 0.8437 0.7952 0.7209 0.9388 1.0103 1.2215 1.2227 
0.6499 0.8359 0.8351 0.8016 0.7304 0.9263 1.0187 1.2303 1.2018 
0.6549 0.8343 0.8259 0.8072 0.7398 0.9249 1.0290 1.2402 1.1822 
0.6667 0.8321 0.8166 0.8096 0.7457 0.9201 1.0373 1.2485 1.1755 
0.6751 0.8293 0.8155 0.8136 0.7539 0.9153 1.0472 1.2551 1.1751 
0.6806 0.8273 0.8079 0.8163 0.7625 0.9115 1.0515 1.2664 1.1759 
0.6823 0.8259 0.7996 0.8183 0.7702 0.9080 1.0571 1.2767 1.1746 
0.6887 0.8243 0.7927 0.8209 0.7721 0.9017 1.0632 1.2828 1.1771 
0.6912 0.8224 0.7867 0.8225 0.7766 0.8929 1.0687 1.2918 1.1775 
0.6970 0.8202 0.7855 0.8272 0.7795 0.8891 1.0738 1.2990 1.1819 
0.6999 0.8178 0.7834 0.8322 0.7839 0.8893 1.0770 1.3043 1.1821 
0.7032 0.8160 0.7792 0.8361 0.7871 0.8840 1.0801 1.3091 1.1759 
0.7088 0.8159 0.7896 0.8392 0.7910 0.8814 1.0826 1.3117 1.1729 
0.7134 0.8145 0.7864 0.8432 0.7931 0.8769 1.0864 1.3167 1.1727 
152 
0.7166 0.8140 0.7643 0.8458 0.7971 0.8747 1.0900 1.3195 1.1770 
0.7221 0.8135 0.7558 0.8498 0.8000 0.8739 1.0930 1.3200 1.1755 
0.7248 0.8140 0.7557 0.8551 0.8047 0.8697 1.0949 1.3215 1.1754 
0.7321 0.8144 0.7575 0.8586 0.8094 0.8782 1.0969 1.3237 1.1708 
0.7352 0.8156 0.7598 0.8614 0.8122 0.8800 1.0994 1.3243 1.1603 
0.7402 0.8186 0.7621 0.8648 0.8162 0.8785 1.1016 1.3225 1.1504 
0.7426 0.8216 0.7636 0.8683 0.8195 0.8774 1.1050 1.3173 1.1361 
0.7473 0.8232 0.7643 0.8740 0.8248 0.8747 1.1072 1.3061 1.1219 
0.7519 0.8250 0.7622 0.8794 0.8288 0.8644 1.1112 1.3030 1.1055 
0.7550 0.8292 0.7578 0.8836 0.8317 0.8498 1.1137 1.3030 1.0879 
0.7594 0.8322 0.7494 0.8895 0.8348 0.8341 1.1192 1.2984 1.0560 
0.7628 0.8350 0.7339 0.8940 0.8373 0.8129 1.1240 1.2904 1.0248 
0.7672 0.8386 0.7235 0.8984 0.8429 0.7823 1.1263 1.2891 1.0030 
0.7710 0.8418 0.7049 0.9021 0.8493 0.7488 1.1319 1.2880 0.9786 
0.7743 0.8440 0.6825 0.9057 0.8547 0.7204 1.1364 1.2826 0.9585 
0.7771 0.8461 0.6658 0.9136 0.8589 0.7124 1.1392 1.2820 0.9503 
0.7797 0.8495 0.6547 0.9167 0.8634 0.7082 1.1431 1.2832 0.9463 
0.7843 0.8523 0.6505 0.9208 0.8673 0.7021 1.1459 1.2867 0.9450 
0.7875 0.8553 0.6468 0.9244 0.8720 0.6994 1.1505 1.2899 0.9428 
0.7886 0.8581 0.6433 0.9294 0.8774 0.6944 1.1550 1.2895 0.9383 
0.7923 0.8623 0.6413 0.9333 0.8820 0.6876 1.1591 1.2875 0.9355 
0.7966 0.8661 0.6382 0.9378 0.8859 0.6855 1.1658 1.2854 0.9339 
0.7985 0.8691 0.6375 0.9412 0.8902 0.6849 1.1715 1.2785 0.9304 
0.8034 0.8706 0.6367 0.9464 0.8938 0.6820 1.1756 1.2776 0.9290 
0.8059 0.8681 0.6335 0.9508 0.8962 0.6793 1.1780 1.2836 0.9265 
0.8076 0.8645 0.6320 0.9531 0.9007 0.6790 1.1807 1.2874 0.9246 
0.8094 0.8630 0.6292 0.9564 0.9037 0.6780 1.1883 1.2880 0.9238 
0.8107 0.8619 0.6265 0.9578 0.9088 0.6771 1.1947 1.2895 0.9259 
0.8110 0.8606 0.6250 0.9611 0.9114 0.6720 1.1993 1.2921 0.9280 
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e. AFM and SEM images 
i. AFM Images 
Images of an uncoated catheter 
Images of a dip coated catheter 
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Images of a dip with chlorhexidine coated catheter 
Images of a spray coated catheter 
Images of a spray with chlorhexidine coated catheter 
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Images of an aerosolize coated catheter 
Images of an aerosolize with chlorhexidine coated catheter 
Images of a spray and dip coated catheter 
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,. 
Images of a spray and dip with chlorhexidine coated catheter 
Images of a dip and aerosolize coated catheter 
Images of a dip and aerosolize with chlorhexidine coated catheter 
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ii. SEM Images 
Dip outer coating with Chlorhexidine cross section 
Dip inner coating with Chlorhexidine cross section 
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Dip + Nebulizer cross section 
Dip+ Nebulizer cross section 
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Dip outer coating cross section 
Dip inner coating cross section 
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Nebulizer inner coating cross section 
Nebulizer inner coating cross section 
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Nebulizer outer coating cross section 
Spray dip outer coating cross section 
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Spray outer coating cross section 
Thick spray outer coating cross section 
163 
Thick Spray outer coating cross section 
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f. Statistical Analysis 
i. Antimicrobial 
Table 1: ANOVA test for E. coli ZOis (mm) at day 7 
Data sets analyzed A : Unooaced B : 1 C : l +C D : 2 E : 2 + C 
ANOVA summary 
F 10.8 
r value <O.OOOL 
r value summary •••• 
Significant diff. among means (P < 0.05)? Yes 
R square 0.6353 
Brown-Forsythe test 
F (DFn, DFd) 1.351 ( LO, 62) 
rva lue 0.2247 
r value summary ns 
Are SDs significant ly different (P < 0.05)? No 
Bartlett's test 
Bartlett's statistic ( corrected ) +infinity 
Pva lue <O.OOOL 
r value summary •••• 
Are SDs significant ly different (P < 0.05)? Yes 
ANOVAtable ss DF MS F (DFn , DFd) rva lue 
Treaanent (between columns) 233.5 10 23.35 F (LO, 62) = 10.!! P<0.0001 
Residual (within columns) 134 62 2.162 
Total 367.6 72 
Data summary 
Number of treatments (columns) 11 
Number of values (total) 73 
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Table 2: Comparison test for E. coli ZOis (mm) at day 7 
arisons test Mean Diff. 95.00"/4 Cl ofdifT. Si Ad ·u.s1ed r Value 
Uncoated vs. I -0.1667 -2 .82 10 2 .487 No l1ll >0 .9999 A-B 
Uncoated vs. I + C -0.5 -2.957 10 1.957 No l1ll 0.9998 A·C 
Uncoated vs. 2 0 -2.654 10 2.654 No l1ll >0 .9999 A-D 
Uncoated vs. 2 + C -3 -5 .654 10 -0 .3464 Yes 0 .0 146 A-E 
Uncoated vs. 3 0 -2.654 10 2.654 No llS >0.9999 A-F 
Uncoated vs. 3 + c -0.5 -2.957 10 1.957 No llS 0.9998 A-G 
Uncoated vs. 4 0 -2.654 to 2.654 No l1ll >0 .9999 A-H 
Uncoated vs. 4 + C -4.429 -6.972 10 -1.886 Yes .... <0 .0001 A-I 
Uncoated \'S. 5 -0.5 -3.154 10 2 .154 No llS >0.9999 A•J 
Uncoated vs. 5 + C -5 • 7 .654 10 -2.346 Yes <0 .0001 A-K 
I vs . l -C -0.3333 -2.987 10 2 .32 No llS >0.9999 B-C 
I vs . 2 0 .1667 -2.6710 3.003 No l1ll >0 .9999 B•D 
I vs . 2-C -2.833 -5.67 10 0.003485 No l1ll 0.0505 B•E 
vs . 3 0 .1667 -2.6710 3.003 No llS >0 .9999 B-F 
vs. 3-C -0.3333 -2.987 10 2 .32 No l1ll >0.9999 B-G 
VS. 4 0. 1667 -2.6710 3.003 No l1ll >0.9999 B-H 
vs . 4-C -4.262 -6.996 10 -1.528 Yes 0.000 1 B-1 
VS. 5 -0.3333 -3. l 7 10 2.503 No l1ll >0 .9999 B•J 
vs. 5-C -4.833 -7.6710 -1.997 Yes <0 .0001 B•K 
+ C\•s . 2 0.5 -2.15410 3. 154 No llS >0 .9999 C-D 
+ Cvs . 2 + C -2.5 -5.15410 0 .1536 No l1ll 0.082 1 C•E 
+ C vs. 3 0.5 -2.154 10 3. 154 No l1ll >0.9999 C·F 
+ Cvs . 3 + C 0 -2.457 10 2 .457 No l1ll >0 .9999 C-G 
+ CVS. 4 0.5 -2.154 10 3.154 No l1ll >0.9999 C-H 
+Cvs . 4 + C -3 .929 -6.472 10 -1.386 Yes 0 .000 1 C-1 
+ C vs . .5 0 -2.654 10 2 .654 No l1ll >0.9999 c.J 
l +Cvs . .5+ C -4.5 •7.15410 -1.846 Yes .... <0 .0001 C-K 
2vs. 2-C -3 -5 .837 10 -0 .1632 Yes 0 .0296 D·E 
2 vs . 3 0 -2.837 10 2 .837 No l1ll >0.9999 D•F 
2vs . 3 - C -0.5 -3. 154102 .154 No l1ll >0.9999 D-G 
2 vs . 4 0 -2.837 10 2 .837 No l1ll >0.9999 D•H 
2 vs . 4 - C -4.429 •7.16210 - 1.69.5 Yes .... <0 .0001 D•I 
2 vs . 5 -0.5 ·3.337 10 2.337 No l1ll >0.9999 D•J 
2vs . 5-C -5 -7.837 10 -2.163 Yes .... <0.0001 D•K 
2 + Cvs . 3 3 0 .1632 to .5.837 Yes . 0.0296 E·F 
2 + C\·s . 3 + C 2.5 -0.153610 5.154 No l1ll 0.082 1 E•G 
2+Cvs . 4 3 0 .1632 to .5.837 Yes 0.0296 E•H 
2+C\ •s. 4+C •1.429 •4 .162 10 1.305 No llS 0.8055 E•I 
2 + C\'S . 5 2.5 -0.3368 10 5.337 No l1ll 0.1329 E-J 
2 + Cvs . 5 + C -2 -4.837 10 0 .8368 No llS 0.4 11 E-K 
3 vs . 3-C -0 . .5 -3.154102 .154 No l1ll >0.9999 f.Q 
3 vs . 4 0 -2.837 10 2.837 No l1ll >0 .9999 F-H 
3 vs . 4-C -4.429 -7.16210- 1.695 Yes .... <0.0001 f.J 
3 vs . .5 -0 . .5 -3.337 10 2 .337 No llS >0.9999 f.J 
3 vs . 5- C • .5 •7.83710 -2 .163 Yes .... <0.0001 f•K 
3+Cvs . 4 0 .5 •2.154 10 3.154 No l1ll >0.9999 G·H 
3+Cvs.4 + C -3.929 -6.472 10 -1.386 Yes ... 0.000 1 G-1 
3 + Cvs . .5 0 -2.654 10 2 .654 No l1ll >0.9999 Q.J 
3 + C\·s . .5+ C -4.5 -7.15410 -1.846 Yes .... <0.0001 G·K 
4vs. 4-C -4.429 -7.162 10 -1.695 Yes <0 .0001 H•l 
4 vs . 5 -0.5 -3.337 10 2 .337 No l1ll >0.9999 H•J 
4 vs. 5- C .5 •7.837 10 -2. 163 Yes .... <0 .0001 H•K 
4+C\'S . .5 3.929 1.195 to 6.662 Yes ... 0.0005 l•J 
4+Cvs . .5+C -0.5714 .J .305 10 2 .162 No l1ll 0.9998 l•K 
5 vs. 5- C -4 . .5 -7.33710 -1.663 Yes .... <0 .0001 J•K 
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Table 3: Comparison test for E. coli ZOis (mm) at day 7 
Test details Mean I Mean2 Mean Diff. SEo f diff. n l n2 9 OF 
Uncoated vs. I 8 8.167 -0. 1667 0.794 1 8 6 0.2968 62 
Uncoated vs. I + C 8 8.5 -0.5 0.7352 8 8 0.96 18 62 
Uncoated vs. 2 8 8 0 0.794 1 8 6 0 62 
Uncoated VS. 2 + C 8 11 -3 0.794 1 8 6 5.343 62 
Uncoated vs. 3 8 8 0 0.794 1 8 6 0 62 
Uncoated vs. 3 + C 8 8.5 -0.5 0.7352 8 8 0.96 18 62 
Uncoated vs. 4 8 8 0 0.794 1 8 6 0 62 
Uncoated vs. 4 + C 8 12.43 -4.429 0.76 1 8 7 8.23 62 
Uncoated vs. :5 8 8.5 -0.5 0.7941 8 6 0.8904 62 
Uncoated vs. :5 + C 8 13 -5 0.794 1 8 6 8.904 62 
vs. 1-C 8.167 8.5 -0.3333 0.794 1 6 8 0.5936 62 
vs. 2 8.167 8 0.1667 0.8489 6 6 0.2776 62 
vs. 2-C 8.167 11 -2.833 0.8489 6 6 4.72 62 
VS. 3 8.167 8 0.1667 0.8489 6 6 0.2776 62 
vs. 3-C 8.167 8.5 -0.3333 0.794 1 6 8 0.5936 62 
vs. 4 8.167 8 0.1667 0.8489 6 6 0.2776 62 
vs. 4-C 8.167 12.43 -4.262 0.8181 6 7 7.368 62 
vs. 5 8.167 8.5 -0.3333 0.8489 6 6 0.5553 62 
vs. 5-C 8.167 13 -4.833 0.8489 6 6 8.052 62 
+ Cvs . 2 8.5 8 0.5 0.7941 8 6 0.8904 62 
+ Cvs . 2 + C 8.5 11 -2.5 0.794 1 8 6 4 .452 62 
+ C vs. 3 8.5 8 0.5 0.7941 8 6 0.8904 62 
+ Cvs . J + C 8.5 8.5 0 0.7352 8 8 0 62 
+ C vs. 4 8.5 8 0.5 0 .7941 8 6 0.8904 62 
+ Cvs . 4 + C 8.5 12.43 -3.929 0.76 1 8 7 7.301 62 
+ C vs. 5 8.5 8.5 0 0.7941 8 6 0 62 
+ Cvs . :5+ C 8.5 13 -4.5 0.7941 8 6 8.0 14 62 
2 vs. 2-C 8 11 -3 0.8489 6 6 4.998 62 
2 vs. 3 8 8 0 0.8489 6 6 0 62 
2 vs. 3-C 8 8.5 -0.5 0.7941 6 8 0.8904 62 
2 vs. 4 8 8 0 0.8489 6 6 0 62 
2 vs. 4-C 8 12.43 -4.429 0.8181 6 7 7.656 62 
2 vs. 5 8 8.5 -0.5 0.8489 6 6 0.8329 62 
2 vs. 5-C 8 13 .5 0.8489 6 6 8.329 62 
2 + Cvs . 3 II 8 3 0.8489 6 6 4.998 62 
2 + Cvs . 3 + C 11 8.5 2 .5 0.7941 6 8 4.452 62 
2 + Cvs . 4 11 8 3 0.8489 6 6 4.998 62 
2 + Cvs . 4 + C 11 12.43 -l.429 0.8181 6 7 2.47 62 
2 + Cvs . :5 11 8.5 2.5 0.8489 6 6 4.165 62 
2 + Cvs . :5+ C 11 13 -2 0.8489 6 6 3.332 62 
3 vs. 3-C 8 8.5 -0.5 0.794 1 6 8 0.8904 62 
3 vs . 4 8 8 0 0.8489 6 6 0 62 
3vs . 4-C 8 12.43 -4.429 0.8181 6 7 7.656 62 
3 vs . 5 8 8.:5 -0.5 0.8489 6 6 0.8329 62 
3vs. 5-C 8 13 .5 0.8489 6 6 8.329 62 
3 + Cvs . 4 8.5 8 0.5 0.794 1 8 6 0.8904 62 
3 + Cvs . 4 + C 8.5 12.43 -3.929 0.761 8 7 7 .301 62 
3 + Cvs . 5 8.5 8.5 0 0.794 1 8 6 0 62 
3 + Cvs . :5+ C 8.5 13 -4.5 0.794 1 8 6 8.0 14 62 
4vs . 4-C 8 12.43 -4.429 0.8181 6 7 7.656 62 
4vs . 5 8 8.5 -0.5 0.8489 6 6 0.8329 62 
4vs . 5-C 8 13 -5 0.8489 6 6 8.329 62 
4 +C vs. :5 12 .43 8.5 3.929 0.8181 7 6 6 .792 62 
4+C vs. :5 + C 12 .43 13 -0.5714 0.8181 7 6 0.9879 62 
:5 VS. 5 - C 8.5 13 -4.5 0.8489 6 6 7.496 62 
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Table 4: Column statistics for E. coli ZOis (mm) at day 7 
Uncoated I + C 2 2 + C 3 3+C 4 4 + C s S+C 
Number of values 8 6 8 6 6 6 8 6 7 6 6 
Minimum 8 8 8 8 3 8 8 8 8 8 12 
25% Percentile 8 8 8 8 9.75 8 8 8 12 8 12.75 
Median 8 8 8 8 12 8 8 8 13 8 13 
75% Percentile 8 8.25 9 8 13.25 8 8 8 14 8.75 13.25 
Maximum 8 9 10 8 14 8 12 8 14 II 14 
Mean 8 8.167 8.5 8 II 8 8.5 8 12.43 8.5 13 
Std. Deviation 0 0.4082 0.7559 0 4 0 1.414 0 2.07 1.225 0.6325 
Std. Error of Mean 0 0. 1667 0.2673 0 1.633 0 0.5 0 0.7825 0.S 0.2582 
Lower 95% Cl of mean 8 7.738 7.868 8 6 .802 8 7.318 8 10.SI 7.2 15 12.34 
Upper 95% CI of mean 8 8.595 9.132 8 15.2 8 9.682 8 14.34 9.785 13.66 
Sum 64 49 68 48 66 48 68 48 87 51 78 
Table 5: ANOVA test for S. aureus ZOis (mm) at day 7 
Data secs analyzed A : Unooated B : 1 C : 1 -t-C D : 2 E:2-t-C 
ANOVA summary 
f 61.56 
Pva lue <0.0001 
r value summary •••• 
Significant diff. among means (P < 0.05)? Yes 
Rsquare 0.90 18 
Brown-Forsythe rest 
F (DFn , DFd) 3. 173 ( 10, 67) 
Pva lue 0.0022 
r value summary •• 
Are SDs significantly different (P < 0.05)? Yes 
Bartlett's test 
Bartlett's statistic (corrected) +infinity 
rva lue <0.0001 
r value summary •••• 
Are SDs significantly different (P < 0.05)? Yes 
ANOVA table ss OF MS F (DFn , DFd) Pva lue 
Treacment (between columns) 564.5 10 56.45 F ( 10, 67) = 61.56 P<0.0001 
Residual (within columns} 6 1.44 67 0.9 17 
Total 625.9 77 
Data summary 
Number of treatments (columns) II 
Number of values (total} 78 
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Table 6: Comparison test for S. aureus ZOis (mm) at day 7 
arisons test Mean Diff. 95.00% Cl of diff. Si ificant? Summ Ad'usted r Value 
Uncoated vs. I -1 -2.514100 .5 137 No I\S 0.5119 A-B 
Uncoated vs. I + C -0.625 -2. 139 10 0 .8887 No I\S 0.950 1 A-C 
Uncoated vs. 2 .0.1667 -1.815 to 1.48 1 No I\S >0 .9999 A-D 
Uncoated vs . 2 + C -5.667 -7.315 to -4.0 19 Yes .... <0.0001 A-E l 
Uncoated vs . 3 -0.3333 -1.981 to 1.315 No I\S 0.9998 A-F 
Uncoated vs . 3 + C -0.1667 -1.815 to 1.48 1 No I\S >0.9999 A-G 
Uncoated vs . 4 0 -1.648 to 1.648 No I\S >0.9999 A-H 
Uncoated vs. 4 + C -6.6 -8.027 to -5.173 Yes .... <0 .0001 A-1 
Uncoated vs . :S 0 -1.648 to 1.648 No I\S >0.9999 A-J 
Uncoated vs. :S + C -6. 167 -7.815 lo -4.5 19 Yes •••• <0 .0001 A-K 
vs . 1-c 0 .375 -1.221 to 1.97 1 No I\S 0.9994 B-C 
vs . 2 0 .8333 .0 .890 I 10 2 .557 No I\S 0.87 19 B-D 
vs . 2 - C -4.667 -6 .39 10 -2.943 Yes .... <0 .0001 B-E 
vs. 3 0 .6667 • 1.057 to 2 .39 No I\S 0.9676 B-F 
vs . 3-C 0 .8333 -0.890 I 10 2 .557 No I\S 0.87 19 B-G 
vs . 4 -0. 7234 to 2. 723 No I\S 0.6934 B-H 
vs. 4-C -5.6 -7.114to-4 .086 Yes .... <0 .0001 B-1 
vs . 5 -0.7234 to2 .723 No I\S 0.6934 B-J 
VS. 5-C -5. 167 -6.89 10 -3.443 Yes .... <0 .0001 B-K 
+Cvs . 2 0.4583 -1.265 to 2 . 182 No I\S 0.9982 C-D 
+Cvs . 2 + C -5.042 -6.765 to -3.3 18 Yes .... <0 .0001 C-E 
+ C vs. 3 0.29 17 -1.432 to2.0 15 No I\S >0.9999 C-F 
+Cvs . 3 +C 0 .4583 -1.265102 .182 No I\S 0.9982 C-G 
+ C vs. 4 0.625 -1.098 10 2 .348 No I\S 0.9794 C-H I 
+Cvs . 4+C -5.975 -7.489 to -4.46 1 Yes .... <0 .0001 C-1 
+C vs. :S 0.625 -1.09810 2.348 No I\S 0.9794 C-J 
+Cvs . 5+C -5.542 -7.265 10 -3.818 Yes .... <0 .0001 C-K 
2vs . 2-C -5.5 -7.342 to -3.658 Yes •••• <0.0001 D-E 
2 vs . 3 -0. 1667 -2.009 10 1.676 No I\S >0.9999 D-F 
2vs . 3-C 0 -1.842 IO 1.842 No I\S >0.9999 D-G I 
2 vs. 4 0.1667 -1.676 to 2.009 No Ill! >0 .9999 D-H 
2vs . 4-C -6.433 -8.08 I to -4. 785 Yes .... <0.0001 D-1 
2 vs. 5 0 .1667 -1.676 to 2.009 No Ill! >0.9999 D-J 
2vs.5-C -6 -7.842 to-4. 158 Yes .... <0.0001 D-K 
2+Cvs . 3 5.333 3.49 1 to 7.176 Yes .... <0.0001 E-F 
2+Cvs . 3+C 5.5 3.658 to 7.342 Yes .... <0.0001 E-G 
2+Cvs . 4 5.667 3 . 824 to 7.509 Yes .... <0.0001 E-H 
2+Cvs . 4 + C -0.9333 -2.581100 .7145 No Ill! 0.723 E-1 
2+C vs. :S 5.667 3.824 to 7.509 Yes .... <0.0001 E-J 
2 + C vs . 5 + C -0.5 -2.342 to 1.342 No l1ll 0.9978 E-K 
3 vs . 3-C 0. 1667 -1.676 to 2.009 No Ill! >0.9999 F-G 
3 vs. 4 0.3333 -1.509 to 2 .176 No Ill! >0.9999 F-H 
3 vs . 4-C -6.267 -7.915 to -4.6 19 Yes .... <0 .0001 F-I 
3 vs . 5 0.3333 -1.509to2. 176 No I\S >0.9999 f.J 
3 vs . 5-C -5.833 -7.676 to -3.99 1 Yes .... <0.0001 F-K 
3 +C vs . 4 0. 1667 -1.676 to 2.009 No Ill! >0.9999 G-H 
3 +C vs. 4 +C -6.433 -8.081 to -4.785 Yes .... <0.0001 G-1 
3 +C vs . :S 0. 1667 -1.676 to 2.009 No l1ll >0.9999 G-J 
3 + C vs. :S +C -6 -7.842 to -4.158 Yes .... <0.0001 G-K 
4vs . 4- C -6.6 -8.248 to -4.952 Yes .... <0.0001 H-I 
4vs . 5 0 -1.842 to 1.842 No I\S >0 .9999 H-J 
4vs . 5-C -6.167 -8.009 to -4.324 Yes .... <0 .0001 H-K 
4+C vs. :S 6 .6 4 .952 to 8.248 Yes .... <0.0001 1-J 
4+ C vs . S +C 0 .4333 -1.215 to 2 .08 I No l1ll 0.9983 1-K 
5 vs. 5-C -6. 167 -8.009 to -4.324 Yes .... <0.0001 J-K I 
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Table 7: Comparison test for S. aureus ZOis (mm) at day 7 
Test details Mean l Mean2 Mean Diff. SEo f diff. n l n2 9 DF 
Uncoated , •s. I 8 9 -1 0.4542 10 8 3.IIJ 67 
Uncoated vs. I + C 8 8.625 -0.625 0.4542 10 8 1.946 67 
Uncoated vs. 2 8.167 -0.1667 0.4945 10 6 0.4766 67 
Uncoated vs. 2 + C 8 13.67 ·5.667 0.4945 10 6 16.2 1 67 
Uncoated ,·s. 3 8 8.333 -0.3333 0.4945 10 6 0.9533 67 
Uncoated vs. 3 + C 8 8.167 -0 .1667 0.4945 10 6 0.4766 67 
Uncoated , •s. 4 8 8 0 0.4945 10 6 0 67 
Uncoated ,•s. 4 + C 8 14 .6 -6 .6 0.4283 10 10 2 1.79 67 
Uncoated vs. 5 8 8 0 0.4945 10 6 0 67 
Uncoated vs. 5 + C 8 14.17 -6.167 0.4945 10 6 17.64 67 
Vll. I -C 9 8.625 0.375 0.4788 8 1.108 67 
Vll. 2 9 8.167 0.8333 0.5172 6 2.279 67 
Vll. 2 - C 9 13.67 4 .667 0.5172 6 12 .76 67 
Vll. 3 9 8.333 0.6667 0.5172 6 1.823 67 
Vll. 3 -C 9 8.167 0.8333 0.5172 6 2 .279 67 
Vll. 4 9 8 I 0.5172 6 2 .734 67 
vs . 4-C 9 14.6 -5.6 0.4542 10 17.43 67 
Vll . 5 9 8 0.5172 6 2. 734 67 
Vll. 5 - C 9 14.17 -5.167 0.5172 6 14 .13 67 
+ C vs. 2 8.625 8.167 0.4583 0.5172 6 1.253 67 
+ C, •s. 2 + C 8.625 13.67 -5.042 0.5 172 6 13.79 67 
+ C vs. 3 8.625 8.333 0.29 17 0.5172 6 0 .7976 67 
+ C, •s. 3 + C 8.625 8.167 0.4583 0.5172 6 1.253 67 
+ C vs. 4 8.625 8 0.625 0.5172 6 1.709 67 
+ C,•s . 4 + C 8.625 14 .6 -5.975 0.4542 10 18.6 67 
+ C vs. 5 8.625 8 0.625 0.5 172 6 1.709 67 
l+ C,·s . 5 + C 8.625 14. 17 -5.542 0.5 172 6 15.15 67 
2vs . 2-C 8.167 13.67 .5.5 0.5529 6 6 14.07 67 
2 Vll. 3 8.167 8.333 -0.1667 0.5529 6 6 0.4263 67 
2vs . 3-C 8.167 8.167 0 0.5529 6 6 0 67 
2 Vll. 4 8.167 8 0.1667 0.5529 6 6 0.4263 67 
2 Vll. 4 -C 8.167 14.6 -6.433 0.4945 6 10 18.4 67 
2 Vll. 5 8.167 8 0.1667 0.5529 6 6 0.4263 67 
2Vll. 5 -C 8.167 14 .17 -6 0.5529 6 6 15.35 67 
2 + C, •s. 3 13.67 8.333 5.333 0.5529 6 6 13.64 67 
2 + C, •s. 3 + C 13.67 8.167 5.5 0.5529 6 6 14.07 67 
2 + Cvs . 4 13.67 8 5.667 0.5529 6 6 14.49 67 
2 + Cvs . 4 + C 13.67 14.6 -0.9333 0.4945 6 10 2.669 67 
2+Cvs . 5 13.67 8 5.667 0.5529 6 6 14.49 67 
2 + Cvs . 5 + C 13.67 14 .17 -0.5 0.5529 6 6 1.279 67 
3 Vll. 3 -C 8.333 8.167 0 .1667 0.5529 6 6 0.4263 67 
3 Vll. 4 8.333 8 0.3333 0.5529 6 6 0.8526 67 
3 Vll. 4 - C 8.333 14.6 -6.267 0.4945 6 10 17.92 67 
3 Vll. 5 8.333 0.3333 0.5529 6 6 0.8526 67 
3 Vll. 5 - C 8.333 14. 17 •5.833 0.5529 6 6 14.92 67 
3+Cvs . 4 8.167 8 0.1667 0.5529 6 6 0.4263 67 
3 + C,·s . 4 + C 8.167 14.6 -6.433 0.4945 6 10 18.4 67 
3 + Cvs . 5 8.167 0.1667 0.5529 6 6 0.4263 67 
3 + Cvs . 5 + C 8. 167 14. 17 -6 0.5529 6 6 15.35 67 
4Vll. 4 -C 8 14.6 -6.6 0.4945 6 10 18.87 67 
4 Vll. 5 8 8 0 0.5529 6 6 0 67 
4 Vll. 5 -C 8 14.17 -6.167 0.5529 6 6 15.77 67 
4 + Cvs . 5 14.6 8 6.6 0.4945 10 6 18.87 67 
4 + C,•s . 5 + C 14.6 14 .17 0.4333 0.4945 10 6 1.239 67 
5 Vll. 5 - C 8 14.17 -6.167 0.5529 6 6 15.77 67 
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Table 8: Column statistics for S. aureus ZOis (mm) at day 7 
Uncoated I + C 2 2 + C 3 3 + C 4 4+ C 5 5 + C 
Number of va lues 9 7 10 6 6 6 6 6 9 6 6 
Minimum 8 8 8 8 12 8 8 8 9 8 13 
25% Percentile 8 8 8 8 12 .75 8 8 8 9.5 8 13 
Median 8 9 8.5 8 14 8 8 8 13 8 14 
n% Percentile 8 II 14 .75 8.25 14.25 9 8.25 8 14.5 8 15.25 
Maximum 8 II 18 9 15 9 9 8 16 8 16 
Mean 8 9.143 I I.I 8. 167 13.67 8.333 8.167 8 12.44 8 14.17 
Std . Deviation 0 1.345 4 .04 0 .4082 1.033 0.5 164 0 .4082 0 2.555 0 1.169 
Std . Error of Mean 0 0 .5084 1.278 0 .166 7 0 .42 16 0.2 108 0 .1667 0 0 .85 17 0 0 .4773 
Lower 95% CI of mean 8 7.899 8.2 1 7.738 12.58 7.79 1 7.738 8 10.48 8 12.94 
Upper 95% CI of mean 8 10.39 13.99 8.595 14 .75 8.875 8.595 8 14.4 1 8 15.39 
Swn n 64 I l l 49 82 '.10 49 48 112 48 8'.l 
Table 9: ANOV A test for S. marcescens ZOis (mm) at day 7 
Data sets analyzed A: Unooated B : 1 C : 1 + C D:2 E : 2 + C 
ANOVA summary 
F 2 1.66 
rva lue <O.OOOL 
P value summary •••• 
Significant diff. among means fP < 0.05)? Yes 
Rsquare 0.7557 
Brown-Forsythe test 
F (DFn , DFd) 13.68 ( LO, 70) 
rvalue <O.OOOL 
r value summary •••• 
Are SDs significantly different (P < 0.05)7 Yes 
Ban lett's test 
Ban lett's statistic (corrected) +infinity 
rva lue <O.OOOL 
P value summary •••• 
Are SDs significant ly different fP < 0.05)? Yes 
ANOVAtable ss DF MS F (DFn , DFd) rva lue 
Treatment (between columns) 170.2 10 17.02 F (LO, 70) = 21.66 r-<0.0001 
Residual (within columns) 55.02 70 0.7859 
Total 225.2 80 
Data summary 
Number of treatments (columns) II 
Number of values (total) 81 
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Table 10: Comparison test for S. marcescens ZOis (mm) at day 7 
MeanD itT. 95 .00% Cl ofdi ff. Si ificant? Summ Ad .usted r Value 
Uncoated vs. 1 0 • 1.497 to 1.497 No ns >0.9999 A-B 
Uncoated \'S. 1 + C 0 -1.289 10 1.289 No ns >0.9999 A·C 
Uncoated vs. 2 0 -1.497 10 1.497 No ns >0.9999 A-D 
Uncoated vs. 2 + C -2.5 -3.997 to -1.003 Yes .... <(J.0001 A-E 
Uncoated vs. J 0 -1.426 to 1.426 No ns >0.9999 A•F 
Uncoated \'S. J + C 0 -1.497 to 1.497 No ns >0.9999 A·G 
Uncoated vs. 4 0 -1.497 10 1.497 No ns >0.9999 A-H 
Uncoated \'S. 4 + C -3.273 -4.531 to -2.0 15 Yes .... <0.0001 A-I 
Uncoated \'S. 5 0 -1.497 to 1.497 No ns >0.9999 A -1 
Uncoated \'S. 5 + C -3.667 -5.164 10 -2.17 Yes .... <0.0001 A-K 
vs . 1-c 0 -1.523 10 1.523 No ns >0.9999 B-C 
vs . 2 0 -1.703 to 1.703 No ns >0.9999 B-D 
VS. 2- C -2.5 -4.203 10 -0. 7969 Yes 0.0003 B•E 
vs. 3 0 -1.641 to 1.64 1 No ns >0.9999 B-F 
vs. 3- C 0 •1.703 10 1.703 No ns >0.9999 B•G 
vs. 4 0 •1.703 to 1.703 No ns >0.9999 B-H 
vs. 4- C -3.273 -4.77 to -1. 776 Yes .... <0 .0001 B-1 
vs. 5 0 -1.703 10 1.703 No ns >0.9999 B-J 
vs. 5- C •3.667 •5.37 to -1.964 Yes .... <0.0001 B•K 
+ C\ •s.2 0 -1.523 to 1.523 No ns >0.9999 C·D 
+ C\·s . 2 + C -2.5 -4.023 to -0 .9767 Yes .... <0.0001 C•E 
+ C vs. 3 0 -1.454 10 1.454 No ns >0.9999 C•F 
+ C\•s . J + C 0 • 1.523 to 1.523 No ns >0.9999 C·G 
+ C\'S.4 0 -1.523 10 1.523 No ns >0.9999 C·H 
+ Cvs . 4 + C -3.273 -4.562 to -1.984 Yes .... <0.0001 C•I 
+ C\•s.5 0 -1.523 10 1.523 No ns >0.9999 C•J 
+ Cvs . 5 + C -3.667 -5.19 to •2 .143 Yes .... <0.0001 C-K 
2 vs. 2- C -2.5 -4.203 to -0 . 7969 Yes ... 0.0003 D•E 
2 vs. 3 0 -1.64110 1.64 1 No ns >0 .9999 D-F 
2vs . 3- C 0 -1.703 10 1.703 No ns >0.9999 D-G 
2vs . 4 0 -1.703 10 1.703 No ns >0.9999 D-H 
2 vs . 4- C -3.273 -4.77 to - 1.n6 Yes .... <0.0001 D•l 
2vs . 5 0 • 1.703 10 1.703 No ns >0.9999 D-1 
2vs . 5- C -3.667 •5.37 to - 1.964 Yes .... <0.0001 D·K 
2+C\'S . 3 2.5 0.8589 to 4. 141 Yes ... 0.0002 E-F 
2 + C\•s . 3 + C 2.5 0.7969to 4.203 Yes ... 0.0003 E-0 
2 + C\ 'S.4 2.5 0. 7969 to 4.203 Yes ... 0.0003 E•H 
2 + C\·s . 4 + C .0.7727 -2.27 lo 0.7244 No ns 0.82 15 E•I 
2 + C\•s . 5 2 .5 0. 7969 to 4 .203 Yes ... 0.0003 E•J 
2 + C\'S.5 + C -1.167 -2.87 to 0 .5364 No ns 0.459 1 E-K 
3 vs. 3-C 0 -1.641 to 1.64 1 No ns >0.9999 f •G 
3 vs. 4 0 •1.64110 1.64 1 No ns >0.9999 f •H 
3 vs. 4-C •3.273 -4.699 10 -1.847 Yes .... <0 .0001 f •I 
3 vs . 5 0 -1.641 to 1.64 1 No ns >0.9999 f.J 
3 vs. 5- C -3.667 •5.308 10 •2.026 Yes .... <0.0001 f •K 
3 + Cvs . 4 0 -1.703 10 1.703 No ns >0.9999 G-H 
3 + C\ •s. 4 + C -3.273 -4.77 to -1.776 Yes .... <0.0001 G•I 
3 + C\ 'S.5 0 -1. 703 10 I. 703 No ns >0.9999 G-J 
3+C\•s.5+C -3.667 -5.37 to - 1.964 Yes .... <0.0001 G-K 
4 vs. 4-C -3.273 -4.77 10 -1. 776 Yes .... <0 .0001 H-I 
4vs . 5 0 -1. 703 10 I. 703 No ns >0.9999 H•J 
4 vs . 5-C -3.667 -5.37 to - 1.964 Yes .... <0.0001 H•K 
4+Cvs . 5 3.273 I. 776 to 4 . 77 Yes .... <0.0001 l•J 
4 + C\•s . 5 + C .0.3939 •1.891 to 1.103 No ns 0.9984 1-K 
5 vs . 5-C •3.667 •5.37 10 • 1.964 Yes .... <0.0001 J•K 
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Table 11: Comparison test for S. marcescen s ZOis (mm) at day 7 
Test details Mean I Mean2 MeanDitT. SE of dltT. n l n2 9 DF 
Uncoated vs. 1 8 0 0.4499 11 6 0 70 
Uncoated vs. 1 + C 8 0 0.3874 11 10 0 70 
Uncoated vs. 2 8 0 0.4499 11 6 0 70 
Uncoated vs. 2 + C 10.5 -2.5 0.4499 11 6 7.858 70 
Uncoated vs. 3 8 0 0.4286 11 7 0 70 
Uncoated vs. 3 + C 8 0 0.4499 11 6 0 70 
Uncoated vs. 4 8 0 0.4499 11 6 0 70 
Uncoated vs. 4 + C 11.27 -3.273 0.378 11 11 12.24 70 
Uncoated vs. 5 8 0 0.4499 11 6 0 70 
Uncoated vs. 5 + C 11.67 -3.667 0.4499 11 6 11.53 70 
vs. I -C 8 0 0.4578 6 10 0 70 
vs. 2 8 0 0.5 118 6 6 0 70 
vs. 2-C 10.5 -2.5 0.5118 6 6 6.908 70 
vs. 3 8 0 0.4932 6 7 0 70 
vs. 3- C 8 0 0.5118 6 6 0 70 
vs. 4 8 0 0.5 118 6 6 0 70 
vs. 4-C 8 11.27 -3.273 0.4499 6 11 10.29 70 
vs. 5 8 8 0 0.5118 6 6 0 70 
vs. 5- C 8 11.67 -3.667 0.5118 6 6 10.13 70 
+ Cvs.2 8 8 0 0.4578 10 6 0 70 
+ C vs. 2 + C 10.5 -2.5 0.4578 10 6 7.723 70 
+ C vs. 3 8 0 0.4369 10 7 0 70 
+ Cvs . J+C 8 0 0.4578 10 6 0 70 
+ Cvs . 4 8 0 0.4578 10 6 0 70 
+ Cvs . 4 + C 11.27 -3.273 0.3874 10 11 11.95 70 
+ C vs. 5 8 0 0.4578 10 6 0 70 
+ Cvs . 5 + C 11.67 -3.667 0.4578 10 6 11.33 70 
2 V5. 2-C 10.5 -2.5 0.5118 6 6 6.908 70 
2 vs. 3 8 0 0.4932 6 7 0 70 
2vs . 3-C 8 0 0.5118 6 6 0 70 
2 vs. 4 8 0 0.5118 6 6 0 70 
2 vs. 4- C 11.27 -3.273 0.4499 6 11 10.29 70 
2 vs. 5 8 0 0.5118 6 6 0 70 
2 VS. 5- C 11.67 -3.667 0.5118 6 6 10.13 70 
2 + C vs. 3 10.5 8 2.5 0.4932 6 7 7.168 70 
2 + Cvs . 3 + C 10.5 8 2.5 0.5118 6 6 6.908 70 
2 + C vs. 4 10.5 8 2.5 0.5118 6 6 6.908 70 
2 + Cvs . 4 + C 10.5 11.27 -0.7727 0.4499 6 11 2.429 70 
2 + Cvs . 5 10.5 8 2.5 0.5 118 6 6 6.908 70 
2 + Cvs . 5 + C 105 11.67 -1.167 0.5118 6 6 3.224 70 
3 vs. 3- C 8 0 0.4932 7 6 0 70 
3 vs. 4 8 0 0.4932 7 6 0 70 
3 vs. 4-C 11.27 -3.273 0.4286 7 11 10.8 70 
3 vs. 5 8 0 0.4932 7 6 0 70 
3vs.5-C 11.67 -3.667 0.4932 7 6 10.51 70 
3 + C vs. 4 8 0 0.5118 6 6 0 70 
3 + C vs. 4 + C 11.27 -3.273 0.4499 6 11 10.29 70 
3 + C vs. 5 8 0 0.5118 6 6 0 70 
3 + C vs. 5 + C 11.67 -3.667 0.5118 6 6 10. 13 70 
4 VS. 4- C 11.27 -3.273 0.4499 6 11 10.29 70 
4vs.5 8 0 0.5118 6 6 0 70 
4 vs. 5- C 11.67 -3.667 0.5118 6 6 10.13 70 
4 + C vs. 5 11.27 8 3.273 0.4499 I I 6 10.29 70 
4 + Cvs . 5 + C 11.27 11.67 -0.3939 0.4499 11 6 1.238 70 
5vs . 5-C 8 11.67 -3.667 0.5118 6 6 10. 13 70 
Table 12: Column statistics for S. marcescens ZOis (mm) at day 7 
Uncoated I + C 2 2 + C 3 3 + C 4 4 + C 5 S + C 
Number of va lues 11 6 10 6 6 7 6 6 I I 6 6 
Minimum 8 8 8 8 10 8 8 8 8 8 10 
25% Percentile 8 8 8 8 10 8 8 8 9 8 10.75 
Median 8 8 8 8 10.5 8 8 8 II 8 11.5 
75% Percentile 8 8 8 8 11 8 8 8 14 8 13 
Maximum 8 8 8 8 I I 8 8 8 14 8 13 
Mean 8 8 8 8 10.5 8 8 8 11.27 8 11.67 
Std. Deviation 0 0 0 0 0 .5477 0 0 0 2. 149 0 1.2 11 
Std . Error of Mean 0 0 0 0 0.2236 0 0 0 0 .6479 0 0.4944 
Lower 95% Cl of mean 8 8 8 8 9.925 8 8 8 9.829 8 10.4 
Upper 95% CI of mean 8 8 8 8 11.07 8 8 8 12 .72 8 12.94 
Sum 88 48 80 48 63 56 48 48 124 48 70 
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ii. Friction 
Table 13: Average ANOV A test for friction 
Dam secs analyzed A : Uncoated B : 1 C : 1 + C D : 2 E : 2 + C 
ANOVA summa,y 
F 34.311 
Pva lue --:0.0001 
r value summa,y •••• 
Significant diff . among means (P < 0 .05)? Yes 
Rsquare 0.7962 
Brown-Forsythe rest 
F (DFn , DFd) 3.5711 (10, 88) 
Pva lue 0.0005 
r value summary ••• 
Are SDs significant ly different (P < 0.05)? Yes 
Bartlett's test 
Bartlett's statistic ( corrected) 63.1111 
Pva lue --:0.000 I 
r value summa,y •••• 
Are SDs significant ly different (P < 0 .05)? Yes 
ANOVAtable ss DF MS F (DFn , DFd) Pva lue 
Treatment (between columns) 69.47 10 6.947 F (10, 88) = 34.38 P<0.0001 
Residual (within columns) 17.711 1111 0.202 1 
Total 117.25 911 
Dam summary 
Number of treatments (columns) 11 
Number of values (total) 99 
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Table 14: Average comparison test for friction 
Dunnect's mult iple compar isons test Mean Diff. 95.00"A, C l ofdi ff. Significant? Summary Adjusted r Value A•? 
Uncoated \ 'S. I 3.029 2.44 1 to 3.617 Yes •••• <O.000l B 
L1ncoated \'S . I + C 3.029 2.44 1 to 3.617 Yes •••• <O.000l C I + C 
Uncoated \'S . 2 3.029 2.44 1 to 3.617 Yes •••• <O.000l D 2 
Uncoated \'S. 2 + C 2.6 16 2.028 to 3.204 Yes •••• <0.0001 E 2+C 
Uncoated \ 'S. 3 2.93 1 2.343 to 3.518 Yes •••• <0.0001 f 3 
Uncoated vs. 3 + C 2.404 1.817 to 2.992 Yes •••• <O.000l G 3 + C 
Uncoated vs. 4 2 .465 1.877 to 3.052 Yes •••• <0 .0001 H 4 
Uncoated \ 'S. 4 + C 2.744 2.156to 3.332 Yes •••• <O.000l I 4+C 
Uncoated vs. 5 2.419 1.832 to 3.007 Yes •••• <O.000l J 5 
Uncoated \ 'S. 5 + C 3.10 1 2.5 13 to 3.688 Yes •••• <0.0001 K 5 + C 
Table 15: Average comparison test for friction. 
Test details Mean I Mean2 Mean Diff. SE of diff . n l n2 9 OF 
Uncoated \ 'S. I 3.764 0.7349 3.029 0.2 119 9 9 14.29 88 
Uncoated \'S . I + C 3.764 0.735 3.029 0.2 119 9 9 14.29 88 
Uncoated \'S . 2 3.764 0.735 3.029 0.2 119 9 9 14.29 88 
Uncoated vs. 2 + C 3.764 1.148 2.6 16 0 .2 119 9 9 12.35 88 
Uncoated \ 'S. 3 3.764 0.8334 2.93 1 0.2 119 9 9 13.83 88 
Uncoated \'S. 3 + C 3.764 1.359 2 .404 0 .2 119 9 9 11.35 88 
Uncoated vs. 4 3.764 1.299 2.465 0.2 119 9 9 11.63 88 
Uncoated vs. 4 + C 3.764 1.02 2 .744 0 .2 119 9 9 12.95 88 
Uncoated vs. 5 3.764 1.344 2 .4 19 0 .2 119 9 9 11.42 88 
Uncoated \'S. 5 + C 3.764 0.6633 3. 10 1 0 .2 119 9 9 14 .63 88 
Table 16: Average column statistics for friction 
Number of values 9 9 9 9 9 9 9 9 9 9 9 
Minimum 3.424 0.5093 0.5093 0.5093 0.5278 0.4398 0.66 1 0.352 1 0.6 104 0.46 15 0.425 
25% Percentile 3.559 0.6 109 0.6 109 0.6 109 0.7827 0.552 0.9668 0.5827 0.654 0.6568 0.5142 
Median 3.834 0.7273 0.7273 0.7273 1.047 0.776 1.444 1.311 0.8 105 0.9259 0.689 1 
75% Percentile 3.923 0.8805 0.8736 0.8736 1.708 1.181 1.78 2.05 1 1.534 2.55 1 0.8068 
Maximum 4.02 0.9399 0.955 0.955 1.798 1.363 1.94 2.154 1.796 2.589 0.9 12 
Mean 3.764 0.7349 0.735 0.735 1.148 0.8334 1.359 1.299 1.02 1.344 0.6633 
Std. Deviation 0.205 1 0. 1475 0.148 0.148 0.4742 0.3363 0.4452 0.6897 0.4645 0.9272 0.1668 
Std. Error of Mean 0.06836 0.049 17 0.04933 0.04933 0. 158 1 0.1121 0. 1484 0.2299 0. 1548 0.309 1 0.05559 
Lower 95% Cl of mean 3.606 0.62 15 0.62 13 0.62 13 0.7834 0.5749 1.0 17 0.769 0.6628 0.63 18 0.535 1 
Upper 9.5% CI of mean 3.922 0.8482 0.8488 0.8488 1.512 1.092 1.702 1.829 1.377 2.057 0.79 15 
Sum 33.87 6.6 14 6.6 15 6.6 15 10.33 7.5 12.24 11.69 9.179 12. 1 5.97 
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Table 17: Maximum ANOV A tests for friction 
Dara sets analyzed A : Uncoated B: 1 C: I -rC D : 2 E:2-rC 
ANOVA summary 
F 26.93 
Pvalue <O.OOOL 
r value summary •••• 
Significant diff. among means (P < 0.05)? Yes 
Rsquare 0.7537 
Brown-Forsythe rest 
F (DFn , DFd) 2.427 (LO, 88) 
Pvalue 0.0 133 
r value summary • 
Are SDs significantly different (P < 0.05)? Yes 
Banlett's test 
Banlett's statistic (corrected) 54.56 
Pvalue <O.OOOL 
r value summary •••• 
Are SDs significantly different (P < 0.05)? Yes 
ANOVAtable ss DF MS F (DFn , DFd) Pva lue 
Treatment (between columns) 62.2 10 6.22 : LO, 88) = 26. P<0.0001 
Residual (within columns) 20.32 88 0.2309 
Tocal 82.52 98 
Dara summary 
Number of treatments (columns) 11 
Number of values (total) 99 
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Table 18: Maximum comearison test for friction 
Dunnett's multiple compar isons tesc Mean DifT. 95 .00% Cl ofdifT . Significant? Summary Adjusted r Value A•? 
Uncoated vs. 1 2.956 2.328 to 3.585 Yes •••• <0.0001 B 
Uncoated vs. 1 + C 2 .956 2 .328 to 3.585 Yes •••• <0.0001 C I + C 
Uncoated vs. 2 2.21!2 1.654 to 2.91 I Yes •••• <0.0001 D 2 
Uncoated vs. 2 + C 2.56 1 1.932 to 3.189 Yes •••• <0.0001 E 2+C 
Uncoated vs. 3 2 .745 2 .116 CO 3.373 Yes •••• <0 .0001 f 3 
Uncoated 1,•s. 3 + C 2.20 1 1.572 to 2.829 Yes •••• <0 .0001 G 3+C 
Uncoated 1,•s. 4 2 .377 1.748 to 3.005 Yes •••• <0 .0001 H 4 
Uncoated 1,•s. 4 + C 2.567 1.931! to 3.195 Yes •••• <0.0001 4+C 
Uncoated vs . 5 2.257 1.629 to 2.885 Yes •••• <0.0001 J 5 
Uncoated vs . 5 + C 2.951! 2 .33 to 3.587 Yes •••• <0.0001 K 5+C 
Table 19: Maximum comparison test for friction 
Tesc details Mean I Mean2 MeanDifT . SE of diff . n l n2 9 OF 
Uncoated vs . 1 4 .0 1 1.054 2.956 0.2265 9 9 13.05 l!I! 
Uncoated 1,•s. 1 + C 4.01 1.054 2.956 0.2265 9 9 13.05 l!I! 
Uncoated 1,•s. 2 4.01 1.721! 2.21!2 0.2265 9 9 10.07 l!I! 
Uncoated vs. 2 + C 4.01 1.449 2 .56 1 0.2265 9 9 11.3 l!I! 
Uncoated vs . 3 4.01 1.265 2 .745 0.2265 9 9 12.12 l!I! 
Uncoated 1,•s. 3 + C 4.01 1.1!09 2.20 1 0.2265 9 9 9 .7 15 l!I! 
Uncoated 1,•s. 4 4.01 1.633 2.377 0.2265 9 9 10.49 l!I! 
Uncoated 1,•s. 4 + C 4 .0 1 1.443 2 .567 0.2265 9 9 11.33 l!I! 
Uncoated 1,•s. 5 4 .0 1 1.753 2.257 0.2265 9 9 9.963 l!I! 
Uncoated 1,•s. 5 + C 4 .0 1 1.052 2.951! 0.2265 9 9 13.06 l!I! 
Table 20: Maximum column statistics for friction 
Number of va lues 9 9 9 9 9 9 9 9 9 9 9 
Minimum 3.744 0.82 14 0.82 14 1.115 1.023 0.9834 1.222 0 .8384 I.I 0 .9575 0.8355 
25% Percemile 3.784 0.9174 0 .9 174 1.135 1.028 1.04 1.34 0.8902 1.135 0.992 0.8682 
Median 4 .074 1.038 1.038 1.386 1.3 18 1.125 1.9 1 1.575 1.202 1.328 0.9698 
75% Percentile 4 .123 1.22 1.22 2.653 1.967 1.608 2.209 2.412 1.966 2.953 1.3 19 
Maximum 4 .308 1.254 1.254 2.679 2 .022 1.689 2 .275 2.479 2.098 2.955 1.33 
Mean 4 .0 1 1.054 1.054 1.728 1.449 1.265 1.809 1.633 1.443 1.753 1.052 
Std . Deviation 0.1942 0.153 1 0 .153 1 0 .7 10 1 0 .4246 0.284 0 .4 108 0.6783 0.4292 0 .9 129 0.2098 
Scd. Error of Mean 0.06472 0.05104 0.05 104 0.236 7 0. 14 15 0.09466 0 .1369 0.226 1 0.143 1 0.3043 0.06994 
Lower 95% Cl of mean 3.86 1 0.9359 0 .9359 I.I 82 1.123 1.047 1.493 1.112 1.113 1.05 1 0.8904 
l)pper 95% CI of mean 4 .159 1.171 1.171 2 .273 1.775 1.483 2 .125 2. 154 1.773 2 .454 1.2 13 
Sum 36.09 9.482 9.482 15.55 13.04 11.39 16 .28 14.7 12 .99 15.78 9.465 
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g. Synthetic Spider Silk Protein Sequences 
M4 Protein Sequence: 
(QGAGAAAAAAGGAGQGGYGGLGGQGAGQGGYGGLGGQGAGQGA 
GAAAAAAAGGAGQGGYGGLGSQGAGRGGQGAGAAAAAAGGAGQG 
GYGGLGSQGAGRGGLGGQGAGAAAAAAAGGAGQGGYGGLGNQGA 
GRGGQGAAAAAAGGAGQGGYGGLGSQGAGRGGLGGQGAGAAAAA 
AGGAGQGGYGGLGGQGAGQGGYGGLGSQGAGRGGLGGQGAGAA 
AAAAAGGAGQGGLGGQGAGQGAGASAAAAGGAGQGGYGGLGSQG 
AGRGGEGAGAAAAAAGGAGQGGYGGLGGQGAGQGGYGGLGSQGA 
GRGGLGGQGAGAAAAGGAGQGGLGGQGAGQGAGAAAAAAGGAG 
QGGYGGLGSQGAGRGGLGGQGAGAVAAAAAGGAGQGGYGGLGSQ 
GAGRGGQGAGAAAAAAGGAGQRGYGGLGNQGAGRGGLGGQGAG 
AAAAAAAGGAGQGGYGGLGNQGAGRGGQGAAAAAGGAGQGGYG 
GLGSQGAGRGGQGAGAAAAAAVGAGQEGIRGQGAGQGGYGGLGS 
QGSGRGGLGGQGAGAAAAAAGGAGQGGLGGQGAGQGAGAAAAAA 
GGVRQGGYGGLGSQGAGRGGQGAGAAAAAAGGAGQGGYGGLGG 
QGVGRGGLGGQGAGAAAAGGAGQGGYGGVGSGASAASAAASRLSS 
PQASSRLSSAVSNLVATGPTNSAALSSTISNVVSQIGASNPGLSGCDVLI 
QALLEVVSALIQILGSSSIGQVNYGSAGQATQIVGQSVYQALG) 
179 
M5 Protein Sequence: 
(PGGYGPGQQGPGGYGPGQQGPSGPGSAAAAAAAAAAGPGGYGPGQQG 
PGGYGPGQQGPGRYGPGQQGPSGPGSAAAAAAGSGQQGPGGYGPRQQG 
PGGYGQGQQGPSGPGSAAAASAAASAESGQQGPGGYGPGQQGPGGYGP 
GQQGPGGYGPGQQGPSGPGSAAAAAAAASGPGQQGPGGYGPGQQGPGG 
YGPGQQGPSGPGSAAAAAAAASGPGQQGPGGYGPGQQGPGGYGPGQQG 
LSGPGSAAAAAAAGPGQQGPGGYGPGQQGPSGPGSAAAAAAAAAGPGG 
YGPGQQGPGGYGPGQQGPSGAGSAAAAAAAGPGQQGLGGYGPGQQGP 
GGYGPGQQGPGGYGPGSASAAAAAAGPGQQGPGGYGPGQQGPSGPGSA 
SAAAAAAAAGPGGYGPGQQGPGGYAPGQQGPSGPGSASAAAAAAAAGP 
GGYGPGQQGPGGYAPGQQGPSGPGSAAAAAAAAAGPGGYGPAQQGPSG 
PGIAASAASAGPGGYGPAQQGPAGYGPGSAVAASAGAGSAGYGPGSQAS 
AAASRLASPDSGARV ASA VSNL VSSGPTSSAALSSVISNA VSQIGASNPGL 
SGCDVLIQALLEIVSACVTILSSSSIGQVNYGAASQF AQVVGQSVLSAF) 
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Alexander Cook 
Capstone Reflection 
The capstone process began in the spring of 2017 when the Biological Engineering class 
of 2018 got together to choose their projects and their project team members . Due to the larger 
than normal class size we ended up having project teams of seven or eight people , ours happened 
to be one of seven. I could name everyone in the graduating class because we all had the same 
classes for the past two years and we knew who were over achievers and those who weren't. If I 
am allowed this subjective clause , my group was a group of over-achievers. That worried me. 
I like to get things accomplished and I have been president of enough clubs and been 
through enough organizations that I know how unproductive group work and group meetings can 
be. I am opposed to group meeting on a deep level only because they are not efficient ways to 
manage groups of people and tasks. However, when you get a group of over-achievers together , 
they all want to be able to have equal contribution and they all want to be the lead on the project 
or at least have a working knowledge of all the parts. That may sound like a good thing for a lot 
of people but that is really not a good thing when they are responsible for giving me my grade in 
that class. I chose to do things my way , they didn't like my way , and they gave me a grade to 
reflect how they thought. 
I could use this reflection to describe what I learned throughout the science of and 
research of the project , but that is what the design report is for. What I most learned from this 
project was that if I want a good relationship with team members, it is more important that I 
appeal to their values of contribution rather than make good contributions. I obviously 
understand there is room for both and normally it requires both. However , I chose the latter and 
found that despite many late nights in the lab and likely more hours developing product than any 
of the team members, they didn't ever see me contribute because I wanted to be alone, and as a 
result they believed me to have not contributed. That is a mistake I don't plan on making again, 
even though I disagree with those values deep into my core. 
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